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This thesis examines how the transnational drug policy reform movement attempts to change 
the global discourse on narcotic drugs, as well as how domestic drug policy reform 
movements try to change national discourses on narcotic drugs – exemplified through the 
cases of Germany and Mexico. It elaborates on the development of the drug policy movement 
and of the global discourse on narcotic drugs over time, as well as presenting a snapshot of 
the current situation and the emerging trends in contemporary drug policies.  
More precisely, this thesis is an account of how the global discourse on narcotic drugs is 
changing as states and non-state actors are increasingly contesting the zero-tolerance approach 
to drugs. It examines shifts in drug policies towards harm reduction and drug law reform, 
implying decriminalization of drug-related actions, as well as the emerging debate on 
alternative forms of drug control. It elaborates on how the movement argues and works both 
at a national and at an international level to bring forth such changes as well as examining one 
particular and recently evolving strategy undertaken by the movement, namely human rights 
advocacy in relation to drug policy. 
Furthermore, this thesis investigates, in a governmentality perspective, what principles, 
objectives, values, problem constructions, knowledge, ‘truth discourses’, logics, rationalities 
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and forms of power that are implicated in the policy proposals advocated by the drug policy 
reform movement, how they differ from and are in opposition to those involved in prevailing 
global drug policies, and also how they differ from – and are similar to – those implicated in 
policies at large. It also examines global drug policies in relation to a broader shift in 
governmental rationalities in global politics implying a tendency of governing through non-
state actors such as civil society organizations, to which governmental tasks and 
responsibilities are being outsourced.  
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1 Introduction 
 
“The thing about drug policy is that it seems that it was created in Mars or I don’t 
know where.  Every policy within the UN system is based upon human rights. Most 
policies in most countries around the world are based on their cost-effectiveness. Why 
isn’t drug policy one of them? Why isn’t drug policy based upon human rights and 
why isn’t drug policy based on its cost-effectiveness?” - Aram Barra, interview 
 
The last century has witnessed an increased export of Western crime definitions as well as a 
globalization of certain crimes with a strong transnational dimension and their 
institutionalization into ‘global prohibition regimes’ (Nadelmann & Andreas 2006). ‘Global 
prohibition regimes’ are  
“… intended to minimize and even eliminate the potential havens from which certain crimes can be 
committed and to which criminals can flee to escape prosecution and punishment. They provide an 
element of standardization to cooperation among governments with few law enforcement concerns in 
common. And they create an expectation of cooperation that governments challenge only at the cost of 
some international embarrassment” (Nadelmann & Andreas 2006: 19)  
The failure of a prohibition regime to diminish the crimes persecuted is not crucial for its 
maintenance, but rather “[r]egardless of its effectiveness, part of the appeal of a global 
prohibition regime is its symbolic allure and usefulness as a mechanism to express 
disapproval” (Nadelmann & Andreas 2006: 229). It serves to maintain moral boundaries by 
suppressing undesirable activities (Ibid.).  
Through ‘global prohibition regimes’ ‘global moral norms’ and ‘transnational moral 
consensus’ is created, leading to a homogenization of domestic criminal laws and 
internationalization of crime control.  
However, there are not many crime definitions which evolve into global prohibition regimes. 
Important factors in their creation are moral and emotional factors and “…religious beliefs, 
humanitarian sentiments, faith in universalism, compassion, conscience, paternalism, fear, 
prejudice and the compulsion to proselytize” (Nadelmann & Andreas 2006: 18).  In addition 
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their creation is often instigated by certain governments and nongovernmental organizations 
linked through transnational advocacy networks acting like ‘transnational moral 
entrepreneurs’, which  
“…mobilize popular opinion and political support both within their host country and abroad, they 
stimulate and assist in the creation of like-minded organizations in other countries, and they play a 
significant role in elevating their objective beyond its identification with the national interests of their 
government; indeed, their transnational efforts are often directed toward persuading foreign audiences 
(especially foreign elites) that a particular prohibition regime reflects not merely the peculiar moral 
code of one society but a more widely shared, even universal moral sense” (Nadelmann & Andreas 
2006: 19). 
This thesis is concerned with one particular prohibition regime, namely the global drug 
prohibition regime. According to Nadelmann & Andreas (2006) the successful globalization 
of moral condemnation and prohibition of narcotic drugs owe much to US based 
nongovernmental organizations and the US government acting like ‘transnational moral 
entrepreneurs’. The control of drugs was already institutionalized in the Hague Opium 
Convention of 1912, but globalization and expansion of the international control came to 
increase through numerous treaties and agreements following, and culminated in the three UN 
drug conventions (1961, 1971 and 1988), thus creating transnational moral consensus on drug 
prohibition.  
The last decades have, however, witnessed cracks in the transnational moral consensus as 
‘moderate reforms’ are on the way, and as the criminalization of cannabis as well as of the 
coca leaf is being increasingly disputed in the international society (Nadelmann & Andreas 
2006: 229 f.). Most notably 
“…the global AIDS pandemic is undermining the U.S. efforts to enforce its zero tolerance view of 
global drug prohibition. Whereas until recently the United Stated could count on governments in Asia, 
Africa and Scandinavia to bolster its claim that ‘harm reduction’ principles and practices where 
inconsistent with international antidrug conventions, that is no longer the case. Latin America and much 
of Asia and Africa increasingly endorse the European Union’s view that needle exchange and other 
harm reduction measures are essential to stem the spread of HIV/AIDS and that the antidrug 
conventions must be interpreted accordingly. A new generation of transnational moral entrepreneurs 
has played an important role in these developments, grounding their advocacy in science, compassion, 
health and human rights” (Nadelmann & Andreas 2006: 230, my highlighting).  
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This thesis examines the cracks in the transnational moral consensus on drug prohibition and 
particularly the role of the new generation of ‘transnational moral entrepreneurs’ in 
contributing to these cracks. It is an account of the role of collective human agency in the 
processes of deconstructing (international) crime. 
1.1 Research questions 
In this thesis I seek to answer the questions: How does the drug policy reform movement 
attempt to change the global discourse on narcotic drugs? And: How is the drug policy 
reform movement in opposition to dominant power structures – and how is it not?    
Firstly, this thesis examines the transnational drug policy reform movement as two 
overlapping and intertwined movements, namely the movement for harm reduction and the 
movement for drug law reform. It inquires their philosophical, ethical and political 
underpinnings and elaborates on how they argue to change the prevailing discourse on 
narcotic drugs. Furthermore, how domestic drug policy reform movements, which are part of 
the transnational movement, attempt to change domestic discourses is exemplified through the 
cases of two nongovernmental organizations from Mexico and two from Germany.  
The global discourse on narcotic drugs is understood as the dominating ways to think and talk 
about so called ‘narcotic drugs’1 globally. Neumann defines discourse as “a system for 
obtainment of a set of propositions and practices that through institutionalization appear more 
or less normal, make up the reality for its carriers, and have a certain degree of regularity in 
social relations” (Neumann 2001: 18, my translation). The global discourse (meaning world-
wide) encompasses both the international discourse (referring to the discourses of 
international organizations and governments) as well as the domestic discourses of the general 
public, experts, judicial systems, bureaucrats etc. in countries around the globe. More notably, 
my focus will be on the changes taking place within the global discourse on narcotic drugs, as 
well as the attempts of the drug policy reform movement to instigate such changes. I do not, 
however, systematically inquire the causal relation between the efforts of the movement and 
the changes occurring, as such an approach would require a very advanced and different (and 
                                                 
1
 The term ’narcotic drugs’ is a generic term on multiple psychoactive substances which do not have much in 
common except for being prohibited. On a more extensive discussion of the term ‘narcotic drugs’, see Christie & 
Bruun 2003.  
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maybe even impossible) methodology which would need to correct for all other impacts and 
variables at play. 
Secondly, this thesis investigates, through a governmentality perspective, what logics, 
rationalities, knowledge, problem constructions, ‘truth discourses’ and forms of power that 
are implicated in prevailing drug policies, but more particularly in the alternative policy 
approaches advocated by the movement.  Such a perspective also serves to compare the 
alternative policies on the basis of their logics – not only in relation to policies in the drugs 
field but also in relation to policies at large – and serves to distinguish elements of opposition 
to prevailing drug policies, but also elements of coherence and consistency with policies at 
large. This perspective will be further explained in chapter 3 on theoretical perspectives.  
This thesis provides both a historical account of the drug policy reform movement and of the 
global discourse on narcotic drugs and, more particularly, a snapshot of the current situation. 
1.2 Thesis outline 
In chapter 4 I examine the movement for harm reduction, in accounting for how harm 
reduction can be understood as a philosophy with a particular set of values, and as policies 
with specific objectives, solutions and principles. I investigate how the harm reduction 
movement has developed and how this development has affected its advocacy. Lastly, I 
examine how harm reduction could be understood as forms of bio-politics and how a broader 
shift in governmental rationalities implicates a trend towards governing through harm 
reduction NGOs. 
In chapter 5 I examine the movement for drug law reform. First, I account for the current legal 
framework of drug prohibition, reform possibilities and trends within the current framework, 
as well as the alternative scenario of abolition of the prohibition regime – of de jure 
legalization with models of government regulation. I investigate how the movement argues 
for drug law reform and how it tries to instigate changes in the global drug control discourse. 
Lastly, I examine the alternative and the current drug control policies, as well as the 
amendment of the international drug control discourse, in a governmentality perspective. 
In chapter 6 I examine one particular and recently evolving advocacy strategy adopted by the 
drug policy reform movement, namely human rights advocacy. I elaborate on the rights-based 
argumentation of the movement as well as examine how the grounding of advocacy within the 
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human rights discourse can have, and has, consequences for drug policy and for the global 
discourse on narcotic drugs.  
The subsequent chapters account for my methodological and theoretical approaches. 
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2 Methodology 
2.1 My positioning in the field of inquiry 
Since 2008 I have been a board member of the Norwegian Association for Humane Drug 
Policies
2
, a NGO working domestically to change Norwegian drug policy. The main aim of 
my organization is to create drug policies which are based on principles of public health, 
social equality, harm reduction, non-discrimination and acceptance - rather than punishment, 
deterrence and zero tolerance. We believe that the prohibition of drugs worsens the situation 
for both drug users and society, that the prohibition paradigm should be abolished, and that 
drugs should rather be legally regulated by the government
3
.  
The closeness to Norwegian drug policies and the Norwegian debate is the reason why I have 
chosen to investigate international drug policies and drug policies in other countries, as well 
as the transnational drug policy reform movement
4
 - to which I have more distance.  For this 
reason, the Norwegian context will hardly be mentioned at all in this thesis
5
.  
When I started my research, I knew very little of the transnational drug policy reform 
movement. I knew they were working with similar objectives as my own organization, but not 
how they were working, how they were cooperating, who they were or how large they were. 
Through the international conferences, which I attended with the double role as a member of 
the movement and as a researcher, I also started a slight cooperation between my organization 
and some other NGOs and networks within the transnational movement
6
.  
This account makes it clear that my drug political position is biased. However, I believe most 
researchers inevitably develop opinions about their field (or objects) of research, especially if 
they do thorough field work – and, thus, that the positivistic claim about objectivity is flawed. 
                                                 
2
 Foreningen for human narkotikapolitikk (FHN).  
3
 On a detailed account of this position, see section 5.1.3.  
4
 My organization has always been working quite isolated within the Norwegian context. We have had very little 
cooperation with NGOs in other countries except for sporadic contact with other Scandinavian NGOs. We are 
organizational members of some international NGOs, however, this membership is not very active but rather 
supportive and symbolic.  
5
 I draw very few parallels to Norway in the thesis as there are so many parallels on every topic discussed in this 
thesis that drawing parallels would leave me with very little space for discussing the themes which I do discuss.  
6
 More specifically, I worked with the European Drug Policy Initiative (EDPI), led by the Hungarian Civil 
Liberties Union, in arranging an event in Oslo on the World Drug Day the 26
th
 of June 2011. I have also become 
the official focal point for Norway in the European Harm Reduction Network. I have, however, not yet done any 
practical work in this regard. 
7 
 
The researcher also has ethical obligations in presenting those who are studied in a way that 
does not harm them (Fangen 2004). In the drug policy field the positions between research 
and political positioning is specifically blurred
7
 and, as is a theme of this thesis, the drug 
policy reform movement does to a large part consist of researchers, academics and 
professionals who have done extensive research on drugs and drug political issues. As I show 
throughout this thesis, this constellation of actors is also reflected in the movement’s 
argumentation.  
A strong positioning might make some critique difficult to pose. It might also affect on my 
selectivity of themes and the ways in which I present my empirical findings. As I see it, there 
are two ways in which this problem can be partly neutralized; 1) through total openness about 
my views and my standing in the field, and 2) through analyzing the interviews and the 
literature on their own premises, without making any normative claims. My task is precisely 
that: To present the drug policy reform movement on its own premises, not for instance to 
compare its argumentation with that of the temperance movement, which I believe would 
have posed more problems. The topics of closeness and distance, and the balance between 
them, are central issues in qualitative research. Fangen states that  
“[t]he task of the interpreter is to say the same as those who are to be interpreted, but in different words, 
something that in itself implies distance” (Fangen 2004: 206, my translation). 
The interpretative approach I apply, the governmentality perspective (see subsequent chapter), 
has been particularly useful in creating such a distance – and through conducting the analyses, 
as well as reading previous governmentality analyses on alternative drug policies
8
, I also 
came to understand my own political position in a new light. 
A more pressing problem about the closeness, I believe, has been that certain aspects for me 
have seemed self-evident, whereas they are not necessarily so if you are on the outside 
looking in. For instance in my German interviews I refrained from asking the question “how 
would you define harm reduction?”- which I later regretted in the process of writing. 
Nevertheless, I have tried to counteract the felt self-evidence trough presenting my material in 
a way that is (hopefully) also understandable for readers with little previous knowledge of the 
                                                 
7
 For instance Svanaug Fjær (2000) criticizes Norwegian drug research to have had prohibition as its basic 
premise.  
8
 This is particularly the case for the critiques of harm reduction (Rhodes 2002 & 2009, Moore 2004, Bunton 
2001 and Bourgois 2000) presented and discussed in section 4.4. 
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field. The felt self-evidence is also counteracted through my choice of analytical approach – 
an approach which is particularly aiming to uncover the self-evident.  
On the other hand the closeness can also be advantageous, in that I have had access to spheres 
(and background knowledge) which would not have been accessible if I was not myself a part 
of the movement. The same can probably be said for my communication and possibilities for 
contact with the other activists and the information obtained, which might have been of a 
different character if I had been an outsider. Still, however, ethical considerations make me 
very selective in regard to what information I present in this thesis. I do for instance not 
present any internal information that was given to me in private conversations with other 
activists, or in closed meetings, through my own role as an activist - or any other role for that 
matter.  
2.2 Choice of countries for exemplification of national drug policy reform 
movements 
Originally, I wanted to make a case study of two or three countries where drug law reforms 
and policy changes had occurred, examining the role of domestic drug policy reform 
movements in creating these changes as well as the social consequences of the changes.  
The reasons why my choice fell on Germany and Mexico are the many interesting differences 
and similarities between them. In Germany drug law changes happened several decades ago 
(1981 and 1994), while in Mexico the change of law is very recent (2009). Germany had very 
large problems with open drug scenes, which have diminished due to their change towards 
harm reduction policies, while Mexico is one of the countries in the world most obviously 
experiencing tremendous problems due to violence accelerated by drug cartels. Furthermore, 
both countries are important transit routes for drugs. It would also be particularly interesting 
to see how similar law changes had occurred in two very different geographic, social, legal, 
and political contexts. Germany and Mexico would also serve as examples of countries in the 
two continents, Europe and Latin America, which are the cradles of innovative drug political 
approaches. 
Moreover, Germany was the birthplace and epicenter of the harm reduction movement 
European Cities on Drug Policy (ECDP) in the 1990s. Was this a civil society movement and 
did it instigate national policy and law changes? In Mexico I knew civil society groups were 
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working actively to change drug policy, and 2011 witnessed large mass demonstrations by the 
Movement for Peace with Justice and Dignity against the government’s drug war. Had these 
groupings affected changes in law and policies? 
Through my interviews with drug political activists from Germany and Mexico it became 
clear that such a comparative approach would be nearly impossible – particularly the task of 
examining a causal link between civil society movements and drug law and policy changes
9
. 
The language barriers would also make a systematic examination of the law and policy 
changes very hard. 
After attending the International Harm Reduction Conference (see under), I decided my main 
focus would be on the transnational drug policy reform movement. Still, the drug policy 
reform NGOs in Germany and Mexico will be a theme – but rather serve as examples of how 
drug policy reform movements work – not only internationally and globally – but also 
domestically to instigate national changes. Throughout the writing process it also became 
more and more evident that the NGOs in Germany and Mexico share some fundamental 
similarities in ethical underpinnings and political rationalities which could then be regarded to 
be purported as universal. 
2.3 Data collection 
2.3.1 Conferences 
In a time when I was not yet sure how to angle my thesis I came across a notification for the 
22
nd
 International Harm Reduction Conference, finding place in Beirut, 3
rd
 -7
th
 of April 2011, 
hosted by the international NGO Harm Reduction International (HRI). I understood that if I 
was to study the drug policy reform movement, this conference would be crucial as it could 
be regarded as one of the main platforms for networking and exchange of information, 
gathering activists from all across the world. Prior to the attendance of the International 
Conference, I also attended a pre-conference hosted by the transnational NGO Youth RISE, in 
                                                 
9
 It turned out the ECDP was not a civil society movement, but rather a top-down movement of local officials, 
which does not exist anymore. How it affected national changes (beyond the cities in which it emerged) is very 
hard to say. In Mexico the drug law changes were proposed by the president alone, not by civil society. The large 
grass-root movement for Peace with Justice and Dignity is also not a drug political movement, but rather a 
movement of victims crying out for the violence to stop.  
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Jounieh, Lebanon, 31
st
 of March – 2nd of April 2011, gathering young harm reduction activists 
from all regions of the world
10
. 
These two conferences were my first meeting with the transnational drug policy movement. I 
was surprised to find a very large, well funded and well organized transnational movement 
with dense transnational networking and cooperation between a myriad of national and 
international NGOs, research communities, professional networks and therapeutic institutions. 
Many of the people attending the conferences knew each other from previous conferences and 
from collaboration, and I got the impression that the drug policy reform movement is a truly 
global civil society.  
Later I also attended the 3
rd
 Latin American and 1
st
 Mexican Drug Policy Conference in 
Mexico City, 13
th
 - 14
th
 of September 2011, hosted by the Mexican NGO CUPIHD and 
Argentinean Intercambios, and the (first) European Harm Reduction Meeting in Marseille, 6
th
 
– 7th of October 2011, hosted by the European Harm Reduction Network (EuroHRN).  
I attended these conferences with a double role of researcher and activist. My attendance 
could thus be characterized as participatory observation (Fangen 2004). Still, as a researcher I 
did not know what to look for, particularly not at the first conferences, which was not 
facilitated by the massive overload of information
11
. I have decided not to focus on the 
conferences themselves in this thesis, although such an angle could be interesting for an own 
project – particularly for a political science study12. Rather, the conferences helped me get an 
overview and an understanding of the movement, and also gave the myriad of interconnected 
NGOs and activists faces and made me comprehend who did what and how (although I am 
still not even close of having a complete overview). Thus, the experience from the 
conferences constitute my own background information about and picture of the drug policy 
                                                 
10
 The trip to Lebanon and to the International Conference was funded partly by the Department of Criminology 
and partly by my organization (FHN). The pre-conference attendance was funded by Youth RISE, and the rest of 
the trips I made (to Germany, Mexico and France) were funded by myself.  
11
 I have two or three notebooks full with notes from different panels, seminars, presentations and workshops; up 
to fifty pictures of power points as well as books, booklets, leaflets, movies, magazines etc. left for people to 
take at the conferences (in Lebanon, I even had to buy an extra bag only for the conference materials, which the 
airport scale determined to be around ten kilos).  
12
 Conferences are important networking points for social movements and they are also used as advocacy tactics. 
For instance the International Harm Reduction Conference was located at a Beirut five star hotel, attended by 
important Lebanese politicians and even Miss Lebanon, broadcasted at national television. The Middle East and 
North Africa region has recently started harm reduction projects such as substitution treatment, and the 
conference venue was particularly strategic in bringing attention to the importance of these projects as well as to 
mobilize support for their up-scaling.  
11 
 
reform movement, on which I draw when outlining its argumentation - which I also believe is 
more interesting in criminological terms.  
The conferences, particularly the first two, could thus be seen as door-openers to my field of 
research. They were also arenas for making interviews as well as for recruiting and making 
appointments with interviewees. At the same time they gave me an overview of different 
potential angles for my study and made it more clear what are the main aims, focus and 
argumentation of the movement.  
2.3.2 Expert interviews 
This thesis is mainly a literature study, drawing on publications by members of the 
movement, often scientific articles from international journals. The literature on drug policy 
and the literature, documentation and publications produced by either drug policy reform 
NGOs or individual activists is very extensive. 
I have, however, not yet found any scientific study systematically examining the transnational 
drug policy reform movement itself
13
. My focus is not merely on what prevailing and 
alternative drug policies are and how the movement argues, but also how the movement and 
drug political discourses have developed and changed over time.  
To obtain information about such changes, and particularly about the development of the drug 
policy movement itself, I interviewed eight drug policy experts, holding central positions 
within the drug policy reform movement and their respective NGOs. Although all my 
interviewees have written and published more or less extensively on the topic of drugs and 
drug policy, the advantage of interviewing them was that I could ask questions which would 
provide me with information of direct relevance for my research questions.  
My interviewees are
14
:  
 Mike Trace, chair of the International Drug Policy Consortium (IDPC)15 (interview 
conducted 06.04.11, Beirut). IDPC is a global network of 88 NGOs and professional 
                                                 
13
 Except for the political science study of Kübler (2001), who examines the emergence of the Swiss harm 
reduction movement.  
14
 The NGOs of my interviewees are also interconnected – often in ways over which I do not have the overview. 
For example CUPIHD is a Partner Member of IDPC, Akzept is a member of ENCOD etc.  
12 
 
networks; consisting of global members, Partner members and Network members, 
working towards implementation of drug policies that are effective in reducing drug-
related harm. IDPC produces briefing papers, disseminate the reports of its member 
organizations, and offer expert consultancy services to policy makers and officials 
around the world
16
. 
 Heino Stöver, director of Akzept and professor at the University of Applied Sciences 
of Frankfurt am Main (interview conducted 12.07.11, Frankfurt am Main). Akzept is a 
German-wide network promoting harm reduction and acceptance-oriented drug work 
and drug policies based on integration
17
. 
 Dirk Schäffer, Senior officer for Drugs & Prison Issues in Deutsche AIDS-Hilfe and 
officer and of the JES Network (interview conducted 14.07.11, Berlin). Deutsche 
AIDS-Hilfe is a German-wide network that promotes prevention and health in the area 
of HIV/AIDS for groups at risk
18
. JES Network is a German-wide network for 
‘Junkies, Ex users and people in Substitution treatment’ and they initiate and run self-
help groups all around Germany, and demand ‘a right to a life of human dignity with 
drugs’19. 
 Martin Jelsma, coordinator of the Drugs & Democracy Program of the Transnational 
Institute (TNI) (interview conducted 14.09.11, Mexico City). The Drugs & 
Democracy Program of the TNI is one of the world’s leading international drug policy 
research institutes as well as providing expert consultancy services to policy makers 
and officials around the world
20
. The Program initially defended human rights of 
farmers in Latin America being caught up in the illegal drug industry, but expanded in 
1995 to be concerned with global drug policies in general. 
 Aram Barra, director of the Drugs Program of Espolea and board member of Youth 
RISE (interview conducted 20.09.11, Mexico City). Espolea is a Mexican NGO 
promoting the participation of young people in political debates and in decision-
                                                                                                                                                        
15
 Trace has previously been head of demand reduction in the United Nations Office on Drugs and Crime 
(UNODC) as well as Chairman of the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA). 
16
 http://idpc.net/about 
17
 http://www.akzept.org/en_ziele.html 
18
 http://www.aidshilfe.de/en/about-us/self-image 
19
 http://www.jes-bundesverband.de/en/about-jes.html 
20
 http://www.tni.org/page/about-drugs-and-democracy-project 
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making in areas such as drugs and drug policy, equality in gender and sexual health
21
. 
Youth RISE is a youth-led global network with the aim of rising-up the voices of 
young people affected by drugs and drug policy.
22
  
 Luís Astorga, member of Colectivo por Una Política Integral Hacia las Drogas 
(CUPIHD), doctor in sociology, researcher at the Autonomous University of Mexico 
City and coordinator of the UNESCO Chair “Economic and social transformations 
related to the international drug problem”23 (interview conducted 21.09.11, Mexico 
City). CUPIHD is a Mexican NGO dedicated to research, education, and promotion of 
drug policies based on science, harm reduction and human rights
24
. 
 Jorge Hernández Tinajero, director of CUPIHD and professor in political and social 
sciences at the Autonomous University of Mexico City (interview conducted 21-
22.09.11, Mexico City). 
 Frederik Polak, president of the European Coalition for Just and Effective Drug 
Policies (ENCOD) (interview conducted 7.10.11, Marseille). ENCOD is a pan-
European network of 140 NGOs and individual experts, with the aim of bringing drug 
regulation and policies effectively diminishing drug-related harm on the political 
agenda
25
.  
Four of the interviews were planned in advance, either through appointments made at the 
conferences or through email. This was the case for the country-specific interviews of Stöver 
and Schäffer (Germany), Barra and Astorga (Mexico). For these interviews I also made 
interview guides (see appendix), although the guides were only used on three occasions. The 
interview guides were customized to each interviewee, based on literature they had written 
and my background research on the drug political situation of their country
26
. Four of the 
interviews were entirely spontaneous. These experts I knew from having read their literature 
or from knowing that they held key positions in crucial NGOs within the drug policy reform 
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 http://www.espolea.org/index.html 
22
 http://www.youthrise.org/about 
23
 I owe thanks to Benedicte Bull, Associate Professor at the Centre for Development and Environment (SUM) at 
the University of Oslo for suggesting that I take contact with Astorga.   
24
 http://www.cupihd.org/index.php?sec=1 
25
 http://www.encod.org/info/-English-en-.html 
26
 I perceived making the interview guides to be the probably hardest phase of the whole project, as I did not yet 
know exactly how the focus of the thesis would be, especially in regard to the two earliest interviews.  
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movement. Being surprisingly lucky to get an interview with them, these interviews became 
improvised non-structured interviews, or rather conversations, evolving around my research 
questions, or being an extension and follow-up on topics of which they had talked in their 
conference presentations. 
The interviews lasted between twenty minutes and two and a half hours, of which one was 
conducted in Spanish
27
. My interviewees agreed orally on my use of their interviews and 
names in my thesis. However, in the end of March the three main chapters, which then were 
quite finished, and which is the part of the thesis containing quotes and references to the 
interviews, were sent to my interviewees so they would have the possibility of giving a 
second approval which was more informed, with a two week deadline. I preferred to send 
them the whole text so they could see their quotes in the context in which they were used, in 
order for them to also be able to correct potential misunderstandings or to object to my 
interpretation
28
. This would make the research process ethic and democratic, open up 
possibilities for getting interesting comments, as well as creating what Fangen (2004) calls 
‘respondent validation’29. 
Those who did not answer within the two week deadline received phone calls and/or 
messages on email to make sure they had seen my email. Seven of the interviewees 
answered
30
, approving again of my use of their quotes and three of them also suggested some 
minor adjustments to the wording in their quotes (however, without changing their meaning) 
as well as commenting on one misunderstanding I had about the ECOSOC-status in relation 
to civil society participation within the UN drug control organs. 
                                                 
27
 I owe enormous thanks to Javier Rivas for helping me transcribe this interview, which I later translated. I am 
grateful to Astrid Renland, who borrowed me her interview for the magazine Drugs & Society, with Aram Barra 
from the International Conference to use in my thesis (of which they both agreed), and which I later used as a 
basis for my own interview. I also owe great thanks to Dirk Schäffer for giving me a guided tour to different 
harm reduction cites in Berlin run by a local NGO, and to Aram Barra for inviting me to workshops arranged by 
his organization Espolea in Mexico and to the Youth RISE pre-conference in Lebanon.   
28
 Each interviewee received a version of the thesis where his quotes, references to his interview and 
interpretation of the interview were marked in red so they could easily be found in the text, and where the other 
interviewees were anonymized in case they would change their minds regarding having their names in the thesis. 
The email also stated that if I didn’t receive an answer within the two week deadline, I would regard this as an 
approval.  
29
 Unlike the type of sensitive interviews in qualitative research which are theme in most of the methodological 
literature, my interviewees are not only official heavyweights within the movement but also academically – 
which means they could also test my theoretical validity. I was for instance relieved of my Mexican interviewees 
approving of my interpretation, as this was the part I was most unsure about. One of my interviewees, Frederik 
Polak – who is a psychiatrist, read through my whole text and commented on it, as well as providing me with a 
very interesting article he had written on medicalization of the drugs issue (Polak 2000). 
30
 The one interviewee that did not answer is also the only one who I do not quote directly in the thesis.  
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As the drug political discourse and the debates on alternative approaches are in constant flux, 
I set the deadline of data collection to the 31.12.2011.   
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3 Theoretical Perspectives 
First, this chapter draws on social movement theories in international relations (IR) studies 
and sociology respectively
31
, which serves the purpose of conceptually defining the drug 
policy reform movement, refining the dimensions on which I further focus and outlining some 
of its crucial features as a social movement (in section 3.1.).  
These theories have, however, been criticized for failing to capture the content of politics 
(Neumann & Sending 2010), which in this thesis is imperative as my focus lies upon the 
argumentation of the drug policy reform movement. The analysis of this thesis seeks to 
extend beyond a mere typologizing of advocacy tactics to also grasp the principles, objectives 
and consequences of both the policies advocated by the movement and the currently 
prevailing policies, to comprehend the different logics and rationalities which produce, 
reproduce and instigate changes in these policies, the technologies through which they work 
and the knowledge and values underpinning them, as well as the forms of power and 
opposition implicated herein. To capture all these aspects, I analyze the material from a 
twofold governmentality perspective, drawing on Foucauldian notions of power, knowledge 
and technologies, which have been further developed by other scholars; First, in relation to 
how drug policies could be understood from a governmentality perspective, second, how the 
role of the drug policy reform movement within global drug policies could be understood from 
a governmentality perspective. The second part of this chapter introduces some key questions, 
notions and tools for this analysis (section 3.2).   
3.1 Social movement theories 
Many scholars have noted the increasingly important role of transnational advocacy networks 
in international and domestic politics the last decades. Some interpret them as the third source 
of political power besides governments and business or as sources of ‘resistance from below’, 
which for many - also for suppressed voices - constitute the only possibility to get heard in 
national and international politics (Khagram et al. 2002, della Porta et al. 2006). 
Technological and communicational developments as well as the accelerating process of 
globalization have given birth to what some call a ‘global civil society’ (Savelsberg 2010). 
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 Social movements have traditionally been of very little criminological concern, which is why I here draw on 
knowledge from other scientific fields.  
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This thesis is concerned with non-governmental organizations (NGOs), defined as “private, 
voluntary, nonprofit groups whose primary aim is to influence publicly some form of social 
change” (Khagram et al. 2002: 6) and international non-governmental organizations 
(INGOs), which are NGOs that “…have a decision making-making structure with voting 
members from at least three countries, and their aim is cross-national and/or international in 
scope” (Ibid.). Moreover, NGOs and INGOs are primary actors in transnational collective 
action
32
.  
In this thesis I choose to refer to transnational collective action aiming to reform drug policy 
as a movement. Transnational movements differ from transnational advocacy networks
33
 and 
transnational coalitions
34
 in that they involve joint and sustained mobilization exercised by 
groups in at least three countries (Khagram et al. 2002). The reason for this choice is the 
constant and dense cooperation between NGOs and INGOs in the drug policy movement, and 
their constant and sustained campaigning and coordinated work at many levels. It should be 
noted that while some of the NGOs and INGOs in the movement are emphasizing 
international cooperation, campaigning and outcomes, other NGOs are working more 
domestically and are in this regard rather part of the transnational drug policy reform 
advocacy network or coalition. For the sake of operationalization, especially as such a 
differentiation will not serve any purpose in my further analysis, I will call all the NGOs and 
INGOs collaborating on the aim of drug policy reform ‘the drug policy reform movement’. 
As I see it, the drug policy reform movement consists of two overlapping movements, namely 
the harm reduction movement and the drug law reform movement. Both are seeking to reform 
drug policy. However, the harm reduction movement
35
 is primarily promoting the 
                                                 
32
 Besides NGOs and INGOs foundations are also important actors although they usually do not themselves 
initiate projects or create organizations (Sikkink 1993: 421). Rather, they fund and strengthen existing ones. In 
the drug policy reform movement examples of very important and central foundations are the Open Society 
Foundations and the Beckley Foundation.  
33
 Defined as ”…sets of actors linked across country boundaries, bound together by shared values, dense 
exchange of information and services, and common discourses” (Khagram et al. 2002: 7). Furthermore, networks 
are the most informal configuration of non-state actors, and its main characteristic is exchange and use of 
information (Ibid.).   
34
 Defined as ”…sets of actors linked across country boundaries who coordinate shared strategies or sets of 
tactics to publicly influence social change” (Khagram et al. 2002:7).  These tactics and strategies are identified as 
transnational campaigns, which also are the coalitions’ main characteristic (Ibid.).  
35
 The Global State of Harm Reduction (2010) divide harm reduction networks into 1) regional networks, such as 
the Asian Harm Reduction Network (AHRN), Eurasian Harm Reduction Network (EHRN), Caribbean Harm 
Reduction Coalition (CHRC), Middle East and North African Harm Reduction Association (MENAHRA), 
Intercambios Asociación Civil, Sub-Saharan African Harm Reduction Network (SAHRN) and European Harm 
Reduction Network (EuroHRN), 2) global networks, such as Youth RISE, International Network of People who 
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implementation of harm reduction policies (which will be the theme of chapter 4) and might 
be indifferent to the question of the legality of drugs, which is the reason why I will examine 
them as two separate, albeit interconnected, movements. The drug law reform movement is 
also promoting harm reduction policies, but in addition it explicitly advocates drug law 
reform either through decriminalization of certain drug related actions or through de jure 
legalization
36
 (this will be the theme of chapter 5). Still, the NGOs which I have specifically 
studied, and whose representatives I have interviewed, are advocating both harm reduction 
policies and drug law reform of some sort. They are thus both part of the harm reduction 
movement and the drug law reform movement. 
3.1.1 Dimensions of transnational collective action 
My emphasis will be on the macro dimensions of the drug policy reform movement, that is, 
the relation between the movement and its environment (della Porta et al. 2006). This means 
that the micro dimensions (meaning the characteristics of the activists involved) and the meso 
dimensions (meaning the different NGOs’ and networks’ organizational structure and their 
interconnectedness) (Ibid.) will only be briefly touched upon, and then in relation to how the 
micro and meso dimensions affect on the macro dimension. For instance the characteristics of 
the actors involved will only be examined in relation to how they affect on the movement’s 
efficiency and success in terms of advocacy
37
.  
Furthermore, the transnational dimensions of transnational collective action can differ on 
“…whether they involve transnational sources of problems, transnational processes of 
collective action and/or transnational outcomes” (Khagram et al. 2002: 10). The sources of 
problems which the drug policy reform movement is concerned with are transnational, as 
drug-related harms and problems transgress national boundaries. So is the global prohibition 
regime, which is particularly seen as a source of problems by the drug law reform movement. 
The processes through which the movement works are both national, international (cross-
border cooperation between national NGOs) and transnational (NGOs and configurations of 
NGOs with members from many different countries). The outcomes which the movement 
                                                                                                                                                        
Use Drugs (INPUD), International Drug Policy Consortium (IDPC), and 3) ‘networks of networks’, such as the 
Canadian Harm Reduction Network (CHRN) and CUPIHD.  
36
 It might be possible that some activists in the drug law reform movement are advocating drug law reform 
while being indifferent to harm reduction. I have, however, not yet met any such activists in the movement, but 
that does not necessarily mean that they do not exist. 
37
 This rules out topics such as for example the movement’s collective identity, which could have been 
interesting for an own study given the very different actors involved. 
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tries to produce are also both national (domestic NGOs advocating domestic changes or 
INGOs putting international, external pressure on single countries to make domestic changes), 
international (through influencing a change in the discourses and actions of international 
organizations and governments) and transnational (through mobilizing ‘global public opinion’ 
– for example through social media campaigns – to change the global discourse on narcotic 
drugs).  
3.1.2 Crucial features of social movements: Values, ideas and norms 
The most central feature of social movements is that their formation and action is motivated 
by values and principled ideas
38
, which also differentiates them from other non-state actors. 
Keck & Sikkink note that advocacy networks are often formed around issue areas with a high 
value content and informational uncertainty (1998: 2). They go on to note that the new about 
advocacy networks is “…the ability of nontraditional international actors to mobilize 
information strategically to help create new issues and categories and to persuade, pressure 
and gain leverage over much more powerful organizations and governments” (Ibid.). They do 
not only bring new ideas, norms, discourses, information and narratives to the political 
debates, but they also try to change the terms and nature of these debates (Keck & Sikkink 
1998). Through influencing a transformation in their discursive positions, they seek to change 
the behavior of states, international organizations (IOs) and other non-state actors. Thus, as 
advocacy networks, coalitions and movements are relatively weak international actors, their 
power (as ability to influence) lies in information, persuasion and moral pressure, namely in 
the arguments and justifications which they advocate (Khagram et al. 2002). 
One particular feature of argumentation strategies is to construct ‘cognitive frames’ (Keck & 
Sikkink 1998: 17). This thesis will examine how the drug policy reform movement frames its 
(at times controversial) arguments in terms of well-known and accepted discourses, using the 
specific terminology of these discourses. For instance the movement often draws on the 
language of prevention in public health discourse. The concepts of ‘frame bridging’ or ‘frame 
amplification’ (Khagram et al. 2002: 15 f.) refer to how already existing powerful norms are 
drawn upon, conceptually expanding these norms to apply to a respective field. Such a 
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 The IR literature distinguish between two types of ideas (defined as beliefs held by individuals), namely 
causal and principled ideas. Whereas causal ideas are ideas about cause and effect, often ideas supported by 
scientific evidence, principled ideas are about right and wrong. The latter ideas “…may be related to causal ideas 
but cannot be easily resolved by appeals to evidence” (Khagram et al. 2002: 14). 
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framing strategy will be examined in chapter 6, in relation to how the movement draws on 
human rights norms in their argumentation.  
Furthermore, Keck & Sikkink (1998) differentiate advocacy networks and social movements 
from other types of non-state actors such as economic networks and private enterprises, or 
from ‘epistemic communities’ and ‘knowledge-based networks’39. I argue, however, that in 
the case of the drug policy reform movement a distinction to epistemic communities cannot 
be easily made. As I argue in chapter 4, one of the main arguments of the movement is the 
scientific evidence-base – and thus the causal ideas – for the effectiveness of the harm 
reduction policies which they advocate as well as for the failure of current policies to 
diminish drug-related problems. As we will see, different epistemic communities play an 
important role within the movement precisely because their scientific findings imply that 
alternative drug policies are more effective in diminishing problems which arise from drugs
40
. 
3.1.3 Advocacy tactics 
Keck and Sikkink (1998) divide advocacy tactics undertaken by advocacy networks and 
movements into four: 1) information politics, referring to the movements and networks as 
providers of alternative sources of information that otherwise might not be obtained, 
uncovering, documenting and investigating problems and ‘reporting facts’ as well as 
‘monitoring’, which refers to the use of “information strategically to ensure accountability 
with public statements, existing legislation and international standards” (1998: 17); 2) 
symbolic politics, referring to symbolic interpretation of certain events to use them for 
creating awareness around an issue as well as to reshape understandings (1998: 20); 3) 
leverage politics, meaning how to bring forth changes in target actors (governments, IOs etc.) 
through gaining influence over them through material or moral leverage
41
 (1998: 23f.); and 4) 
accountability politics, implying bringing attention to the discrepancy between discourse (e.g. 
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 Referring to “…networks of scientists and experts whose professional ties and shared causal ideas underpin 
their efforts to influence policy” (Keck & Sikkink 1998: 1).  
40
 Researchers from different universities are engaged in the movement, as well as whole research institutes and 
networks, such as for example the International Centre for Science in Drug Policy and the International Centre 
on Human Rights and Drug Policy. The INGO Harm Reduction International also publishes a critical scientific 
journal, The International Journal of Drug Policy.  
41
 Material leverage refers to linking an issue to money, goods, prestige or other benefits, whereas moral 
leverage involves ‘mobilization of shame’ in showing how target actors for instance are violating international 
standards or not living up to its own claims (Keck & Sikkink 1998: 23f.). 
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devotion to human rights and democracy) and practice, in order to persuade target actors to 
publicly change their positions on certain issues (1998: 24f.).  
How the drug policy movement uses information politics, leverage politics and accountability 
politics will be accounted for in this thesis. The movement does also draw on symbolic 
politics; arranging events, demonstrations, conferences and press conferences around 
international declarations and petitions. However, such advocacy tactics will not be focused 
upon in this thesis. I do also not systematically analyze advocacy tactics and their efficiency 
in relation to different political opportunity structures (although this will partly be a theme), 
as could have been a methodological approach in a political science study.   
Rather, the politics and argumentation advocated by the movement will be analyzed in 
relation to the values, knowledge, principles and rationalities which underpin them, which 
elements within these that do or do not appeal to, or translate into, official policy discourse as 
well as discussing reasons for how it could be so. In this manner my analysis could be said to 
be more discursive – although I do not do a discourse analysis.   
My task is also not to make an exhaustive presentation of the movement’s argumentation, but 
rather to focus upon the arguments which I perceive to be the ones most frequently drawn 
upon – the main arguments. However, my aim extends beyond presenting the arguments to 
also make the reader understand the many dimensions of the alternative policies advocated.  
3.2 A governmentality perspective 
One of the aims of this thesis is to identify the ‘political rationalizations’ of alternative drug 
policies and to compare them with those of prevailing drug policies and with those of policies 
in other fields. Rose writes about political rationalizations that:  
“Foucault’s own work on governmentality implied that one could identify specific political 
rationalizations emerging in precise sites and at specific historical moments, and underpinned by 
coherent systems of thought, and that one could also show how different kinds of calculations, strategies 
and tactics were linked to each” (Rose 1999: 24).  
In this thesis I argue that the alternative drug policies advocated by the drug policy reform 
movement emerge from a coherent system of thought, or from particular rationalities, which 
could be defined as “…styles of thinking, ways of rendering reality thinkable in such a way 
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that it [is] amenable to calculation and programming” (Rose & Miller 2008: 16). I also argue 
that the coherent system of thought and the rationalities from which the alternative drug 
political approaches emerge, are different from, and sometimes in opposition to, the system of 
thought and rationalities implicated in prevailing drug policies. However, although it might be 
in opposition to prevailing drug policies, I also argue that the movement’s system of thought 
is not necessarily that ‘alternative’ if looking at the systems of thought implicated in other 
policy fields. Rather, they are in consistency with broader ways of thinking and acting in 
society.  
Thus, this thesis examines drug policies in a governmentality perspective through asking 
questions like: What ‘problem constructions’ or ‘truth’ about drugs and drug political issues 
give rise to the techniques and practices through which these problems are to be managed? 
What kind of rationalities, logics and knowledge are employed in the forms of governing (or 
the potential forms of governing) in the field of drug policy?  How do ‘thought’, or these 
rationalities, logics and knowledge seek to render particular issues, domains and problems 
governable (Dean 1999: 31)? 
These questions are asked in relation to drug policies in general, but more particularly my 
focus will be on the alternative drug policies advocated by the drug policy reform movement 
– asking questions like: How do the thoughts of the drug policy reform movement seek to 
transform the current practices? What alternative ‘truth’ or ‘problem constructions’ are they 
advocating and how do they argue that these ‘problems’ can be made governable? What 
rationalities and logics are implicated in their alternative policy proposals and how do they 
differ from (and how are they similar to) the rationalities and logics implicated in prevailing 
policies? The latter question calls for seeing the policies advocated by the drug policy reform 
movement not only in relation to prevailing drug policies, but also in relation to policies at 
large - in relation to politics as (‘advanced liberal’) governmentalities and bio-politics. These 
notions will be presented under.  
A second ‘layer’ of governmentality analysis focuses on the role of the drug policy reform 
movement in global politics, and put forward questions like: Could the development of the 
drug policy reform movement and the partial adoption of their discourses into official politics 
be seen in relation to a broader shift in governmental rationalities implying a governing 
through civil society organizations and other non-state actors?  
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3.2.1 Governmentality 
Foucault develops three conceptualizations of power throughout his writings, whose 
constellations are historically specific, namely ‘sovereignty’, ‘discipline’ and 
‘governmentality’. As sovereignty refers to ‘strategy’ as a ‘play between sovereign wills’ and 
is characterized by mechanisms such as the constitution, the rule of law and parliaments 
whose power is exercised through its juridical and executive arms, discipline is a power form 
of ‘domination’, concerned with the bureaucratic apparatuses of the state and exercises its 
power through organizing and ordering people as well as disciplining their bodies and souls to 
make them productive (Dean 1999: 19-20, Neumann 2003). Governmentality emerges in the 
seventeenth century to supplement and complement the two other forms of power and 
develops to play its main role in late modernity. Crucial to its emergence and concern is the 
discovery of ‘the population’, ‘the society’ and ‘the economy’ as ‘new’ aspects or entities of 
reality to be governed (in opposition to territory as before), following their own laws and 
mechanisms, discovered through new kinds of knowledge such as statistics, demography and 
epidemiology
42
. Governmentality is thus a new form of power, or ‘mentality of government’ 
(thereof governmentality) which seeks to improve the welfare of the population, its 
conditions, wealth etc. (Foucault in Neumann & Sending 2010: 9). It does not, however, do so 
by imposing law on men, as in sovereignty, or to dominate as in discipline, but rather through 
‘disposing things’ and ‘employing tactics’ (Ibid.). Moreover, it also reconfigures, rather than 
replaces, the two other forms of power. For example the law (and its obedience) is no longer a 
goal in itself, but is rather employed as a ‘tactic’ to regulate and order things and people 
(Ibid).  
Governmentality is interconnected with the principle or method of rationalization of 
liberalism, which aims to maximize the effectiveness of government at the same time as it 
reduces its (political, economic etc.) costs and constantly aims to govern less (Foucault 2008: 
318-9). It implies extending the economic model into ways of thinking and acting in society
43
 
(Foucault 2008: 242), or implying what Garland calls ‘economic rationality’ with an 
economic-rational analytical language, objectives and technologies (Garland 1999: 17-18). In 
keeping with the tenets of governing less, governmental rationalities seek to render 
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 This also highlights the essential link between power and knowledge, in that certain forms of knowledge 
renders subjects or objects governable in particular manners, which is essential in Foucault’s works. 
43
 Like for instance in terms of supply and demand which is particularly evident in the field of drug policy 
(Foucault 2008). 
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individuals autonomous subjects, capable of governing themselves in a responsible manner. 
Governmentality as a form of power could be said to work through mediating the dominant 
view (or norm), with reference to which people would assess themselves, and ‘choose freely’ 
to act in accordance with it (Manokha 2009). In this manner power produces behavior which 
is in conformity with the norm. External coercion is no longer necessary (meaning people are 
now ‘free subjects’), except for cases where people are unwilling or unable to act in 
accordance with the norm - or to act and govern themselves ‘responsibly’. In these cases more 
direct disciplinary or sovereign techniques may be applied, however, reconfigured by 
governmentality to what Dean (1999) calls forms of ‘authoritarian governmentality’ or what  
Neumann & Sending (2010) call ‘police forms of governmentality’44.  
Following Garland, governmentality can be divided into two; ‘the government of others’, 
which are forms of power through which authorities govern populations – or conduct the 
conduct of men (Foucault 2008: 186) -, and ‘the government of one’s self’ referring to ‘self-
technologies’ - technologies through which individuals work on themselves to create their 
own subjectivities (Garland 1999). Individuals are thus ‘governed at a distance’, indirectly, 
through ‘technologies of freedom’. The historical situation of ‘liberal’ democracies 
presupposes free subjects who are individualized – which means that governmentality is a 
response to a historically specific situation where the individual needs to be ‘free’, but at the 
same time increasingly ‘responsibilized’, in order to fulfill his or her function in the ‘liberal’ 
democratic society (Neumann 2003). 
Many scholars have argued that there has occurred a shift away from the governmental 
rationalities implicated in the welfare or ‘social’ state, which sought to enframe the whole 
population within ‘apparatuses of security’ – from cradle to grave, towards what Rose calls 
‘advanced liberal’ forms of governmentality (Rose 2000, Dean 1999). In these forms of 
governmentality the role of the state is changed from being a ‘guarantor and ultimate provider 
of security’ to be a partner and facilitator for multiple autonomous actors (Rose 2000: 323), 
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 Through his genealogical account, Foucault describes governmentality as a hybrid between ‘public spirit’ or 
‘citizenship mindedness’, characteristic of the republican tradition where the (free) citizens had internalized the 
interests of the ‘polis’ as their own, taking upon them duties and responsibilities, and ‘pastoral power’, peculiar 
to the Judeo- Christian tradition, characterized by the shepherd’s guidance of his flock from cradle to grave, the 
flock’s obedience to the shepherd and their dependence upon him, and respectively the pastor’s duty to know 
every aspect of the flock members’ lives and to protect them from dangers   (Neumann 2003, Neumann & 
Sending 2010). While liberalism’s indirect techniques of government stems from the republican tradition, the 
techniques of more detailed control extend from pastoral power (Neumann & Sending 2010: 41). 
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where its role is to ‘steer and regulate rather than to row and provide’ (Rose 2000: 324). 
Governing thus implies ‘action at a distance’, depending upon alliances with a myriad of 
independent non-state actors and powers who are then responsibilized. Privatization, 
marketization and consumerism is followed by an increase in ‘techniques of accountability’ 
and new ‘technologies of freedom’. The strategies of welfare have been replaced by a 
dichotomy of inclusion and exclusion – or rather circuits of inclusion- , through which people 
are regulated by shared norms and values about appropriate conduct – or what Rose calls 
‘ethopolitics’ (Ibid.). Those who cannot or will not govern themselves in a responsible 
manner are excluded, criminalized and ‘governed through crime’ (Rose: 336). However, 
exclusion is framed in terms of subjective immorality, namely what Rose calls the ‘new 
morality’ (Ibid.).  
One important point made by Neumann & Sending is that the politics of global governance 
are “…increasingly organized around debates and struggles over what should be governed 
through liberal forms of government and what should be governed through police forms of 
government” (2010: 11). As we shall see, in the field of drug policy this struggle is 
particularly evident. 
3.2.2 Bio-politics 
Bio-power or bio-politics are specific power constellations concerned with the management 
of the life, health and welfare of the population or, rather, ways of rationalizing and dealing 
with “…problems posed to governmental practice by phenomena characteristic of a set of 
living beings forming a population: health, hygiene, birthrate, life expectancy, race…” 
(Foucault 2008: 317). Bio-politics operate through specific kinds of knowledge as they 
emerged inseparably from the ‘life sciences’, human sciences and clinical medicine, which 
gave birth to “techniques, technologies, experts and apparatuses for the care and 
administration of life of each and all, from town planning to health services” (Rose 2001: 1). 
According to Rose (2001), the ‘social’ states in the first half of the 20th century were 
concerned with the health and fitness of the population as a whole, protecting them from 
internal or external threats, such as for example epidemics.  
Similarly as the shift towards ‘advanced liberal’ governmentalities, Rose (2001) argues that a 
shift in biopolitical rationalities occurred in the second half of the 20
th
 century due to a crisis 
in national political government and a fragmentation of ‘the society’, ‘the culture’ and ‘the 
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community’ into a range of ‘cultures’ and ‘communities’. The problem of health is no longer 
framed in terms of health of the population, but rather in “economic terms – the cost of ill-
health in terms of days lost from work or rising insurance contributions – or moral terms – the 
imperative to reduce inequalities in health” (Rose 2001: 5). The state tries to free itself from 
the comprehensive responsibility for the health and welfare of the population (as in the 
‘social’ state), and favors to secure general conditions for health and abstain from direct 
interference. Epidemiology produces knowledge about at-risk groups (with a focus on risky 
practices rather than individuals), which are either advised to change their behavior or put on 
a drug regime aimed at reducing risk (Rose 2001: 8). ‘Advanced liberal’ bio-politics are risk 
politics (Rose 2001: 1). Neo-liberal health discourses thus seek to responsibilize the 
individual to take care of his or her own health through health promotion. The ‘patient’ is 
reconfigured to be a health ‘consumer’ capable of making free and healthy choices (Rose 
2000, Moore 2004, Rhodes 2009). Every citizen and community must take the responsibility 
for their own health and the health of the community; they must become active partners in 
promoting their own health. In this manner they are governed ‘at a distance’. 
3.2.3 Concluding remarks 
A governmentality perspective is not only valuable in identifying the many (at times 
obscured) aspects constituting policies but it is also useful for viewing particular policies in 
relation to broader ways of thinking and acting in society which extend beyond that particular 
policy area. I will argue that such an approach can also allow for a different way of 
understanding why some elements within alternative policies are more easily adopted into 
official policy discourses than others.  
In this thesis I argue that the policies, philosophy and values advocated by the drug policy 
reform movement are in line with the logics and rationalities of ‘advanced liberal’ 
governmentalities and bio-politics. I also claim that this might be a way to understand the 
partial adoption of the movements’ discourses and practices into official policies – as well as 
the increasing tendency of governing through the movement. Although the logics and 
rationalities of the drug policy reform movement resemble those increasingly employed in 
other policy areas – and particularly in the human rights paradigm –, I argue that this kind of 
thinking is ‘new’ in the field of drug policy, which operates through different sets of logics 
and rationalities, and which accordingly makes the alternative policies, and more notably 
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some specific elements within them, to be in opposition to the dominating power structures 
and discourses in that particular field. 
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4 Harm Reduction 
In Europe, harm reduction is best known as a generic term for a set of interventions aiming to 
reduce harms of drug use, most often injection heroin use, such as needle exchange, 
substitution treatment with methadone and buprenorphine, safe injection rooms, heroin 
assisted treatment and street-based outreach. Often, harm reduction interventions have led to 
heated media debates and critiques that the interventions keep addicts ‘stuck’ in their 
addiction, which equals ‘giving them up’, that they encourage drug use, or that they constitute 
a ‘backdoor’ for legalizing drugs (Hunt 2003). Harm reduction interventions seem to always 
be controversial when first proposed and initiated as they break with what can be seen as a 
hegemonic discourse of ‘zero tolerance’; only to be gradually accepted (or at least tolerated) 
into official political discourse, although harm reduction for a long time has been part of 
official EU policy. This chapter, however, aims to take a step beyond the European 
discussions to examine harm reduction in a global context. 
This chapter seeks to examine the processes of how harm reduction sometimes becomes part 
of official discourse (or rather part of some official discourses) - at the national and 
international level - whereas it sometimes does not. It will examine the role of human agency 
in these processes, but also the political, social and cultural contexts in which these processes 
occur or do not occur. The underlying question of this chapter is if - and in that matter how - 
harm reduction might be in opposition to dominant power structures.  
The two first sections of this chapter seek to define harm reduction in a global context. The 
disconnection from the European context makes it clearer that there are certain principles and 
rationalities that underpin harm reduction as a global movement
45
.  
First, I examine the underlying ethics and philosophy of harm reduction. Through drawing on 
interviews with harm reduction advocates in Germany and Mexico respectively, I argue that 
harm reduction is underpinned by a philosophy and a set of values purported as universal.  
Second, I investigate harm reduction as a policy, or rather policies, based on specific problem 
articulations and offering specific solutions to these problems. Harm reduction will in this 
section be discussed in relation to its (European) origins, its interventions and its scientific 
evidence-base. Furthermore, I discuss how the harm reduction principles have been proposed 
                                                 
45
 These principles and rationalities might, however, be ‘Northern’ exports into the global realm. 
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as a basis for creating interventions in contexts that are very different from the European. The 
section shows how harm reduction as a policy is context (and history) dependant and, thus, 
not that easily definable and generalisable, although its underlying principles could also be 
regarded to have universal applicability.  
Third, I elaborate on how the harm reduction movement goes forth in advocating harm 
reduction policies and interventions as well as discussing challenges and obstacles to harm 
reduction advocacy in Germany, Mexico and internationally. In this section I also examine 
the professionalization of the harm reduction movement and the significance of this 
development in terms of advocacy. 
Lastly, I argue that harm reduction is in coherence with neo-liberal discourses on health and 
can be seen as forms of ‘advanced liberal’ bio-politics. I also assert that the value-base and 
philosophy of harm reduction are part of such logics and bolsters them, but also that the 
values of harm reduction are the most hardly advocated elements as they are in opposition to 
the set of values employed in the zero-tolerance discourse. Still, I claim that the logics of 
harm reduction as a kind of ‘risk thinking’ and its principles of pragmatism, cost-efficiency, 
priority of immediate goals and local community participation, as well as the scientific 
evidence-base for its effectiveness, might help contribute to explaining the political support 
for harm reduction and its adoption into official public health discourse. Moreover, I go on to 
assert that there is a tendency for states and international organizations (IOs) to outsource the 
responsibility for the health and welfare of drug users to harm reduction NGOs, through 
which they govern as active and autonomous non-state ‘partners’.  
4.1 Harm reduction as a philosophy 
Due to the perceived inextricability of European harm reduction policies to its interventions 
(primarily for injection drug users), I was interested in hearing how the concept of harm 
reduction would be defined in a Mexican and Latin American context, where the pattern of 
drug use is different both regarding injection culture and the drugs being used
46
. However, my 
Mexican interviewees talked about harm reduction primarily as an underlying philosophy and 
a basic view of the human being. This underlying philosophy was also something I identified 
                                                 
46
 The most used drugs in Mexico are marihuana and cocaine, while heroin use is low except for the states 
bordering to the U.S. However, drug use in general seems to be increasing in Mexico, particularly for women 
(Encuesta Nacional de Addicciónes 2008). 
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in the responses of my German interviewees, although defining harm reduction was not a 
question I posed in the German interviews. This section will therefore deal with the 
underlying philosophy, ethics and values of harm reduction. 
My German interviewees are talking about a basic respect for the drug user or the patient as a 
basis for harm reduction:  
“Our position is: It’s a patient, like any other patient with tumor or diabetes, they do their 
own decisions. Drug use is not inflicting on their perspective and, so, we should let them 
decide what’s best for them. And we don’t have to take that decision – we have to support 
them, we have to make their decision an informed one, but not more. Give all a good frame, 
but not decide for the people, but let the people decide themselves. And all the time we 
collaborate with them” (Heino Stöver, Akzept, interview).  
Stöver is thus underlining that the core of harm reduction is to support people who use drugs 
in their own decisions instead of forcing them into something they do not want. They should 
be treated with the same respect as any other person, regardless of their drug use.  
Although the Mexican reality is very different from the German in most ways, Aram Barra is 
describing the core of harm reduction in a very similar manner as Heino Stöver:  
“I think the core of the philosophy [in Latin America] is the same core as the practice in 
Europe and in North America, which is: You create policy and programs that reach a 
community at their own level. So I am not asking to make a drug prevention policy by having 
drug users or people who have had addiction before to come up and raise to my debate and 
we’ll talk there. It’s more like: I’ll come to whatever level and level up as to reach them there. 
We can not part from being idealistic, we need to work with what the reality is and attempt to 
be very pragmatic. I think that’s what the core is [...] It comes down to being very humane 
and attempting to reach the community where they’re at” (Aram Barra, Espolea, interview) 
With this harm reduction can be understood as community-based programs emphasizing the 
users’ perspectives and a philosophy where the very basis is acceptance of the human being 
which also implies an acceptance of the individual using drugs.  
In this way the underlying philosophy of harm reduction contrasts the zero tolerance 
philosophy where the aim is to force the individual to be drug free either through treatment, 
through criminal sanctions or through deterrence. On the contrary both the theorists and the 
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practitioners of harm reduction are committed to bringing up the drug users’ own voice; be it 
in policies concerning them or in the creation of harm reduction measures. Heino Stöver is 
telling about how the German movement the last twenty years created professional standards 
in harm reduction that emphasize the users’ own views: 
“So it became more of a form of a dialogue between the users’ views, the patient’s views and 
the professional views. So we tried to bring them all together into a dialogue which makes 
treatment or services more shaped to the needs of those who have problems with the drugs” 
(Heino Stöver, Akzept, interview). 
With this, Stöver is also touching upon the important point that not every drug user has a 
problem with drug use:  
“I think within the European countries the last twenty years the social movements were 
responsible for a different view on drug addiction. They said: It’s not only a disease, it is a 
disease if you take opiate addiction, and the WHO classify it and assess it as a disease, but on 
the other hand it’s also life style [...] I think this, the users’ views in these specific countries in 
Europe, they changed the form of discussion, saying it’s more differentiated now than it was 
twenty years ago. Then all was thrown in the same pot, as we would say, and nobody would 
make a differentiation. But now I think we have that, saying: party drugs, people take it only, 
mostly in weekends, and then stop it, cannabis: 95 or 90 percent [who] use it recreationally 
don’t have any problems with it, 5-10 percent take it on a regular, very regular basis to 
several times a day, this might also be without problem, but might cause problems taken by 
very young people in the wrong period of their biography; juridical, school problems, 
anyway.  I think, in total this process of differentiation has led to differentiated politics in 
Europe” (Heino Stöver, Akzept, interview).  
Bringing the users’ own voices into the political debate through collective action has, 
according to Stöver, led to increasingly differentiated drug policies in Europe. The process of 
differentiation between types of drug use is also brought up by Aram Barra. He is talking 
about this process in terms of understanding, accepting and meeting different realities: 
“And I think that in that debate the very first step that we need to take is to attempt to further 
understand why people use drugs. In particular young people, but in general: why do people 
use drugs? And understand that people use drugs for many reasons. There’s traditional use, 
there’s recreational use, but there’s also a whole different area of drug users that use because 
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they are trying to hide away trauma or because they are trying to hide away hunger or 
because of mental health. And so we need to tackle all those realities with different 
approaches” (Aram Barra, Espolea, interview). 
With this, Heino Stöver and Aram Barra are highlighting the importance of acknowledging 
drug use as a complex phenomenon, where differentiation between different drugs, different 
modes of use, different contexts of use as well as different reasons for use is crucial. They are 
thus outlining a different problem perception of drugs than the problem construction which is 
the basis for the global prohibition regime (the latter will be discussed in the next chapter). In 
Frederik Polak’s words47, they articulate a need to differentiate between the phenomenon of 
drug use and the problem of drug use. They claim that the majority of drug use is not 
problematic (especially regarding use of soft drugs), and for those that do develop 
problematic use, it is not necessarily the drug use per se that is the problem but it can be 
individual, social, cultural, economic, political or structural factors. People use drugs for very 
different reasons, and those reasons need to be understood and respected in order to work with 
people who use drugs or in order to create drug policies.  
As noted in the theoretical chapter, the core feature of a social movement is their formation 
around core values and principled ideas. Through what I’ve shown above harm reduction can 
be understood as a philosophy or as a basic ethical view which articulates the core values of 
the movement, where: 1) All people are treated humanely with a basic respect, regardless of 
drug use, 2) acceptance of all individuals implies tolerance of their drug use, 3) when helping 
people with problematic drug use this means respecting their own choices and decisions and 
helping them on their own premises, 4) try to understand why people use drugs and realize 
that there are a lot of different drug user realities – some of them not implying a problematic 
use at all, 5) creating different pragmatic approaches to meet the different realities of drug 
users which encourage safer behavior, which means attempting to reduce whatever harms the 
drug user would meet in their specific context and reality, and 6) bringing the drug users’ own 
voices into the discourses concerning them; whether being their own treatment, development 
of initiatives concerning them or the political debate. 
                                                 
47
 “Proposal of a model for the debate about new drug policies” by Fredrik Polak, an unpublished document to a 
meeting in the EU Civil Society Forum in Brussels, October 2011, which he provided me with. 
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These values are regarded as universal by the movement, and seem to be a fundamental 
similarity between the German and the Mexican NGOs within the movement although these 
NGOs are working in very different social, political and cultural contexts.  
4.2 Harm reduction as public health policies 
While the previous section examined harm reduction as a philosophy, based on specific 
values, this section will deal with harm reduction as policies based on specific problem 
articulations, and offering specific solutions to these problems. First, I draw on definitions of 
the objectives and scope of harm reduction measures and policies in section 4.2.1. before I go 
on to briefly account for harm reduction interventions, focusing on their underlying 
principles, in section 4.2.2., presenting what I perceive to be the strongest argument for harm 
reduction, namely its scientific evidence-base in section 4.2.3., examining its history and 
development, especially in relation to HIV-prevention in section 4.2.4., and, lastly, accounting 
for how harm reduction principles can apply to interventions and policies outside the 
European context, specifically in the Latin American reality in section 4.2.5. 
4.2.1 The objectives and scope of harm reduction policies and interventions 
Harm reduction policy is best known as injection drug-related harm reduction, which is 
“...concerned with harmful effects or consequences of illicit (non-medical) injection drug use” 
(Rumbold and Hamilton 1998 in Ezard 2001: 208). Ezard goes on to emphasize that it is the 
harmful outcomes as a result of drug use that is important, which might for instance make 
harm reduction unconcerned with initiation into drug use.  
“A review of the evidence-base for harm reduction” presents these drug-related harms as the 
main task for harm reduction to reduce: 1) HIV/AIDS, 2) viral hepatitis, 3) local and systemic 
bacterial infections, 4) overdose, 5) dependence, 6) other physical and mental problems, 7) 
accidents and aggression, 8) public nuisance, 9) crime and 10) harms caused by 
criminalization (Hunt 2003: 5-7). This presentation reflects the emphasis of harm reduction 
on harms to health, primarily making it a health policy and a social policy, as well as having 
consequences also for criminal policy.  
However, Hunt (2003) offers a wider definition of drug-related harms than what does Ezard 
(2001) as he takes harms caused by criminalization into account, whereas Ezard only takes 
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into account those harms which rise from drug use per se. The harms caused by 
criminalization will be a theme in the next chapter. In this chapter I will rather focus on harm 
reduction in relation to health harms and social harms caused by drug use per se, as reducing 
these harms is the main objective of harm reduction policies and interventions.  
Ezard is concerned with the over-all social, structural and political context of drug-related 
harms, and she argues for a conceptual framework for harm reduction following three levels 
(individual level, community level and society level) as well as expanding the harm reduction 
paradigm to incorporate not only harms and risks, but also vulnerability. She argues that the 
levels are interconnected and at times hardly separable, feeding back to one another. Yet, that 
it is a useful framework for analysis and especially for identifying gaps of research and 
intervention (Ezard 2001).  
First, drug-related harm is defined broadly as “…a negative consequence of drug use to the 
individual, the immediate community or larger society” (Ezard 2001: 208). Harm reduction 
interventions can thus target all these three levels. Examples of harms could be infection as a 
result of injection at the individual level (where the intervention should be accessible health 
services), lack of responsibility for child-care at the community level (intervention: child-care 
services), and increased level of homelessness at the social level (intervention: emergency 
accommodation services) (Ezard 2001: 209).  
Second, Ezard notes that harm reduction to a large degree is targeting risk, namely through 
risk reduction.  She draws on a practical, operational understanding of ‘real risk’ defined as 
“…the likelihood of harmful consequences as a result of drug use” (Ezard 2001: 211), which 
she separates from the concept of risk discussed in social theory and especially in 
governmentality literature. Risks are also found on all three levels, for example; at the 
individual level shearing paraphernalia will lead to the risk of transmission of blood-borne 
diseases (intervention: needle exchange programs), at a community-level a high prevalence of 
blood-borne diseases will increase the risk of transmission (intervention: peer education in 
safer behavior and injection techniques), and at the social level prohibition or restriction of 
needle exchange programs will increase the risk of needle shearing (intervention: legislative 
change).  
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Third, Ezard argues that what she calls a ‘vulnerability paradigm’ should be included into 
harm reduction. She defines vulnerability as “…predisposition to the risk of drug related 
harm” (Ezard 2001: 213). Furthermore, she writes that:  
The notion of vulnerability incorporates the complex of underlying factors that promotes harmful 
outcomes as a result of drug use, and limits attempts to modify drug use to make harmful outcomes less 
likely. Vulnerability factors constrain choices and limit agency. Vulnerability factors arise out of and 
are reinforced by past and present social context and experience” (Ezard 2001: 213).   
Examples of vulnerability factors at the three levels could be personal features, history of 
sexual abuse or violence, low self-esteem at the individual level (intervention: treatment of 
depression, individual therapy), at the community level Ezard introduces the notion of 
‘collective vulnerability’, which refers to marginalized communities with high levels of 
unemployment and low levels of education (intervention: educational programs, employment 
programs), which is closely connected with the societal level and ‘structural vulnerability 
factors’  or ‘macro-level vulnerability factors’, referring to economic inequalities, racism and 
structural violence (intervention: improved immigration programs, reconciliation programs, 
programs that target (racial) discrimination).  
Ezard’s conceptual framework is valuable for understanding the larger social and political 
context of drug use as well as for outlining the broad scope for harm reduction interventions 
and advocacy. Her notion of vulnerability is specifically developed in order to raise awareness 
to how structural inequality can contribute to higher prevalence of drug use as well as more 
risky patterns of drug use. However, Ezard herself notes that the focus of harm reduction 
policies and interventions have been the individual and community level, as “…the practice of 
harm reduction interventions for illicit (non-medical) injection drug use has tended to focus 
on risk reduction through behavioral modification” (2001: 207). This internal critique of harm 
reduction will be discussed more thoroughly in section four of this chapter.  
In this section I have outlined the objective for harm reduction policies, namely reducing 
drug-related harm, risk and vulnerability at the individual level, the community level and the 
structural level. A harm reduction perspective thus differs notably from ‘hegemonic’ drug 
policy discourse which frames ‘the problem of drugs’ in terms of supply and demand where 
the goal is for these to be eliminated. Rather, it seeks to reduce the harms and risks stemming 
from, and the vulnerability factors contributing to, drug use. In the following section some of 
the interventions meant to respond to these objectives will be presented. 
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4.2.2 Harm reduction interventions 
This section will briefly account for different harm reduction interventions aiming at reducing 
drug-related harm and risk. The aim of this section is not to exhaustively present harm 
reduction interventions, but rather to make the reader understand their differential forms as 
result of the principle of pragmatism
48
.  
Harm reduction interventions, most notably exchange of needles and other sterile injection 
equipment, was initiated in the Netherlands in the 1970s to stem up for the spread of HIV and 
hepatitis C among injecting drug users – which spread through shearing paraphernalia. Needle 
exchange programs (NSP) are, together with opioid substitution treatment (OST) with 
methadone and buprenorphine
49
, the most known harm reduction interventions towards 
injecting drug use. Although contested when initiated, these measures are now largely 
accepted and recommended by among other WHO, UNAIDS, EU and UNODC. In addition 
community-based outreach have always been at heart of harm reduction, involving face-to-
face contact with drug users; implying provision of information, referral to services, 
counseling, motivational interviewing, risk assessment and HIV testing, community 
organizing support (Hunt 2003) or sometimes just conversations. Measures to make injecting 
users switch to less risky modes of consumption through distribution of heroine smoking foil 
are also initiated in many countries. More recent, and often regarded as more controversial, 
are interventions such as drug consumption rooms (DCR), NSPs in prison facilities as well as 
heroine-assisted therapy (HAT).  
Although traditionally developed to target harms stemming from injection drug use, harm 
reduction interventions are increasingly developing in relation to recreational use as well as 
stimulant use in many countries. Through outreach work on party scenes harm reduction 
workers, and often peers, provide safer use information, ‘safer use-kits’ (with sterile snorting 
equipment), free water
50
 and fruit, condoms, developing warning systems on pills reported to 
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 Hunt describes pragmatism in harm reduction like this: “Harm reduction accepts that some use of mind-
altering substances is a common feature of human experience. It acknowledges that, while carrying risks, drug 
use also provides the user with benefits that must be taken into account if drug using behaviour is to be 
understood. From a community perspective, containment and amelioration of drug-related harms may be a more 
pragmatic or feasible option than efforts to eliminate drug use entirely” (CCSA 1996 in Hunt 2003: 3-4). 
49
 In many countries opioid substitution treatment is also extended with other opioids such as morphine and slow 
release morphine, and combination products such as the combination of buprenorphine and naltrexone, known in 
Europe under the brand name of Suboxone. 
50
 Many deaths related to party drugs occur due to dehydration. 
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have unknown or specifically dangerous contents, and in some countries providing pill testing 
where users can test content of the pill/powder they possess.  
Often, harm reduction interventions are directed at sub-groups and communities most at risk 
of drug-related harm, for instance specifically targeting sex workers or open drug scenes. A 
crucial feature is that measures are customized to that specific target group, involving peers 
from that group in initiation and implementation of measures. 
Here I have merely provided some examples of harm reduction interventions with the purpose 
of giving the reader an idea of the nature and purpose of such measures. Their aim is to make 
drug consumers aware of risks as well as change their behavior towards less risky patterns 
and their initiation and implementation is highly pragmatic. However, most often these 
measures are closely monitored and evaluated by researchers, partly because some of them 
would be illegal if not conducted as medical or scientific projects. The extensive evidence-
base that has been accumulated through these measures will be presented subsequently.  
4.2.3 The evidence-base for harm reduction interventions 
This section will elaborate on what I perceive to be the strongest argument for harm reduction 
interventions, namely that they are scientifically proved to be effective in reducing drug-
related harm. 
Since the 1980s a substantial body of research and evaluation has been made about the effects 
of harm reduction measures. For instance research shows that substitution treatment and 
needle exchange programs have a significant effect in reducing HIV-infection, hepatitis C and 
tuberculosis in the population of (injecting) drug users (Hunt 2003, Rhodes & Hedrich 2010) 
as well as numbers of overdose deaths (Hunt 2003, Papendorf 2011). Substitution treatment 
as well as heroin prescription and community-based outreach also have an effect on the over 
all physical and psychic health and life quality of the users (Hunt 2003). In addition 
substitution treatment has proven effective in reducing use of illegal drugs as well as drug 
related crime (see among other Stevens, Trace & Bewley-Taylor 2005). 
Rhodes & Hedrich (2010) note that harm reduction interventions have enhanced efficiency if 
multiple interventions are delivered in combination, in so called ‘combination interventions’. 
Furthermore, a crucial determinant for success is the coverage of interventions, access to 
interventions – through avoiding high thresholds or obstructing factors such as the presence of 
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law enforcement agents near interventions
51
 - , as well as their customization to the social 
environment in which they are delivered.  
Another related and crucial argument is that harm reduction interventions are not merely 
effective but also cost-effective. They are much less expensive than abstinence-based (in-
patient) treatment and antiretroviral therapy (ART), at the same time as they save costs in the 
general health system due to reduced morbidity among users as well as costs of drug-related 
crime. 
Above I have solely outlined some of the most notable findings of the efficiency and cost-
efficiency of harm reduction measures from an otherwise very extensive body of research. 
The purpose of this (very brief) account was to present what I see as the strongest argument 
for harm reduction in political terms. As I will show in the subsequent sections, and especially 
in section 4.3., the evidence-base is crucial for the (type of) advocacy in which the movement 
engages and also for its possibilities for successful advocacy. 
4.2.4 Harm reduction and HIV/AIDS 
The argumentation of the harm reduction movement is to a very large degree concerned with 
prevention of HIV, and increasingly also with hepatitis C and tuberculosis, among injecting 
drug users. As I showed in the last section, a large part of the (particularly medical) scientific 
evidence-base concerns around the measures’ effectiveness in reducing the prevalence of 
these diseases as well as drug-related mortality in general. This has to be seen in terms of 
historical continuation of the naissance and growth of harm reduction policies and 
interventions.  
Kübler identifies the HIV/AIDS epidemic to be the crucial ‘non-cognitive event’ that changed 
the terms of the drug policy debate in Switzerland in the middle of the 1980s (2001: 631). 
Needle shearing among drug users exposed them to a large risk of contamination and drug 
prostitution was a major factor for spreading HIV to the general population. This, he asserts, 
together with the involvement of medical professionals specialized in infectious diseases and 
in public health, which had not previously been engaged in the drugs field, made harm 
reduction measures important public health interventions.   
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 Some NGOs also provide harm reduction training for law enforcement officials, such as for instance ‘drug 
action teams’ in the U.K. and Australia which provide health-focused training to police in order for the police to 
give out health and social service referral cards to drug users in stead of arresting them (Jürgens et al. 2010: 6). 
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In many European countries harm reduction measures such as methadone treatment was 
available already in the 1970s and in the early 1980s. However, what fuelled the development 
of harm reduction responses was that the HIV/AIDS epidemic was put on the political agenda 
in the 1980s (Grieg & Kershnar 2002, Nadelmann & Andreas 2006, Kübler 2001). Harm 
reduction thus developed as a public health strategy to stem up the spread of HIV/AIDS 
among drug users, sex workers and the general population. Despite the critique that harm 
reduction measures would lead to keeping addicts stuck in their addiction as well as 
encouraging drug use (Hunt 2003: 7-8), parts of Western Europe, Canada and Australia 
acknowledged that HIV/AIDS constituted a larger immediate threat to public health than drug 
use itself (Grieg & Kershnar 2002, Kübler 2001, MacCoun & Reuter 2001). Methadone 
programs and needle exchange programs were either initiated or scale up. 
In other words, the threat of HIV, its particular prevalence among drug users and the risk of 
its spread to the general population constituted a kind of political break through for the harm 
reduction movement. Its pragmatic measures and interventions now became essential in 
stemming up the spread of HIV in the population – which in most countries became a public 
health priority
52
. Keck & Sikkink argue that the stage of issue creation and agenda setting 
often requires a modification of the ‘value context’ in which policy debates take place as the 
value positions of movements are very strong (1998: 25). As I later argue, the pragmatic harm 
reduction policies that got adopted by official public health policies in many countries did to a 
large degree get separated from their original value context or from their philosophical 
underpinnings.  
Another transformation that took place was the medicalization of the issue ‘injecting drug 
users and HIV’. Stöver (interview) depicts how the drug field in Germany until the early 
1980s was dominated by psychosocial professions such as social workers and psychologists, 
who defined drug addiction as a social problem
53
. With the HIV epidemic, however, medical 
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My experience from the conferences is that harm reduction activists call for attention to other diseases such as 
hepatitis C and tuberculosis, which constitute a risk and harm just as grave to drug users, but which they claim 
has been neglected in favor of the attention for HIV. I think that the reason for this emphasis on harm reduction 
as HIV-prevention is a specifically strategic one due to the panic which occurred around HIV in the early 1980s 
onwards. 
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 Boekhout von Solinge (1999) argues that national definitions of the ‘drug problem’ as well as the political 
responses to it have to do with the social and cultural traditions as well as dominating national paradigms of 
knowledge. He shows three examples of definitions of the ‘drug problem’ from Sweden, where the 
epidemiologist Nils Bejerot defined drug use as an epidemic, as well as basing drug policy on the total 
consumption model, Netherlands, where sociologists were dominant in forming drug policy based on strategies 
of social inclusion and normalization, and France, where psychiatrists were the dominant profession, placing 
drug use as a problem within the individual, viewing drug taking as transgression and expression of an inner 
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doctors started playing a large role through the introduction of pharmaceutical therapy. Today 
there are 80 000 patients in substitution treatment in Germany, which makes this the main 
type of treatment, and which correspondingly makes the medical doctors the main profession 
in the drugs/health field. Stöver tells how the social workers and psychologists are put in a 
more defensive position and are now fighting to get a better stand in the drugs field:  
“They now start to really ask for money, for attention, and they contribute to high percentage 
of course to the success of a treatment. They do counseling, they do treatment. And it’s not the 
doctor alone who is, let’s say, only providing a medication. This is not the solution for the 
problem. But it’s also not neglectable. The medication is giving people time not to go on the 
black market, not to prostitute themselves, not to steal, not to do anything for the drug... but 
it’s more something that gives people time to get some distance to the drug scene and to do 
then their own dealings” (Heino Stöver, Akzept, interview).  
The HIV-epidemic thus led the medical profession to get an important role in the drugs field, 
especially through substitution treatment, at the same time as it partly defined harm reduction 
interventions in terms of HIV- prevention. The problem of drug addiction was also 
increasingly defined in medical terms, leading to what could be called a ‘medicalization’ of 
drug addiction
54
. The EuroHRN survey identifies a Northern European phenomenon of a 
“…visible shift from harm reduction services as a human rights-based set of interventions 
toward a highly integrated, medicalised and streamlined approach more appropriately deemed 
‘harm management’” (Stoicescu & Cook 2011: 39). In the Netherlands a comprehensive and 
integrated Social Support Strategy (SSS) was implemented in 2006/2007 to meet all the needs 
of the most vulnerable groups such as problematic drug users, homeless people and 
psychiatric patients (Schatz et al. 2011). Although this ‘intervention package’, which also 
includes punitive interventions, has contributed to reduction in homelessness and an increase 
in social support to this group, it is criticized for being too focused on aims of public order 
and crime reduction (which has been most effectively reduced by the Strategy) and security as 
well as a related trend towards medicalization as a main means of treatment (Ibid.). 
                                                                                                                                                        
desire to break law and norms (Ibid.). In addition, he claims cultural traditions had impacts on the drug political 
approaches, such as the temperance movement in Sweden, the emphasis on individual freedom in the 
Netherlands and a strong, influential police force in France. 
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 Both the psychiatric diagnostic systems DSM and ICD include drug addiction as a psychiatric diagnosis, hence 
a disease. According to Polak the DSM system uses two criteria which as very context-dependant, thus including 
many drug users due to the illegal status of the drug (2000: 6).  
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The scientifically proven success of harm reduction measures in reducing HIV-prevalence 
among drug users, as well as numbers of overdose deaths (it could be added: reduction in 
drug-related crime), has made it be adopted as official policy by the EU and the WHO, 
UNAIDS, the Global Fund and eventually also UNODC. According to Rhodes & Hedrich 
studies have shown that there is a growing emphasis on harm reduction in EU countries, 
where harm reduction has been described as a ‘common position’ (2010: 21). The EU Action 
Plan on drugs 2009-2012 explicitly includes harm reduction as one of the main means in its 
demand reduction strategy.  Rhodes & Hendrich thus call harm reduction a ‘mainstream’ drug 
policy in Europe. 
The emphasis of harm reduction on HIV-prevention has also allowed the harm reduction 
movement to form strategic alliances with the very large international HIV movement, which 
has not traditionally been concerned about HIV among drug users. As such, the harm 
reduction movement tries to influence the HIV movement to put the issue of drug users on 
their agenda
55
.  
Although harm reduction could be perceived as ‘mainstream’ policy in Europe, as argued by 
Rhodes & Hedrich (2010), my interviews indicate that it is still contested and that the 
existence of harm reduction interventions is not self-evident. The European Harm Reduction 
Network survey states that the over-all coverage of harm reduction interventions in Europe is 
highly insufficient, especially outside larger cities as well as in certain regions. Some places 
the insufficiency prevents measures to have any effect on HIV, hepatitis or tuberculosis 
prevalence (Stoicescu & Cook 2011). Furthermore, the report identifies multiple barriers to 
harm reduction interventions in Europe despite harm reduction being part of official policy in 
nearly all countries in the region
56
. This shows that there is still a large discrepancy between 
official policy aims and practice. 
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 Through subscribing to newsletters and mailing-lists from different drug policy NGOs, I very frequently 
receive news on different projects and conferences made in collaboration with the HIV movement, which makes 
me draw the conclusion that the cooperation between the harm reduction movement and the HIV movement is 
quite extensive.  
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 Harm reduction NGOs across Europe reported these obstacles and barriers to harm reduction interventions at 
national and local levels: 1) insufficient funding for measures, aggravated by the economic crisis (in Eastern 
Europe a reliance upon international funds due to domestic political reluctance to fund measures), 2) political 
opposition or lack of political will, 3) public opposition, 4) stigma, 5) discrimination (especially against 
migrants, women and young people), 6) users of interventions experience fear of arrest and criminal sanctions by 
law enforcement officials, 7) restricted access to services such as limited opening hours, age restrictions and 
other criteria, 8)  lack or absence of drug use data that is needed for effectively targeting harm reduction 
measures as well as existing data focusing on prevalence of use in the population rather than mapping 
specifically harmful patterns of use (Stoicescu & Cook 2011). 
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On a global basis the coverage of harm reduction measures is highly insufficient despite the 
WHO, UNAIDS, Global Fund, EU and high income countries support for and funding of 
harm reduction interventions world wide
57
 (The Global State of Harm Reduction 2010). In 
some regions, hostility towards harm reduction, leading to no or insufficient coverage, causes 
large numbers of new cases of HIV, hepatitis C and tuberculosis infections as well as high 
levels of drug user mortality (see among other Hunt 2003, The Global State of Harm 
Reduction 2010). 
This section has shown that the initiation, development and increase in harm reduction 
policies and interventions need to be seen in relation to its scientifically proven effectiveness 
in preventing the HIV epidemic. The medicalization of drug addiction as well as the 
securitization of HIV has enabled harm reduction to be put on the political agenda as a 
‘mainstream’ public health issue in Europe as well as in many UN institutions58. However, it 
has also shown that despite the rhetoric there is still a large discrepancy between the official 
public health goals and the reality – even in Europe. 
The next section will examine harm reduction outside of the context of (opiate) injection drug 
use with a strong correlation to the HIV-epidemic, which I will later argue might have 
significance for the possibilities for advocating harm reduction at a political level. 
4.2.5 Harm Reduction outside the context of opiate injection drug use 
This section examines how harm reduction policies and interventions can be understood 
outside of the context of (opiate) injection drug use. More notably, it will deal with harm 
reduction in Latin American contexts, both in relation to non-injection drug use (often of 
stimulants), in relation to social harm such as violence, and in relation to drug crop producing 
farmers.  
The Mexican NGO Espolea also has HIV, sexual health and inequality in gender on their 
political agenda besides drug policy. Aram Barra (interview) is convinced that there is a 
strong correlation between HIV and drug use also in cases of non-injection use, particularly 
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 Many predict that this situation might be aggravated by the economic crisis which leads to cuts in 
interventional funds to harm reduction interventions. 
58
 Albeit not all. Some UN institutions are still hostile towards harm reduction, which will be a theme in the 
subsequent chapters. 
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due to risky sexual activity. The problem, however, he asserts, is that there is no strong 
scientific evidence-base to prove this correlation. 
Nevertheless, harm reduction measures can also be understood as promoting a less risky 
behavior also in cases of non-injecting drug use or in cases of non-opiate use and in case of 
non-problematic, albeit potentially risky, behavior;  
“Many times for instance to Mexicans and in Latin America I explain harm reduction as ‘if 
you drink, don’t drive policy’. The campaign ‘don’t drink and drive’, it’s not telling you 
‘don’t drink’ which is prevention, it’s not telling you ‘go to treatment for alcohol’, which is 
treatment, it’s telling you the middle point, which is: if you’re going to use the drug don’t go 
out and encourage behavior that will put you and your community in danger. Don’t drive, 
right? [...] And then I say: Now apply the same philosophy to every other drug, and people 
are: ok, that has a rationale to it, it’s quite pragmatic, but it has a rationale” (Aram Barra, 
Espolea, interview).  
Harm reduction as public health policies could thus also be understood in terms of 
encouraging and promoting the healthiest and safest behavior possibly in the population given 
(and accepting) the societal circumstances. Harm reduction policies have long existed in 
relation to different other health risks, including legal psychoactive drugs such as alcohol and 
tobacco. Aram Barra suggests harm reduction in the drugs field means expanding this strategy 
to also apply to illegal drugs. Luís Astorga (interview) talks about harm reduction in terms of 
creating policies that are basically preventive in stead of punitive.  
Martin Jelsma argues that the harm reduction model cannot simply be transported to Latin 
America, “where injecting drug use is a major concern only in Mexico (heroin) and in Brazil 
and Argentina (cocaine)” (2009: 17). Rather, he suggests that harm reduction interventions in 
Latin America should focus on smoking/inhaling stimulants (crack/paco and coca base paste) 
and draw experience from such experimental interventions done in the U.S., Canada and 
Brazil, where ‘safer crack use kits’ have been distributed. Most notably, he argues that harm 
reduction in Latin America should not only target health harms, but also social harms, as 
drug-related violence is one of the major concerns in the region (Ibid.). 
Furthermore, Martin Jelsma (2004a) argues for an application of the principles of pragmatism 
and user and community participation of harm reduction to alternative development projects 
and crop eradication programs in drug crop producing countries:  
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“- Shifting away from the current obsession with counting and reducing the numbers of hectares [of 
drug crops eradicated] toward prioritizing the policy goal of reducing the harm associated with the 
existence of illicit crops, including measures to reduce the harm done to the environment and attempts 
to reduce their importance in fueling armed conflict. - Opening up spaces for dialogue with involved 
communities – free of deadline and ‘zero-option’ thinking – about their own problems with drug-linked 
crops, allowing flexible, gradual reduction processes. - Defining small growers more as economic 
victims that have become ‘addicted’ to illicit crops for survival. Similarly to the harm reduction 
approach to drug addicts, this means trying to provide considerations that allow them to leave their 
situations; if that doesn’t work, assisting them in a way that reduces the harm to themselves and to 
society at large rather than spraying, incarcerating, or killing them. - Supporting the option of de-
penalization or law enforcement leniency toward small illicit cultivation similar to the tolerance trend in 
several European countries toward individual consumption of soft drugs or the possession of small 
quantities for personal use. - Exploring options for direct linkages between harm reduction interventions 
on the supply side and the demand side in order to stimulate the global debate on alternative measures 
of counter-narcotics action. – ‘De-demonizing’ certain aspects of illicit drugs by differentiating more 
between specific substances and their potential harms and benefits on the basis of scientific studies” 
(Jelsma 2004: 221).  
This section has shown how harm reduction principles and rationalities of promoting less 
risky behavior as well as pragmatic community-based programs with participation of those 
affected can be applied to realities that do not resemble the European context of (opiate) 
injection drug use with a strong correlation to the HIV-epidemic. In the next section I will 
examine how these different contexts and realities can have significance for the political 
advocacy of harm reduction principles, policies and interventions.   
4.3 Harm reduction advocacy 
In the two previous sections I attempted to define harm reduction as a philosophy, with 
specific values, and as policies, with specific objectives and principles. At the same time, I 
outlined the main arguments for harm reduction policies and interventions, namely their 
scientifically proved efficiency and cost-efficiency in reducing drug related harm and risk – 
most notably in relation to HIV prevention.  
This section will deal with how the harm reduction movement goes forth in advocating for 
harm reduction policies and interventions as well as discussing challenges and obstacles to 
harm reduction advocacy in certain political, social, economic and cultural contexts. First, I 
examine how the harm reduction NGOs go forth to advocate the scientific evidence-base 
through information politics, and outline the problems and obstacles they encounter in this 
regard, in section 4.3.1. Second, I explore the professionalization of the harm reduction 
movement and how it has affected on its advocacy efforts and opportunities at different levels 
in section 4.3.2. 
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4.3.1 How do the NGOs use the evidence-base for harm reduction in their 
argumentation? 
My interviewees claim the drug service systems and policies in their countries is often driven 
by morals and beliefs. In contrast, their argumentation for the implementation of harm 
reduction measures it based on the scientific evidence for their effectiveness:  
“Still we have a system, especially in the health field, of health belief which is the basis for 
policy. And it’s not driven by evidence-based research – to a very little extent. I’ll give you an 
example: We had extended research on this heroine treatment trial. And it turned out that 
heroine was for a certain target group a much better medication than methadone or Subutex. 
And then politicians came and said: No, I don’t believe it. And maybe it’s too expensive, 
heroine [...] The consequence was that the introduction of heroine as a medication was 
prolonged by five to seven years, I would say. The research data are already from 2002. But 
only 2010, heroine is now a prescribable drug” (Heino Stöver, Akzept, interview). 
Although the evidence-base is there, the movement still has a job to do by advocating it to 
make it known and accepted by the health system and by the policy makers. In their strategy 
paper, Espolea is pointing out the clear and urgent need for Mexico to “…generate, publish 
and disseminate more comprehensive scientific information, free from dogmas, regarding 
drugs, their use and the impact of policies implemented to control them, in order to put an end 
to the taboo surrounding them and be able to reduce their negative impacts on individuals and 
society” (Barra & Sánchez 2010: 27). Luís Astorga (interview) tells me that CUPIHD has a 
large focus on conducting research, in disciplines such as sociology, politics, medicine and 
international relations, in order to propose policy changes on a scientific basis. This means 
that while in countries where a lot of research is made the task of the movement is to advocate 
it as to become basis for policies, while in countries with little research the movement will 
first need to advocate for scientific research to be conducted and engage in the time-
consuming and expensive activity of conducting it, in order to be able to propose practical 
policy on its basis.  
Aram Barra is telling about a research project Espolea did together with CUPIHD on 
documenting the consequences of the new Mexican drug law, the so called Narcomenudeo. If 
a person is caught three times with small quantities of drugs, he will be sent to court where he 
can decide whether he wants to go to prison or to treatment. They contacted both the courts 
and the health system to get information on how many people the court had sent to treatment. 
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Both places, however, they were denied the information as both agencies claimed these 
statistics were nonexistent. Espolea and CUPIHD thus appealed to the Transparency Institute 
(The Mexican institute for access to information) where they won the case. Still, the 
information could not be provided.  
“It also really tells you that in the particular case of Mexico the capacity of the law making 
process is really slow, it’s really corrupt, it’s really secluded, it’s really difficult to access 
information that in this case is sensible information. We understand that the president doesn’t 
want us to have that information because it means that his whole war, his whole law, are all 
wrong, or that they’re not doing it right. [...] And within that context I think it’s really hard to 
attempt to change reality, to attempt to propose any sort of policy anywhere, at whatever 
level. Because if you’re not allowed to have access to information, if you’re not allowed to 
review what the current status is or the state of the subject is, then you cannot propose 
anything” (Aram Barra, Espolea, interview).  
A lack of research, or restrains from access to information that can provide that research or 
even monitoring of the current system, thus limits the possibilities of the movement from 
policy proposals at a national level. This might especially be the case in countries where the 
results from Northern scientific research is not easily transferable.  
Mike Trace (interview) tells how the EU internally has helped its member states to agree on 
basic harm reduction principles. However, he claims the EU’s impact on the area of harm 
reduction probably has been greater externally rather than internally by promoting 
progressive, health based, human rights based policies. In the area of drug policy the EU has 
recognized the harm reduction movement as professionals in the field and even directly drawn 
on their expertise in external negotiations:  
“There have been situations where representatives from the NGO movement have directly 
supported the policy work of the EU. [...] I think it was about three or four years ago there 
was a big summit meeting between the European Union and the U.S. on harm reduction. The 
U.S. were seriously trying to say that needle exchange was not backed by evidence and it 
should be stopped everywhere and that sort of thing. And the European Union disagreed. And 
it was IHRA
59
 and IDPC that prepared the briefing for the European negotiators and that was 
the meeting at which, sounds like the battle at Waterloo, it’s where the Americans backed off. 
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 The International Harm Reduction Association, now Harm Reduction International (HRI). 
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Because they knew they couldn’t win the argument. Well, it didn’t stop them from being 
politically difficult, but they never tried again to argue that needle exchange was not 
evidence-based. And if you would have sent a couple of diplomats or civil servants into that 
room, they wouldn’t have known how to win that argument. But we as the transnational 
networks gave them all the briefing” (Mike Trace, IDPC, interview).  
As the quote from Mike Trace shows, the harm reduction movement does have status as 
professionals and experts in some forums through what he calls a bureaucratic type of 
advocacy. This is not, however, necessarily a common example in drug policy forums 
internationally or nationally, and the task for the movement is still to claim their place as 
experts in seats earlier exclusively occupied by the temperance movement. They do this 
primarily through claiming that “…drug policies must be based on solid empirical and 
scientific evidence” (The Global Commission on Drug Policy 2011: 5).  
 The role of the scientific evidence-base in policy proposals and advocacy is reflected in the 
constellation of actors within the movement, which to a large degree consists of professionals 
and academics from different fields. Still, one of the core aims of the harm reduction 
movement is to bring the users’ own voices into the debate as well as promoting the 
acknowledgement of their voices as expert voices. The next section will examine these 
themes as well as how an incremental professionalization of the movement has affected on its 
advocacy outcomes and efficiency.  
4.3.2 How has the professionalization of the movement affected advocacy at different 
levels? 
Mike Trace claims that the drug policy reform movement has changed a lot the last twenty 
years, which has enhanced its possibilities of resonance within politics: 
“The big difference over the last twenty years is… there’s still those good grass-root 
movements, drug reform movements, but they are now mixed in and intertwined with 
professional networks, funded networks, policy networks, like ours. So it’s all like a much 
more vibrant and varied community. They don’t all share the same policy approaches or 
tactical approaches, but it’s grown, it’s broadened out, there’s lots of connections into other 
areas of policy” (Mike Trace, IDPC, interview). 
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At a national level Heino Stöver tells how the German movement has gone through a process 
of professionalization by first initiating harm reduction measures and later developing 
professional standards for harm reduction work through evaluations and research:  
“And of course in the development of the last twenty years the discourse of what is 
professional harm reduction work came into force and we developed some standards how to 
run a drug consumption room, how to do acceptance oriented work, how to do housing 
projects, how to do substitution treatment with integrating the patient’s views but at the same 
time the doctor’s views” (Heino Stöver, Akzept, interview).  
Another way the movement has professionalized is to bring in expertise from different fields. 
Dirk Schäffer is telling that one of the ways to reach the goals of comprehensive, evidence-
based harm reduction policies is involving researchers and experts in the movement:  
“And we have a network with the doctors which are in methadone treatment, they have an 
own organization, and to work with them together, and it’s an organization of lawyers who 
are interested in harm reduction and to cooperate with them and to build up a network of 
different professions that are all interested in harm reduction. And it’s one way to reach our 
goals. To build up a network with different professions with different people in different 
places. And that works very well in Germany, we have a network like this with Akzept and the 
German AIDS organization and many other organizations” (Dirk Schäffer, Deutsche AIDS-
Hilfe, JES, interview).  
The Mexican organizations are also highly professional and consist of well-educated people, 
professors and researchers which draw on their professional knowledge and professional 
connections and networks in their advocacy.  CUPIHD started as a kind of think tank of 
experts and professionals on drug issues around three law propositions (about allowing for 
recreational personal use and medical use of marihuana and of industrial hemp) that were to 
be presented by the now ex-deputy of the Social Democratic Alternative, Elsa Conde
60
. They 
have managed to become regarded as an expert organization and a point of reference that is 
consulted by government officials and agencies as well as other civil society groups, and 
brought into different government and local commissions. The law propositions also led 
progressive debates to take place in the Mexican Congress (Astorga, interview). 
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 These law propositions have either been discarded or frozen (Barra 2010). 
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Still, the movement in Germany, Mexico and internationally involve drug users, ex drug users 
and people in substitution therapy, who hold expert roles within the movement. The 
International Network of People who Use Drugs (INPUD) has an important role within the 
transnational drug policy reform movement, as well as in facilitating the organization of drug 
users in networks in different regions of the world. The European Harm Reduction Network 
survey identified one of the main goals of the harm reduction movement to be meaningful 
involvement of people who use drugs in service design, implementation, monitoring and 
evaluation across three levels; individual-level (involvement in the work of NGOs), 
organizational-level (participation in consultations, decision-making and policy-making 
bodies) and in autonomous groups working towards self-determined agendas (Stoicescu & 
Cook 2011: 16).  
Still, Heino Stöver (interview) asserts that the German movement has by far had most impact 
at a professional level, among other through arranging professional conferences on health and 
harm reduction topics. They were much less successful, if successful at all, in confronting 
politicians directly or through general public media campaigns.  It is rather through a strong 
standing at a professional level that they have been able to influence the political level 
indirectly, namely through becoming the expertise, through a bureaucratic type of advocacy. 
Both Stöver and Schäffer tell about being invited to expert hearings at different levels where 
they are taken seriously. 
In Mexico, CUPIHD hosted the 1
st
 Mexican and 3
rd
 Latin American Conference on Drug 
Policy, a professional conference with participation of civil society activists, researchers, drug 
policy experts, drug users, and policy makers.  
However, Aram Barra claims that it’s not necessarily strategic to bring harm reduction to a 
political level at all: 
“I think that there are risks about politicizing harm reduction. I think Latin America is at a 
quite very early stage around harm reduction, around particularly the debate [...] It’s a little 
worrying where the discussion could go, which is a question. On the one hand you have a lot 
of arguments that say: As soon as you say harm reduction, people that read a little bit more 
about addiction and drug use they’ll immediately say: They’re talking about harm reduction, 
which means; you understand the reality of Europe, which means: you’re pro legalization. So 
it’s a very quick snap that takes you from harm reduction to legalization. And many times it’s 
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not so in Europe and in many countries that have applied harm reduction. And so I think 
there is a danger of that, of that the response and the reception will be that you’re pro-Yankee 
or pro-European in your policy. Second worry that could exist, it’s the second troubling 
thing, is that it’s hard….. Because it’s hard to define the problem. I should go one step back, 
because the thing is: Because it’s hard to define what harm reduction is in Latin America, it’s 
hard to define it as a concept, right? And so the troubles with bringing it into a political 
debate is that sometimes you’ll talk about harm reduction and some people will think about 
you as a pro-Yankee, pro-European, some people will think about you as pro OST
61
, pro  
needle exchange, and they’ll all say: This doesn’t make sense in this reality. Some people will 
understand the philosophy and they’ll say: Ok, let’s think about it” (Aram Barra, interview).  
Barra is thus pointing out four arguments against politicizing the concept of harm reduction in 
Mexico: 1) People would think harm reduction equals legalization, 2) harm reduction is a pro-
Yankee and pro-European policy, 3) harm reduction measures, as we know them from Europe 
and North America, do not fit the reality of Mexico and 4) this is because it is hard to define 
what harm reduction is in Latin America.  
A strategy Barra and Espolea are using for promoting harm reduction at a political level 
without explicitly using the term is to frame the concept within other, already accepted, 
discourses. One example is the ‘don’t drink and drive’ policy as earlier described. Other 
discourses are those of prevention, HIV-prevention, health and sexual reproductive health. 
Luís Astorga (interview) describes harm reduction as policies that are preventive rather than 
punitive. 
Harm reduction interventions do exist in Mexico, albeit on a small scale and specifically in 
the north where injection opiate use is prevalent. These measures are run by NGOs and 
supported by the government or through private clinics (Philbin et al. 2009). They are not, 
however, very well known, and according to Barra it might be better that they stay that way 
due to the above mentioned reasons as well as to a hostile public opinion.  
The harm reduction movement promotes values that to a large degree are controversial. 
Conventional norms define drug use as an unwanted activity which is most often 
criminalized. In most countries propaganda against drugs defines the drug user as a criminal 
who should be rejected and punished. 
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The professionalization of the movement and the increased evidence-base of harm reduction 
interventions have led to the acknowledgement and implementation of harm reduction 
measures world wide despite an at times hostile public opinion. However, the humanistic 
values which lies at the heart of the philosophy of harm reduction are not that easily accepted. 
Heino Stöver tells how the evidence-base for harm reduction forced the dominating 
institutions in the drugs field in Germany to change their opinion about harm reduction 
measures, although they did not embrace the humanistic respect for the drug user and patient:  
“The main institutions who are the dominating actors in the field, they of course changed, 
and they couldn’t do anything else but change. Otherwise they would have lost credibility of 
course, and professionalism. The Deutsche Hauptstelle für Suchtfragen [...] they are the 
biggest actors in the field. And they changed the views, I would say, not completely, but they 
had to acknowledge that harm reduction, acceptance oriented drug work, substitution 
treatment, is a major, major thing. And now, when you look at for instance the opiate 
addiction treatment, it is clear to say that substitution treatment is the means of the choice, or 
the first choice treatment [...] Also these groups, the former prohibitionist oriented big 
umbrella organizations, like Deutsche Hauptstelle für Suchtfragen, there’s another one, 
Fachverband Drogen und Rauschmittel, in the end they’re quite conservative. And they have 
a patient image that to a large extent Akzept would not go with. Because they still believe, or 
they put the patient as non-conscious of their decisions and, so, somebody else has to decide 
for them. Our position is: It’s a patient, like any other patient with tumor or diabetes, they do 
their own decisions” (Heino Stöver, Akzept, interview).  
With this it becomes clearer that the evidence-based and cost-effective interventions can often 
be separated from the philosophy and humanistic values of harm reduction. This will be 
further discussed in the subsequent section, in relation to the logics and rationalities 
implicated in harm reduction.  
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4.4 Discussion 
The previous section showed that in Germany and at an international level harm reduction has 
been accepted into professional discourse due to its scientifically proved effectiveness in 
reducing drug related harm. This section goes on to examine the logics and rationalities 
employed in harm reduction to see if these can also have significance for the adoption of harm 
reduction interventions and discourse.  
Firstly, I draw on scholars who have criticized harm reduction for being in consistency with 
‘advanced liberal’ bio-political risk thinking in two different ways (in section 4.4.1.). The first 
critique targets one particular harm reduction intervention, namely methadone treatment, and 
highlights its functionality in maintaining social and moral order (Bourgois 2000), whereas 
the second set of critiques rather could be seen as a harm reduction movement’s critique of 
itself, targeting the particular knowledge and view of the drug user upon which harm 
reduction interventions are built – with a focus on (rational) individual behavioral change – 
which these scholars claim are in consistency with neo-liberal health discourses (Rhodes 2002 
and 2009, Moore 2004, Bunton 2001). The second set of critiques also propose a way to 
overcome these problems through taking into account dimensions of reality which have been 
neglected, thus offering a framework for creating ‘enabling environments’ for harm reduction.  
Secondly, I discuss how the consistency of harm reduction with ‘advanced liberal’ bio-
politics might have had significance for its elevation into official public health politics. Here I 
also suggest that the rationality of ‘risk thinking’ implicated in harm reduction interventions - 
together with their evidence-base - could be what makes these interventions adopted into 
official policy. Yet, the philosophy and values underpinning the harm reduction movement 
are not that easily accepted, and could thus be regarded as elements of opposition to the 
dominating drug political discourse.  
Lastly, I examine the harm reduction movement in relation to a broader shift in governmental 
rationalities in global politics implying a tendency towards governing through civil society 
organizations. Here I argue that there seems to be a process of outsourcing the responsibility 
for the health and welfare of drug users to harm reduction NGOs, which then become active 
and autonomous non-state partners in this particular task of government.  
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4.4.1 Harm reduction as forms of bio-power 
Several scholars have analyzed the emergence of harm reduction policies as being in 
coherence with a broader shift in power as ‘advanced liberal’ governmentality, and, more 
specifically, as ‘advanced liberal’ bio-politics.  
Harm reduction is dependant on a specific knowledge which focuses on distribution of harm 
in the population as an aggregation of individual risk factors (Rhodes 2009), where 
epidemiology has played an important role in measuring the ‘truth’ about risk distribution in 
the population and at-risk sub-groups and categories of individuals (Moore 2004). “Harm 
reduction discourses act as forms of ‘bio-power’ in the social regulation of danger emanating 
from drug use and drug users” (Rhodes 2009: 197). It is also argued that the emergence of 
harm reduction coincided both conceptually and historically with the ‘new’ public health 
movement, claimed to embrace a broader concept of health than the bio-medical perspective, 
in that it brought in social and environmental influences on health through ecological 
approaches (Rhodes 2002 and 2009, Bunton 2001, Moore 2004). The five principles of the 
new public health movement, which were embraced by the WHO, underlines the notion of a 
shift towards health being the responsibility of the individual and local communities with the 
role of the state being reduced to a facilitator: 
“The five principles are: developing individual and social skills; re-orienting health services towards 
improving access, availability and use; facilitating and strengthening community participation and 
collective action; creating local environments that are conductive to individual and community health; 
and, lastly, creating public policies supportive of health” (WHO 1986 in Rhodes 2002: 85).  
Rhodes goes on to argue that these principles are identical to those of effective harm 
reduction, which include “...responses which are rapid and pragmatic, community-based and 
community-level, and which develop user-friendly and low threshold services” (Rhodes 2002: 
86, emphasis in original). 
Furthermore, these ‘harm reduction-governmentality scholars’ criticize harm reduction for its 
different constructions of the drug user as a bio-political object or subject. In his ethnographic 
study Bourgois (2000) focuses upon the disciplining features of methadone treatment, making 
it an exceptional bio-political project of social control and moral discipline; creating docile, 
socially conform and self-controlled bodies of patients that are, if not made economically 
productive, at least pacified, controlled and managed, and no longer engaging in criminal 
activities and risky injection practices. Rhodes (2002, 2009), Moore (2004) and Bunton 
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(2001) rather focus upon the wider discourse of harm reduction as ‘new’ public health, and its 
individualized focus on behavioral change despite its rhetoric, constructing drug users as 
rational decision-making individuals capable of calculable risk-avoidance.  Harm reduction 
interventions, such as overdose prevention programs, are in this manner seen as ‘technologies 
of the body’ based upon an expert power/knowledge, targeting the behavior of injecting drug 
users through recommendations of risk-avoidance practices by means of peer-based education 
and health promotion (Moore 2004). This is specifically evident in the HIV-prevention 
discourse which views drug users more as ‘health consumers’ than addicts, implying a shift in 
discourse that Rhodes (2002) identifies to have found place in England in the 1980s. Harm 
reduction thus implies a kind of ‘risk thinking’ which Rose defines as “family of ways of 
thinking and acting, involving calculations about probable futures in the present followed by 
interventions into the present in order to control that potential future” (2001: 7). Harm 
reduction involves identifying risks related to drug use in order to manage and reduce them, 
with the goal of enhanced present and future health and well-being of drug users and 
communities.  However, those drug users failing to act responsibly, changing their risky 
injecting practices, will be labeled as ‘chaotic’ in the individualized risk discourse (Moore 
2004: 1554). 
Through focusing on ‘risk factors’62 and assuming their individual, rational avoidance, 
Rhodes (2002, 2009) and Moore (2004) claim that many harm reduction interventions will 
only be partly successful in reducing harm as they fail to take different social, cultural, 
economic, legal, policy and political contexts into account. Rhodes thus introduces the notion 
of ‘risk environment’ which he defines as “a space – whether social or physical – in which a 
variety of factors interact to intersect and increase the chances of drug related harm” (Rhodes 
2002: 88). A risk environment consist of both micro level aspects, such as social norms, rules, 
values, social relationships and networks, peer group and social influence, immediate social 
setting and local neighbourhood context, whereas macro level aspects include public and 
legal context such as economic, gender and ethnic inequalities, cultural organization of risk 
and harm and the ‘political economy’ of health (Rhodes 2002: 89). Through taking these 
aspects into account, it is possible to create ‘enabling environments’ for harm reduction 
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 For example Moore identifies these statistically evidence-based risk factors to be focused upon in the overdose 
prevention program in Melbourne where he did his ethnographic field work, where risk reduction advices 
focused on  avoiding these factors: “i) mixing heroin with nervous system suppressants (…); ii) being out of 
drug treatment; iii) using the drug under the conditions of changed tolerance (…); iv) using heroin by oneself; v) 
failing to call for assistance with an overdose of fear of arrest or because of lack of knowledge (2004: 1549).  
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interventions (Rhodes 2002). This conceptual framework is drawn upon by Ezard (2001) in 
her notion of the ‘vulnerability paradigm’ examined in section 4.2. As I will show in chapter 
6, this framework is also specifically significant for the relation between drug policy and 
human rights.  
Moore (2004) is very aware that such a conceptual framework can be seen as just another 
form of governmentality. Nevertheless, he claims that “…this should not prevent those of us 
working at the intersection of social science and drug policy from developing alternative 
frameworks that might produce less social suffering” (Moore 2004: 1555). Thus, the notion of 
‘risk environment’ is meant as “…a social science for harm reduction which first acts to 
reduce social suffering” (Rhodes 2009: 199), and which serves as a bridge-builder between 
“an anthropology of drug use and drug policy, and an anthropology for drug policy” (Moore 
2001: 1555).  
Bourgois’ study of methadone treatment has, however, a somehow different focus of critique, 
although he too draws the conclusion that the omnipresence of bio-power can not lead us to 
be practically paralyzed. His critique is not a ‘harm reduction movement’s critique of itself’, 
which is how I perceive Moore’s and Rhodes’ critiques, but it is rather directed against 
federally supported, private methadone clinics in the U.S., which explicitly rely on medical 
expert knowledge and which completely dismiss the drug users’ lived experience, social 
context and their opinion about their own treatment (a critique that could just as well be posed 
by the movement). It is a critique of expert discourses and practices which have grown out of 
one specific harm reduction intervention and its extensive (and particularly medical) 
evidence-base – a discourse which is disconnected from the principles and philosophy of 
harm reduction. Methadone treatment is maybe the one harm reduction intervention that has 
been most broadly accepted, next to needle exchange programs, by government officials 
around the world. Bourgois’ account of its features of social and moral control and its 
functionality in maintaining and securing social order (Bunton 2001) might just contribute to 
explaining why.  
4.4.2 The rationality and logics of harm reduction 
Following the argumentation of Rhodes (2002,2009), Moore (2004) and Bunton (2001) the 
rationalities and logics implicated in harm reduction policies and practices are just in line with 
those of ‘advanced liberal’ bio-politics and the political rationalities of ‘risk management’ – 
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rationalities which are already underpinning a range of other policy areas. Still, for the 
movement the humanistic values are at the core of these practices.  
The humanistic values cannot, however, be seen as a distinctive rationality next to the 
rationality of ‘risk management’. Rather, values are “…attached to and assembled with 
various technologies and techniques of government” (Dean 1999: 34). Values form part in 
‘regimes of practices’ and ‘mentalities of government’ which means that practices could not 
be merely seen as expressions of values (Ibid.). The values and philosophy (examined in 
section 4.1.) could, in line with the argumentation above, be seen as individually and liberally 
centered; with a focus on the rights of the individual drug user, their autonomy and freedom 
to make their own choices and to participate in decision-making concerning their own lives. 
Out of principles of solidarity and humanism drug users should be helped – but in a manner 
which respects their autonomy – they must be helped on their own premises63. Neumann & 
Sending note that the international sphere is being transformed by virtue of liberally oriented 
norms such as human rights, democracy and market economy (2010: 10). This account might 
show how such (similar) norms are also promoted by the movement in the field of drug 
policy.  
The field of drug policy has, however, been dominated by a discourse of zero-tolerance, 
which implies a different set of values. MacCoun & Reuter note that prohibition often has 
been justified in terms of ‘legal moralism’ where drugs are regarded as ‘mala in se’ (evil in 
themselves) and drug use as an intrinsically immoral activity
64
 (2001: 65). Prohibition has 
also been enforced on paternalistic grounds; not only for protecting the population against 
evil (or external and internal threats), but also to protect the individual from harming himself. 
This is a kind of thinking which could be seen to be in line with older forms of bio-politics, 
which sought to enframe the whole population within ‘apparatuses of security’ from cradle to 
grave, with a larger proportion of ‘pastoral power’.  
However, it may also be that although the legal justifications of zero-tolerance are framed in 
(old) terms of ‘protecting the population’, the practices serve to create the ‘advanced liberal’ 
dichotomy of inclusion and exclusion, where the subjective inability or lack of self-
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 As we will see in chapter 6, the values implicated in harm reduction practices highly resemble those 
institutionalized in the human rights paradigm.  
64
 One could also say that in Durkheimian terms prohibition would serve the purpose of demarking and 
maintaining the moral boundaries of society, and thus the ‘conscience collective’.  
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government is framed in terms of immorality. Those who cannot or will not subject to what 
Rose calls the ‘new morality’ of appropriate conduct are excluded, criminalized and 
‘governed through crime’ (Rose 2000: 336). Drug users are regarded as individuals who 
cannot govern themselves in a responsible manner, unable or unwilling to manage their own 
risk. Following Rose, they are excluded, and thus subject to two kinds of control strategies; 1) 
strategies of reaffiliation, which seek to responsibilize the individual (or community) through 
the principle of activity and empowerment, bringing them back to the circuits of inclusion or 
2) for those who are deemed impossible to reaffiliate, strategies of management or 
neutralization are invoked (like for instance incarceration, preventive detention, custodial 
institutions etc.) (2000: 330).  The governing of drug users through crime is also particularly 
accelerated through the penal populist discourses of being ‘tough on crime’ as well as the 
rhetoric of the ‘war on drugs’ (Rose 2000).  
The humanistic values of acceptance and respect for autonomous choices could be said to be 
elements of opposition to a punitive drug political discourse, although Hunt (2003) notes that 
harm reduction in itself is neutral to the legality of drugs. The harm reduction movement is 
also contesting both the boundaries of the circuits of inclusion and the ‘new morality’ based 
on ability or will to self-control. Values and morality lies at the heart of the movement, but 
central to these values is inclusion of any human being regardless of their ability or will to 
self-government. Still, however, the movement also claims that drug users are capable (and 
willing) of their own risk-management if assisted or if given the individual, social and 
structural opportunities for such risk-management. But self-government should not be a 
condition for being included into society or for having ones rights and autonomy respected. 
There are reasons to believe that there are certain aspects of the rationality and logics of harm 
reduction that more easily appeals to policy-makers and translates into official policy 
discourse than others. Besides humanistic values, Hunt claims that harm reduction is 
underpinned by the principles of pragmatism, focus on harms, balancing costs and benefits 
and the priority of immediate goals (CCSA 1996 in Hunt 2003: 3-4). Such principles could 
easily appeal to (and as I have argued, it is a part of) an ‘economic rationality’ of government.  
However, whereas the harm reduction movement promotes harm reduction measures because 
of their humanistic values to help people that are suffering from harms, politicians might 
accept the initiation of these measures for different reasons. 
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Dirk Schäffer claims that one successful outcome of the German harm reduction movement is 
that the politicians accepted the initiation of safe injection rooms. However, their acceptance 
was rooted in different reasons than of the movement:  
“I don’t know if that changed their view really, but they look that the cities are clean. And 
when it is important to have a safe injection room that the city is clean […] And that is their 
main goal, it is not from the personal human perspective, it is from a political perspective. 
They didn’t totally change their view, but what happens is that they accept that things work 
that they don’t like. But the things work and that changed in Germany and that is a main 
thing. It is not that important that something change in their heads, their view. It would be 
good, but it’s not that an important thing. In my view” (Dirk Schäffer, Deutsche AIDS-Hilfe, 
JES, interview).  
The safe injection room is thus accepted by the politicians because it would make the city 
‘look clean’; it manages the problem of public nuisance. Another argument that could appeal 
to the politicians is that safe injection rooms would (cost-effectively) reduce the prevalence of 
morbidity and mortality among injecting drug users, which saves economic costs for 
treatment etc. in other parts of the health system. 
The bio-political perspective could also help to explain why the harm reduction argument 
about reducing the prevalence of HIV in the population, more than any other argument for 
harm reduction, has had such a great resonance within political structures such as European 
states and international institutions such as the EU, the WHO and the UNAIDS. One could 
say that the medicalization of the drug problem to make it a public health issue together with 
the securitization of the HIV epidemic, which has made HIV being regarded as a larger risk to 
security than drug use per se, has legitimized harm reduction as a bio-political project.  
It might also help explaining why the argumentation in Mexico, where drug use is not that 
directly or obviously connected to the HIV-prevalence in the population, does not have a 
similar resonance within the government. As Aram Barra says, politicizing the philosophy of 
harm reduction in Mexico might be a bad strategy. The Mexican government is also primarily 
concerned with reducing a very different risk, namely the major risk of organized crime, 
rather than that of health harms to drug users.  
Although the humanistic values which the movement advocates might not be that easily 
translated into official policy discourse as the more ‘economic rational’ principles of cost-
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effective risk management, the movement’s devotion to humanistic values might make them 
particularly responsible partners to which the task of taking care of the health and welfare of 
drug users can be outsourced.  
4.4.3 Governing through harm reduction NGOs 
Rose argues that due to the withdrawal of direct state interventions in health, the ‘will to 
health’ in contemporary bio-politics is managed by a variety of different actors and “…a 
whole range of pressure groups, campaigning organizations, self-help groups [that] have 
come to occupy the space of desires, anxieties, disappointments and ailments between the will 
to health and the experience of its absence” (2001: 6).   
The harm reduction movement consists of groups focusing on political advocacy, groups 
focusing on doing harm reduction ground work and running interventions, and groups that do 
both. The German NGOs have developed from harm reduction outreach work, running 
treatment facilities, and engaging in grass-root advocacy, to be professionalized networks 
over the course of the last decades, but who also still organize harm reduction interventions 
(Stöver, interview). The German JES network is engaged in initiating self-help groups for 
active users, ex users and people in substitution treatment all over Germany, and Fixpunkt is 
running low threshold interventions in Berlin. Stöver (interview) tells that there have become 
a lot of self-help groups in Germany from the 1980s onwards, which also have affected health 
political decisions. The Mexican NGOs seem to go the other way around, developing as 
political advocacy networks and increasingly engaging in harm reduction ground work. Barra 
tells me that as the obtainment of information is so hard in Mexico, which makes political 
work difficult, Espolea is now planning to do recreational and stimulant harm reduction 
outreach work and HIV-prevention work on the party scene and in the gay communities in 
Mexico City.  
It seems that Scandinavia is exceptional in the sense that local and national authorities are 
initiating and running harm reduction measures. My experience is that harm reduction 
interventions outside of Scandinavia to a large degree are initiated and run by NGOs and civil 
society groups themselves, funded to a varying degree by local or/and national authorities
65
.  
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 This is also confirmed by Cook who writes that civil society organizations are the primary providers of HIV 
prevention, treatment and care in many countries (2010: 7). What funding is concerned, the EuroHRN survey for 
instance finds that NGOs in many Eastern European countries do not have resources to do political work as they 
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It might then seem that the responsibility and care for the health and well-being of drug users 
in many countries is outsourced to private actors, such as different civil society groups. One 
reason for this might be that the NGOs possess both the local knowledge and the expertise 
necessary to carry out this task, which the state in turn might lack. Furthermore, making use 
of the existing expertise could save costs in the state or municipal budget at the same time as 
the NGOs, which are governing by virtue, would see to it that their limited resources are used 
as efficiently as possible. It might be that the ‘social’ or ‘welfare’ states have discovered their 
limitations in providing for each and all – seeing that this task is impossible as there are 
constant, endless demands to be met (Neumann & Sending 2010: 38) – and are now seeking 
to free themselves from the responsibility and to ‘steer and regulate’ rather than ‘row and 
provide’ (Rose 2000: 324); through creating the framework but outsourcing the responsibility 
to non-state actors. In some countries that have been characterized as having ‘progressive’ 
drug policies, such as certain European countries and Australia, harm reduction NGOs are 
engaged in both forming and implementing official policy, which becomes particularly 
evident in this quote from the President of the Institute of Drugs in Portugal in his foreword to 
the European Harm Reduction Network report:  
“The multi-faceted dimension of the issue and the interaction between diverse areas of public health 
services (Protection Services, Education, Employment, Housing, amongst others) demand holistic 
approaches – and partnership. When it comes to harm reduction, civil society organizations, with their 
specific local knowledge and relationships with those most at risk, are often the most appropriate 
entities to implement these types of interventions (...) This public-social partnership (which also 
includes the private sector) has enabled positive results not just in relation to drug use and health harms, 
but across a wide range of important areas; and not just to individuals, but to communities:  
 A reduction in drug-related crimes, and a greater sense of security in the community 
 A reduction in discarded drug paraphernalia in the community  
 A reduction in risk behavior and the subsequent reduction in the transmission of infectious 
diseases – central to our public health priorities 
 Improved data quality and research on the prevalence and incidence of various infectious 
diseases among people who use drugs, which in turn informed programmes.  
                                                                                                                                                        
prioritize running harm reduction measures – exclusively funded by international funds (Stoicescu & Cook 
2011). In Germany, however, most of the funding of the NGO run harm reduction interventions comes from 
local or national authorities. An exception is opioid substitution therapy that in many countries is administrated 
through general practitioners or state run clinics. Still, there are also many countries where NGOs are the only 
providers of substitution medication.  
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The constant dynamic interaction between the IDT
66
 and civil society organizations clearly translates 
into added value and gains for both sides. These gains are in turn fostering increased knowledge and 
understanding of drug use and related harms in Portugal (...)” (Foreword by João Castel-Branco Goulão 
in Stoicescu & Cook 2011: 6).   
Just as Nikolas Rose (2001) argues that ‘advanced liberal’ bio-politics hold some 
fundamentally new features, among other through involving a variety of (non-state) actors as 
responsible ‘partners’, Neumann and Sending (2010) identify a change in governmental 
rationalities through examining the character and role of NGOs in international politics. They 
claim that the role of NGOs have changed from being “passive objects of government to be 
acted upon and into an active entity that is both and object and a subject of government” 
(Neumann & Sending 2010: 115). They paraphrase Burchell to claim that civil society is 
governing by virtue in a ‘contractual implication’ where the latter means; 
“offering individuals and collectivities active involvement in action to resolve the kind of issue hitherto 
held to be the responsibility of authorized governmental agencies. However, the price of this 
involvement is that they must assume active responsibility for these activities, both for carrying them 
out and, of course, for their outcomes, and in doing so they are required to conduct themselves in 
accordance with the appropriate (or approved) model of action. This might be described as a new form 
of ‘responsibilization’ corresponding to the new forms in which the governed are encouraged, freely 
and rationally, to conduct themselves” (Burchell 1996 in Neumann & Sending 2010: 114-5).  
Neumann & Sending argue that NGOs’ goals and functions are integral to late modern 
practices of governing and thinking, and also that  
“…the self-association and political will-formation characteristic of civil society organizations do not 
stand in opposition to the political power of the state but are instead a central feature of its exercise: 
Civil society organizations are constituted as self-associating units – through ‘technologies of agency’ – 
whose political significance resides both in their capacity to convey and mobilize the preferences and 
concerns of individuals and communities, and in their capacity to carry out regulatory functions” (2010: 
115). 
The new governmental rationality implies governing through NGOs, which is made possible 
because the NGOs are themselves subjects of government. 
Through a case study of international population policy Neumann & Sending (2010) identify 
a shift in the character and role of NGOs from the 1980s onwards, which coincides with the 
emergence of a new governmental rationality.  
                                                 
66
 Institute of Drugs and Drug Addiction (Instituto da Droga e da Toxicodependência, IDT).  
62 
 
Until the two last decades of the twentieth century the main role of NGOs (only some types of 
NGOs were seen as central) was to conduct research and produce and disseminate knowledge. 
Most notably, whereas individuals in general were seen as free and autonomous individuals, 
some were rather seen as objects of government whose behavioral pattern needed to be acted 
upon (which was particularly the case for individuals in developing countries). Through 
(Western) knowledge and expertise as a prerequisite for governing, NGOs would seek to 
change behavior of certain groups in the name of assistance to development.  
From the 1980s onwards however, other types of non-state actors emerged; actors that 
claimed to represent certain societal groups of affected individuals and on their behalf 
advocate their rights. Individuals were no longer merely objects but also subjects with 
autonomy and rights. Central in this regard was the idea of ‘implementing the user’s 
perspective’ as “...these actors assumed identities and action-orientations in keeping with the 
belief that governing is most effectively pursued by enrolling actors who can ground 
governmental efforts in such a way as to render their content consistent with the self-identity 
of these individuals as autonomous actors” (Neumann & Sending 2010: 120). Neumann & 
Sending do note that these ‘new’ NGOs also came to hold key governing roles in service 
delivery, advocacy and expertise (2010: 119); they would be welcomed into relations with 
governmental agencies as partners.  
The case which Neumann & Sending (2010) base this analysis on is the new ‘reproductive 
health and rights approach’ advocated by the transnational women’s health movement. Still, 
harm reduction, and the issues of drug users’ health and rights, are controversial in global 
policies as they collide with the zero-tolerance discourse. Although the last decades have 
witnessed an increased support for harm reduction and an increase in governing through harm 
reduction NGOs, there are still many countries which actively oppose even the term harm 
reduction.  
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4.5 Conclusion 
In this chapter I have shown how harm reduction can be understood both as a philosophy, 
with a set of values purported as universal, and as a set of policies and interventions which are 
context dependant, but which nevertheless embody principles which could also be seen to 
have universal application. 
Furthermore, I examined the development of harm reduction policies and of the harm 
reduction movement, and discussed reasons for the adoption of harm reduction discourse and 
practices into official public health policies.  
Lastly, I argued that harm reduction rationalities and logics are consistent with ‘advanced 
liberal’ governmentality and bio-politics - of broader ways of thinking and acting in late 
modern societies, which can also partly explain the tendency towards governing through harm 
reduction NGOs. I also claimed that although harm reduction in itself is neutral to the legality 
of drugs, its values of acceptance, tolerance and respect for drug users’ individual autonomy 
and rights, contrasts to the discourse of zero-tolerance which has dominated global drug 
policies.  
This chapter has shown how the view of drug use as a differentiated phenomenon, and drug 
addiction as a social and health problem, has gained momentum in global drug policies and 
has become partly incorporated into official public health discourses. I have also examined 
the role of collective agency in these processes.  
In the subsequent chapter I go on to examine what I call the global ‘drug control discourse’, 
which currently is dominated by prohibition, and inquire how the drug law reform movement 
goes forth to transform this discourse.  
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5 Drug Law Reform 
In the last chapter I addressed one of the drug policy reform movement’s main goals, namely 
the implementation of comprehensive harm reduction policies. I noted that harm reduction 
policies are in themselves neutral to questions regarding the legality of drugs. However, a 
large part of the drug policy movement is also in favor of some sort of drug law reform. This 
chapter will thus deal with what I call the ‘drug law reform movement’ although I will also, at 
times, refer to the drug policy reform movement as a whole on issues concerning the 
movement in total.  
In the first section of this chapter I outline the possibilities for drug law reform. First, I 
present the problem construction upon which the global prohibition regime is built and go on 
to briefly account for the international legislative framework of the three UN drug 
conventions. Second, I account for the national room for maneuver under the conventions. 
Third, I elucidate what could be called a ‘trend towards decriminalization’, accounting for 
how drug law reforms have occurred in many countries – however, within the framework of 
the UN conventions. Fourth, I present propositions for de jure legalization of drugs with 
models of government regulation posed by one NGO in the movement.  
The second section examines the movement’s argumentation for drug law reform. First, I 
briefly present what I perceive to be the main argument of the movement, namely the harms 
and costs resulting from drug prohibition and its enforcement. Second, I go on to account for 
how drug law reforms have occurred in the cases of Mexico and Germany, as well as how my 
interviewees assess and argue that these changes are insufficient. This account serves to 
outline and clarify two other main goals of the movement, namely the ‘complete’ 
decriminalization of drug users and the introduction of the debate about alternative regulation 
of drugs in general and cannabis in particular.  
In the third section I investigate how the drug law reform movement goes forth in influencing 
a change in the global drug control discourse. First, I account for how the movement tries to 
influence the discourse of the UN drug control organs. Second, I discuss the role of powerful 
allies through examining the Latin American Commission on Drugs and Democracy as well 
as the Global Commission on Drugs, their relation to the movement and their significance in 
terms of instigating change. Third, I discuss several factors that act like barriers to further 
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change of the drug control discourse, specifically focusing on public opinion and political 
benefit. 
In the last section I discuss global drug control in a governmentality perspective. First, I argue 
that the models for de jure legalization with government regulation could be seen as a 
prospect for how drug control could look like if ‘advanced liberal’ governmental rationalities 
were to be at work in this task. Second, I examine the current system of drug control in a 
governmentality perspective – and claim that it can be seen as an ‘authoritarian’ form of 
governmentality, but also that the rationalities of current drug control agencies should be seen 
not as one, but as a myriad, of system-internal rationalities and logics – which are significant 
if barriers to change are to be investigated. Lastly, I suggest one way of how the amendment 
of the drug control discourse can be understood generally, and more specifically by looking at 
the role of the drug policy reform movement in this process. Moreover, I argue that also in the 
drug control institutions is there a tendency to govern through the drug policy reform 
movement, albeit in a different manner than in the health institutions.  
5.1 How can drug law reform occur? 
This section will deal with different kinds of and possibilities for drug law reform. First, the 
current international legal framework will be dealt with. Second, the different forms of drug 
law reform which the movement is advocating will be dealt with, divided into 1) 
decriminalization of use, possession and production of drugs under the current legal 
framework and 2) de jure legalization of drugs with models of government regulation. 
5.1.1 The international legal framework of drug prohibition 
This section shortly deals with the construction of the problem which the prohibition is meant 
to address as well as give a brief description of the legal framework of international drug 
prohibition.  
The global prohibition regime is necessarily built upon a specific perception of the nature of 
the ‘drug problem’. According to Boister prohibition is built upon the understanding of drug 
use as medical and social pathology (Boister 2001: 5). The medical harms of drug use to the 
user, to children and to others such as brain damage, injuries and violence as well as the 
social harms, such as welfare expenditures, crime rates, violence, joblessness and child abuse, 
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justify the prohibition of drugs (Ibid.). Furthermore, drugs are in themselves construed as a 
moral evil to society and mankind to be fought with all means. Said in other words the 
deontological position of prohibition is a ‘legal moral’ view (MacCoun & Reuter 2001: 4). 
Christie & Bruun (1968, 2003) note that whereas for alcohol problems the general view is that 
certain individuals are predisposed for developing problems, for so called narcotic drugs it is 
the drug itself that is identified as the danger and the problem.  
The ‘drug problem’ has been defined in terms of supply and demand. However, many note 
that the ‘threat of drugs’ has been fought mainly through supply reduction (Boister 2001, 
Sinha 2001, Barrett et al. 2008, Foucault 2008), which is also the reason for the 
internationalization of drug prohibition
67
 (Boister 2001: 4). Subsequently the three UN drug 
conventions which constitute the international legal framework of drug prohibition will be 
briefly accounted for.  
1) The Single Convention on Narcotic Drugs of 1961 (with Protocol Amending the Single 
Convention on Narcotic Drugs of 1972) gathered and replaced all earlier international 
agreements regulating drugs
68
 . It was created “as a universal system to control cultivation, 
production, manufacture, export, import, distribution of, trade in, use and possession of illicit 
substances” (Jelsma 2004b: 6). It specifically prohibits the plant-based substances; 
opium/heroin, coca/cocaine and cannabis; which it schedules in four schedules according to 
varying degrees of control (Ibid.). The preamble of the Single Convention outlines the 
objective of the convention, which is to protect the “health and welfare of mankind”. 
Furthermore, the States Parties must recognize that “addiction to narcotic drugs constitutes a 
serious evil for the individual and is fraught with social and economic danger to mankind”, 
thus their duty is to “prevent and combat this evil” through “co-ordinated and universal 
action”.   
2) The Convention on Psychotropic Substances of 1971 was created primarily as an answer to 
the concern about a rise in the use of synthetic drugs, such as amphetamines, ecstasy, LSD 
                                                 
67
 Boister notes that: “Given that supply follows demand, it would seem logical for the international system to 
address the reasons why people take drugs. The difficulty is that, other than the rather blunt step of criminalizing 
use and possession, using the criminal law against drugs offers few effective options for dealing with demand” 
(2001: 4-5) 
68
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and illegal use of benzodiazepines, which it also distributes into four schedules
69
. Jelsma 
notes that “[a]n important purpose of the first two treaties is to codify internationally 
applicable control measures in order to ensure the availability of drugs for medical and 
scientific purposes, while preventing their diversion into illicit channels” (2004b: 6). 
3) The Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 
1988 is specifically concerned with the trafficking in illegal drugs. It thus creates provisions 
against money laundering, diversion of precursor chemicals and agreements on mutual legal 
assistance (Jelsma 2004b: 6). It also goes further than the other treaties in obliging States 
Parties to impose penal sanctions for production, trafficking and possession (Ibid.).  
5.1.2 Decriminalization  
In the current legal framework of the three UN conventions a certain room for maneuver is 
permitted, however, almost exclusively on the demand side. First, this space for national 
autonomy will be accounted for briefly in relation to 1) production and 2) consumption. 
Second, I will deal with how countries increasingly have taken advantage of this room for 
maneuver to change their domestic drug control, especially in relation to drug use. The latter 
will be framed in the terms of a ‘trend towards decriminalization’.  
Room for maneuver under the UN Drug Conventions 
The 1988 Convention leaves little room for maneuver on the production side other than 
production for scientific and medical purposes (Jelsma 2004b). There is, however, a reference 
to the fundamental right of indigenous people to traditional consumption
70
, although Jelsma 
states that “[i]t is doubtful, however, whether the ambiguously defined exception offers any 
production-side room for maneuver beyond cultivation for personal traditional use” (Jelsma 
2004b: 13).  
On the consumption-side the conventions leave more space for national interpretation, 
although this space is limited (Jelsma 2004b: 12). In addition to legality of drug activities for 
medical and scientific purposes, the signatory states are not obliged to criminalize drug use 
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per se. Furthermore, the acts under paragraph 2 in Article 3 of the 1988 Convention; 
possession, purchase, or cultivation of narcotic drugs or psychotropic substances, are subject 
to constitutional principles, which thus leaves “...a range of legal options with regard to how 
they [countries] treat preparatory acts for personal consumption” (Jelsma 2004b: 12). 
Although the conventions oblige the signatory states to impose penal sanctions, they do not 
require imprisonment to be imposed on drug users (Jelsma 2008).   
A ‘trend towards decriminalization’ 
This room for maneuver or ‘loopholes’ under the UN conventions has allowed for certain 
differentiation in domestic drug control strategies, although the conventions also oblige 
signatory states to loyal enforcement.  How countries have used this space of autonomy will 
be briefly accounted for in this section.  
How the conventions have been implemented into national criminal laws varies widely. As 
most countries impose serious punishment for drug offences regarded as grave, such as 
trafficking, there is more variation in relation to personal consumption and preparatory acts 
for personal consumption. Some countries have never criminalized drug use per se as they 
have found it to be unconstitutional
71
, although they might have punitive reactions for 
preparatory acts which in reality criminalizes the drug user as the ability to consume a drug 
necessarily requires the acts of purchase and possession (Böllinger 2001).  
Jelsma (2009) identifies five emerging trends in global drug policies (meaning: in national 
drug policies across the world), namely in relation to: 1) decriminalization of drug users 
(which will be examined more thoroughly under); 2) alternatives to incarceration, implying 
increased use of drug courts and ‘treatment instead of punishment’ as well as focus on 
innovative resocialization strategies in order to decrease drug-related crime; 3) 
proportionality of sentences, entailing a trend towards harsher penalties and minimum 
sentences as well as an increase in capital punishment for drug offences on the one hand, 
albeit a trend towards differentiation between use, micro-trade, transport/courier and mid-
level trading and organized trafficking (especially implying differentiation between 
user/trafficker); in sentencing and jurisprudence on the other hand 4) harm reduction, 
witnessing an expansion in harm reduction strategies and interventions world wide as well as 
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an increased acceptance of such measures (in some countries this necessarily has implied a 
change in national laws to allow for such measures); and 5) reclassification of substances, 
denoting a differentiation between cannabis and other drugs in legislation or/and prosecutorial 
guidelines, treating the first much less severely.  
Decriminalization of drug users through decriminalization of drug consumption and/or 
absolving drug users from arrest and prosecution for preparatory acts like acquisition, simple 
possession or cultivation for personal use has occurred in many countries
72
. This has mainly 
happened in order to lighten the pressure on law enforcement agencies and the penitentiary 
system, which in most countries have been overcrowded, partly due to harsh enforcement of 
drug laws (Jelsma 2009). This trend towards softening the criminal control of drug users have 
primarily taken place in European countries as well as Australia and some states in the United 
States, and is lately gaining momentum in Latin America. These countries are thus focusing 
on the distinction between possession for personal consumption and possession with intent to 
supply, where the first would lead to either no prosecution or to administrative sanctions, 
while the latter would lead to prosecution and punishment (Ibid.). The way in which this is 
determined also varies. While some countries set quantity thresholds, other leaves the 
determination to the discretion of the judge or the prosecutor in each specific case, following 
certain guiding principles and criteria (Ibid). For examples of quantity thresholds and national 
practices, see Appendix 9.3. 
Böllinger claims that the trend towards decriminalization in Europe can be divided into three 
models: 1) formal procedural law decriminalization
73
, 2) de facto and informal practices of 
not enforcing law
74
 and 3) substantive law decriminalization
75
 (Böllinger 2004: 499).  
There is also what might be called a ‘trend’ in Latin America of Supreme Courts trying the 
constitutionality of the criminalization of drug possession, which in the case of Argentina was 
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found unconstitutional. Bolivia has recently withdrawn from the Single Convention due to the 
unconstitutionality of the coca leaf ban. This theme will be further examined in the next 
chapter.  
States are also increasingly allowing for medical marijuana, where the most prominent cases 
have been thirteen American states allowing for medical marijuana in their jurisdictions 
despite the Federal U.S. government listing marijuana as a schedule I substance. 
Most of the law changes mentioned above have occurred the last decades, which I argue could 
be called a ‘trend towards decriminalization’. However, all these changes have been made 
within the legal framework of the three UN Drug Conventions, utilizing loopholes and 
national room for maneuver (except for the case of Bolivia). Thus the global prohibition 
regime, which the conventions constitute, is still standing firm.  
Rolles claim that the UN conventions are taken for granted, but that it does not necessarily 
have to be so:  
“Yet prohibition has become so entrenched and institutionalized that many in the drugs field, even those 
from the more critical progressive end of the spectrum, view it as immutable, an assumed reality of the 
legal and policy landscape to be worked within or around, rather than as a policy choice” (Rolles 2011: 
60).  
Rolles thus tries to draw attention to the fact that “[l]aws – and even the international 
Conventions – are not written in stone; they can be changed when the democratic will of the 
nations so wishes it” (World Drug Report 1997 in Jelsma 2004b: 1). 
This section has examined different forms of ‘decriminalization’ strategies possible within the 
current juridical framework of the three UN drug Conventions. The next section will examine 
how drug control could look like in the case of total amendment or abolition of the current 
prohibition regime and punitive legal framework; through de jure legalization of drugs. 
5.1.3 De jure legalization of drugs with models of government regulation 
This section deals with legalization of drugs, implying at least total amendment of the three 
UN Drug Conventions. As I will show, the position taken by ‘legalizers’ does not imply a 
totally unregulated drug market, but rather an alternative regulative legal framework other 
71 
 
than criminal law
76. In this regard I will draw on Stephen Rolles “After the War on Drugs: 
Blueprint for Regulation” (2009)77, which some of my interviewees from both Mexico and 
Germany claim that they use as a model and tool for their advocacy. 
Although it is impossible to assess how a completely different scenario of drug regulation 
would look like, I will argue that the publication “Blueprint for Regulation” (Rolles 2009) to a 
large degree changes the terms of the debate as it offers a tangible and detailed proposal for 
how different aspects of the drug market – from production to consumption – should be 
regulated and dealt with.  
The book suggests five main models for legal regulation of drugs, which it assesses in detail, 
in a continuum between the poles of harshly enforced prohibition and unregulated, free 
markets. These are presented from strong to low degree of state regulation, through exploring 
all options for… 
“…controls over aspects of production/supply, availability, and use. This includes control over products 
(dosage, preparation, price, and packaging); vendors (licensing, vetting and training requirements, 
marketing and promotions); outlets (location, outlet density appearance); where and when the drugs can 
be consumed and; […] who has access to the legally regulated availability including age controls, along 
with explorations of licensed buyer and club membership across models” (Rolles 2011: 63).  
The models in the book are based on experiences from legal regulation of tobacco and alcohol 
as well as controls over pharmaceutical drugs. Rolles (2009) suggests that the transition from 
prohibition to regulation of drugs should be slow and closely monitored and continuously 
evaluated by researchers, while potential new challenges should be dealt with consecutively. 
He recommends a first step in the transition process to be the strongest regulated model (an 
expansion of the pharmaceutical control of today), while a gradual liberalization of controls 
could occur regarding the less risky products, following a ‘risk-availability gradient’ (Rolles 
2011: 64). This, he claims, would encourage a move towards safer products, behaviors and 
using environments (Ibid.). Rolles’ proposal of regulation models will be examined and 
discussed more thoroughly in the last section of this chapter.  
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5.1.4 Concluding remarks 
In this section I have presented 1) the current legal framework of drug prohibition, 2) 
decriminalization under the current legal framework, and 3) legalization with alternative 
regulative frameworks. The two latter are main goals of the drug law reform movement. My 
experience is that while parts of the drug law reform movement advocate decriminalization, 
other parts advocate legalization, a large part also advocate both, although with shifting 
emphasis. Still, I have chosen to unite these positions and goals under the umbrella of ‘drug 
law reform movement’. This is because I perceive the boundaries between the positions to be 
somehow blurred, as the aspect of primary importance to the movement seems to be that there 
is a change in discourse and drug law reform at all
78
. In the following section, the reasons 
why the movement advocates drug law reform will be examined.  
5.2 Why is the movement advocating drug law reform? 
This section first examines what I perceive to be the main argument for drug law reform 
posed by the drug law reform movement, namely that the global prohibition regime has not 
only failed in reaching its goals of creating a drug free world, but also that it creates more 
harms than it stems, in section 5.2.1. Second, I examine the cases of Germany and Mexico, 
where drug law reforms have occurred, and show how my interviewees argue that these 
changes are insufficient, in section 5.2.2. This account also serves to outline how 
decriminalization should look like according to the movement, as well as to outline the goal 
of introducing the debate about alternative drug control. 
5.2.1 The harms and costs of drug prohibition 
MacCoun & Reuter (2001) call such a position a ‘consequentialist’ position which 
emphasizes a utilitarian model of regulation that leads to the best total consequences for both 
drug users and society as a whole. Another type of argument for drug law reform can emanate 
from a ‘deontological liberal’ position emphasizing the inherent freedom of the individual to 
hurt oneself. The latter position will rather be examined in the subsequent chapter, in relation 
to the argumentation for civil and human rights.  
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The last chapter examined harms stemming from drug use, or rather drug-related harms and 
risks as well as vulnerability for such harms and risks, following three levels; individual, 
community and structural level (Ezard 2001). This chapter will rather deal with the harms 
created by prohibition by the enforcement of prohibition
79
. Following Ezard (2011) I will 
present examples of the harms and risks stemming from prohibition and law enforcement on 
three levels; individual, community and societal/structural level. The examples will be based 
on my interviews as well as literature written by my interviewees. 
At the individual level incarceration and punishment of drug users (mostly cannabis users) 
leads to harms such as bad relationship with parents, teachers and disadvantages in the labor 
market (Stöver, interview) as well as low self-esteem as result of stigma. Fear of arrest and 
criminal sanctions (due to law enforcement stressing of drug scenes and police presence near 
harm reduction interventions) can also lead to risks, such as risky individual modes of use, 
which enhances the chance of infection with life threatening diseases and overdose (Schäffer, 
interview). 
At the community level fear of arrest and criminal sanctions creates barriers for access to 
health services (Barra & Joloy 2011, Schäffer, interview), leading to risky patterns of drug 
user behavior. Fear of arrest and criminal sanctions also lead drug dealers to develop different 
strategies to omit arrest - that are harmful to third parties. For example drug dealers in Berlin 
send their little brothers under 14 years of age to sell drugs for them, as they cannot be 
punished (Schäffer, interview). In Mexico the violence resulting from law enforcement efforts 
to stem up drug cartels leads to breakdown in families and communities (Barra & Joloy 
2011).  
At the structural level prohibition and law enforcement has led to massive incarceration rates, 
primarily of drug users and small scale dealers as well as blurred the boundaries between drug 
policy and security policy (Barra, interview). This has created overcrowded prison conditions 
in many countries – leading prisons to be hotbeds for the spread of  HIV and other diseases as 
prisons often are reluctant to implement harm reduction interventions such as needle 
exchange or substitution treatment (Stöver, interview). The massive levels of violence 
experienced in among other Mexico due to powerful criminal organizations as well as 
militarization and law enforcement efforts to stem drug cartels has damaged the social, 
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educational, health and political infrastructure of the country (Barra & Joloy 2011). 
Stigmatization and marginalization of drug users due to prohibition leads to the risk of 
making drug users easy victims for structural violence and human rights abuses (Barra & 
Joloy 2011). 
The above mentioned harms and risks are merely some examples of the over all harms and 
risks stemming from prohibition and law enforcement. According to transnational drug law 
reform campaign ‘Count the Costs’80 the harms and risks stemming from the global 
prohibition regime constitute seven main areas of global problems, as it 1) undermines 
development and security and fuels conflict, 2) threatens public health and spreads disease 
and death, 3) undermines human rights , 4) promotes stigma and discrimination, 5) creates 
crime and enriches criminals, 6) leads to deforestation and pollution and 7) wastes billions on 
drug laws and enforcement
81
.   
Thus, the negative consequences of the global drug prohibition regime affect a number of 
policy areas, such as development policy, security policy, international relations, public 
health, international law, social policy, criminal policy, environmental policy and economic 
policy.  
A large part of the advocacy work of the drug law reform movement involves documenting 
these harms and make them known both to policy-makers and to the general public. As I will 
show in the subsequent chapter, many of these harms are also increasingly framed in terms of 
human rights abuses. According to ENCOD
82
 president Frederik Polak, the UN has officially 
acknowledged these harms as what they call ‘unintended consequences of prohibition’, and he 
goes on to ask: “How long will they remain unintended?” (2012).  
This section has attempted to give a broad and brief overview over the harms and risks 
resulting from the global prohibition regime and its enforcement. The purpose of this section 
was not to present an exhaustive list of harms, which would be too extensive for the scope of 
this thesis, but rather to outline the contours of the main argument for drug law change. 
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The next section could be seen as an example of the drug political complexity through 
examining two cases of countries that have gone through drug law changes or procedural 
changes in direction of decriminalization. Through drawing on the critiques of my 
interviewees, I show how these changes are claimed to be insufficient. 
5.2.2 Insufficient drug law change  
In the last section I presented some examples of harms and risks stemming from prohibition 
and law enforcement based on my interviews and literature written by my interviewees. 
However, both Germany and Mexico are countries that have gone through drug law change 
and/or procedural change in relation to drugs – which by some has been called 
‘decriminalization’. In this section I will present these changes and account for how my 
interviewees argue that these changes are insufficient.   
The case of Mexico 
Mexico passed a new drug law in 2009, the so called ‘Ley de Narcomenudeo’, proposed by 
the president Felipe Calderón. The law distinguishes between drug use, small scale dealing or 
‘narcomenudeo’, and large scale drug trafficking. The law establishes quantity thresholds (see 
appendix 9.3) which are allowed to possess. However, consumption, purchase and sale remain 
illegal (Barra 2010: 12).  A person carrying the allowed quantity will still be detained and 
presented before a judge, which will determine whether the detainee has a problematic use, 
and thus will be directed to treatment, or if he does not have a problematic use, which in case 
will leave him with a warning (Barra 2010). However, if caught three times the detainee will 
have a choice between ‘voluntary’ treatment or a criminal sanction (Ibid.).  
Jorge Hernández Tinajero (interview) is positive to the differentiation between use and 
trafficking and claims that this constitutes an acknowledgement that drug use is a matter of 
public health, and at least a starting point for a differentiated policy, although CUPIHD 
criticizes the quantity thresholds for being too low (Luís Astorga, interview). Aram Barra 
(interview) is, however, more critical when assessing that the differentiation between user and 
trafficker is either constructing the drug user as a criminal or as an addict in need of treatment, 
ignoring all other facets of differentiation, such as reason for use, mode of use, context etc. 
Furthermore, it pushes all drug users into these categories, and thus the same healthcare 
system, which does also not have the infrastructure or capacity for receiving all the detainees 
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sentenced to treatment nor a system for securing quality of treatment. Barra (interview) draws 
on WHO-guidelines based on research and best-practices when claiming that forced treatment 
is not working and that the relapse probability is very high. This, he says, was taken into 
account when creating the law that thus creates an artificial ‘choice’ between treatment and 
prison. As noted in the previous chapter, Espolea and CUPIHD tried to monitor and evaluate 
the new system but were denied access to information both by the judicial system and by the 
healthcare system. Barra (interview) points out that the reason behind the Narcomenudeo was 
not to create a health oriented drug policy but rather a response to a demand to the president 
that ‘something had to be done’ at the same time as it allowed for law enforcement recourses 
to be relocated towards dealing and trafficking, setting minimum sentences for the latter and 
facilitating extradition of prisoners to the U.S. 
Both Jorge Hérnandez Tinajero and Aram Barra highlight that they are fighting for Mexico to 
have a (health based) drug policy, which is something that the country has not had. They 
assess that the president is fighting a rhetorical war on drug, which in reality is not a war on 
drugs, but a war on organized crime. Barra claims that there is a need to separate between 
drug policy and security policy as two distinct policy issues:  
“And this is often at times in the media you see for instance politicians or analysts saying: If 
we legalized drugs, what sort of impact would that have in organized crime. And there is 
numbers that I don’t know how people gathered, but there is quite a few numbers saying that 
we would cut this much money going into organized crime...it’s not enough. So, I think we 
need to split that discussion. If we’re attacking organized crime, then let’s attack organized 
crime, which is something that Calderón hasn’t done [...] If we’re going to talk about drugs, 
then let’s talk about drugs. The problem is that Calderón keeps on mixing those two subjects 
because one has the potential of becoming political, whereas the other is not very sexy. If you 
talk about money laundering it is really boring. We’re talking about monetary policy and 
we’re talking about bank regulations, it’s not very interesting, it doesn’t sell. If you want to 
talk about drugs, if you want to talk about the war on drugs, then that’s sexy, it sells” (Aram 
Barra, Espolea, interview).  
The task of CUPIHD and Espolea is to introduce a debate about drug policy in Mexico that 
also evolves around drug use, taking evidence-based policies and best-practices of other 
countries into regard. They are introducing drug policy for the first time in Mexico as an issue 
in itself, and not only as a small part of security policy (Tinajero, interview).  
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The case of Germany 
Germany is by many regarded as a lenient country in regard to drug policy, having a large 
emphasis on public health in relation to demand reduction (Böllinger 2004), and allowing for 
even controversial harm reduction measures. One major reform in German criminal law was 
the introduction of ‘treatment instead of punishment’ in 1981 for drug addicts with a sentence 
to less than two years of prison (Böllinger 2001, 2004). Criminalization of drug use per se has 
always been unconstitutional due to the inherent ‘right to hurt oneself’, although there is a 
number of administrative sanctions available in relation to drug users. In 1994 the German 
Federal Constitutional Court added a procedural option where amounts of drugs for personal 
consumption could be decriminalized by the state attorney through the principle of nolle 
prosequi or depenalized by the criminal court in cases where there is low degree of public 
interest and of personal guilt (Böllinger 2001: 163, Papendorf 2002). It left to the discretion of 
the state attorneys to decide the quantity thresholds. 
Heino Stöver (interview) strongly criticizes that the discretion of the state attorneys has led to 
a large differentiation in quantity thresholds allowed in each of the 16 Bundesländer (German 
states);  
“Taken for instance when you are in Berlin, you might have six grams or ten grams even in 
your pocket of cannabis. Only one kilometer off, in another Bundesland, another German 
state, you would get taken to court for only two grams” (Heino Stöver, Akzept, interview). 
The differences in quantity thresholds are especially large between northern and southern 
states. This is something that Akzept scandalizes as it breaks with the constitutional principle 
of equality for the law. Akzept has also campaigned for heightening the quantity thresholds so 
that at least forty grams of cannabis should be legal in addition to allowing for home growing 
of cannabis (Stöver, interview). 
Böllinger
83
 criticizes the German ‘treatment instead of punishment’ approach for in reality to 
result in traditional punishment plus coerced therapy (2004: 492). He claims that a common 
element in forcing drug users to treatment or prescriptions, as well as the tight control of harm 
reduction programs (such as for instance the high thresholds for heroin dispensing programs), 
to constitute a move towards ‘soft’ control measures which extend to the core of personal 
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privacy, which are legitimized by psychological diagnoses (even in cases where drug use 
could be defined as non-pathological), and which could “…in turn result in ‘net widening’ 
and a further loss of civil liberties”84 (2004: 497).  Elsewhere, he argues that a parallel 
tendency has occurred in German criminal law towards a ‘risk orientation’, implying a 
proactive distinguishing and examination of dangerous classes, sub-groups and lifestyles 
(Böllinger 1997: 153). A new feature of German criminal policy, the ‘endangerment delicts’ 
are “...supposed to serve a purely preventive function by threatening and exerting criminal 
punishment for risky behavior in defined social problem areas like political violence, weapon 
and drug trafficking (...)”85 (Böllinger 1997: 154). Thus, German drug policy could be seen as 
moving towards a more soft control of drug users on the one hand, as well as an increasing 
securitization of drug supply and trafficking on the other.  
Insufficient drug law changes 
The cases of Germany and Mexico show how drug law changes have occurred in two very 
different legal, political, cultural, geographical and social contexts. It also shows that there are 
certain similarities in the critiques posed by the movement in the two countries. In neither 
case the NGOs regard the drug law changes as being sufficient.   
In Mexico drug policy has, if existent at all, been merely a small part of the country’s security 
policy. This might be in the process of changing as the NGOs are pushing for drug policy to 
become a policy of its own, as well as the Narcomenudeo law opening up for a differentiation 
between drug use and trafficking, regarding the pervious increasingly as a matter of health.  
In Germany the division between drug use and trafficking has for a long time been the basis 
for the country’s drug policy and its differentiated strategies in terms of demand and supply. 
However, whereas the strategies towards drug users and addicts have been criticized for a ‘net 
widening’ of soft control, the supply side policy towards drug traffickers seems to have 
become even more ‘securitized’.  
                                                 
84
 Dorn (2001) notes that (so called non-criminal or quasi-criminal) administrative measures or sanctions – such 
as loss of driver’s license, profession, restriction on movement etc. - do not necessarily have a ‘softer’ impact on 
people, and may by some even be experienced as a harsher restriction of personal freedom than criminal 
sanctions.  
85
 Thus, Böllinger’s account of the trends in German criminal law and policy strongly resembles Stanley Cohen’s 
(1994) claim that the (American) criminal justice system has undergone a ‘bifurcation’ with a ‘soft’ and a’ hard’ 
end.  
79 
 
Most notably, the NGOs in Germany and Mexico criticize that drug users are not fully 
decriminalized despite a shift towards more ‘soft’ control. Their explicit goal is that drug use 
is in no regard a criminal matter neither sanctioned by criminal nor administrative sanctions. 
Thus, both the NGOs in Germany and Mexico emphasize that the quantity thresholds need be 
realistically high as to fully exclude drug users from the criminal justice system. Furthermore, 
‘treatment instead of punishment’ constructs drug use as pathology and disease while it 
ignores the multifaceted dimensions of modes, contexts and reasons for use (Barra, 
interview), and fails to acknowledge it as also being a lifestyle (Stöver, interview) which 
sometimes have long historical and traditional roots (Tinajero, interview).  Drug users should 
be offered possibilities of differential modes of treatment or information about risk-reduction, 
but the utilization of such measures should be left to the user’s individual choice, and not be 
something that is coercively administered by the criminal justice system or for that matter by 
the health system.  
Promoting a debate about alternative regulation of drugs 
Apart from completely decriminalizing drug users, the movement claims that there is an 
urgent need to debate alternative modes of drug regulation and control, starting with de jure 
legalization and government regulation of cannabis – which is scientifically proved to be one 
of the least harmful drugs, alcohol included (see for example Room et al. 2008). The problem, 
however, is that the securitization of drugs, the interests involved in keeping it so, as well as 
the framing of drugs in terms of immorality,  has made alternative drug regulation an 
impossible issue even for debate: 
“ENCOD sees international ‘counter-narcotics efforts’ as part of an immoral, failed and damaging 
international drug control apparatus that has succeeded in gaining decisive influence in international 
politics, by creating a global illicit drug market, and huge financial interests. Subsequently, the violence 
and death this market inevitably creates and the large amount of untaxed money it generates, are framed 
as an international threat, to create a supergovernment of a small number of war cabinets. The 
securitisation status excludes the consideration of other policy options and proven alternatives from 
being discussed seriously in the relevant drug control international organs, the same institutions and 
governments responsible for the one-sided, militaristic and failed drug control conventions and for their 
horrendously tragic consequences” (Polak 2012). 
Polak thus specifically highlights the reluctance of the international drug control organs to 
discuss alternative regulation of drugs as a policy option. Luís Astorga (interview) assesses 
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that this is an outcome of international relations between states, where the U.S., alongside 
among other Japan, Russia and Cuba, exerts pressure on other countries as well as 
international organs to keep drugs as a security issue. The pressure is specifically strong 
towards countries that produce drugs destined for U.S. markets – countries that the U.S. 
perceive as a risk or as a potential risk. He goes on to note that even countries which are 
lenient in their domestic drug political approach, such as the Netherlands, Portugal, New 
Zealand and Canada, sometimes vote in favor of stricter measures in the UN General 
Assembly. This is because these countries form parts of political coalitions, having common 
policy interests with the U.S. on other policy issues. In terms of diplomacy, there is always a 
‘give and take’. However, Astorga (interview) claims that there has also been a rupture in the 
UN prohibitive consensus on certain matters, which especially occurred in the debate around 
the term ‘harm reduction’. The U.S., Japan, Cuba and Russia demanded this term to be 
abolished but a coalition of European states, with among other Germany, the Netherlands and 
Portugal formed the counter part.  
This account shows that drug policy is maybe even more complex in terms of international 
relations, as diplomatic efforts extend beyond merely one policy issue. The theme of drug 
political discussions in international relations and international organs cannot be discussed in 
detail here due to the scope of this thesis
86
. However, this shows that drug policy needs to be 
seen in relation to a landscape of international policy and power relations that extends far 
beyond drug policy. This account serves to outline the difficult task of the drug law reform 
movement in their efforts to push for changes in the global discourse on narcotic drugs.  
In this section I first showed, through two case examples, how drug law change has occurred 
in two very different countries, and how the NGOs in these countries argue that the changes 
are insufficient. Second, this account served to clarify the goal of the NGOs of how a 
decriminalization of drug users should look like. Third, I outlined another goal of the NGOs, 
namely to introduce an informed debate about modes of alternative regulation of drugs 
domestically and in international organs. I also indicated the difficulties in this task through 
showing that drug policy is embedded in international power relations extending far beyond 
the topic of drugs.  
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(2004b), and of international relations as well as international police cooperation, see Nadelmann & Andreas 
(2006).   
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The next section will go on to examine how the drug law reform movement goes forth in its 
attempts to become a legitimate party to the global discourse on narcotic drugs in order to 
move on an informed debate about alternative drug policies in international organs. 
5.3 How does the movement go forth to influence a change in the global 
drug control discourse? 
In the previous chapter I showed how the harm reduction movement has increasingly 
managed to become a legitimate party in the debate about health policy domestically and 
internationally, especially through their professionalization and scientifically evidence-based 
advocacy. In international forums on health policy this is reflected among other in the support 
of harm reduction policies and measures by WHO, UNAIDS and the Global Fund, and by the 
EU at a regional level. This means that harm reduction has become, although marginal at 
times, a part of the global health discourse – although it has to be constantly fought for, 
especially in times of financial crisis. This section will, however, rather deal with the 
international drug control discourse, which also implies other forums of policy and law 
making at an international level
87
.  
First, I examine how the transnational movement tries to influence the discourse of the drug 
control organs of the UN, namely the United Nations Office on Drugs and Crime (UNODC), 
the UN Commission on Narcotic Drugs (CND) and (to a lesser degree) the International 
Narcotics Control Board (INCB), as well as what problems they encounter in this task 
(especially in relation to the structures that exist for civil society participation) in section 
5.3.1. Secondly, I will discuss more broadly factors that might influence on the drug control 
discourse and at the debate, such as the emergence of the Latin American Commission on 
Drugs and Democracy and the Global Commission on Drug Policy as well as their relation to, 
and implications for, the drug law reform movement in section 5.3.2. Lastly, I discuss several 
hindering and tasks that the drug law reform movement encounters in their effort to open up 
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 This is partly an oversimplification. The boundaries between health and control discourse in the field of drug 
policy are not necessarily very clear, as the bio-political perspective also contributes to emphasize.  In the EU 
drug strategy, and in many countries, harm reduction forms part of the control strategy of ‘demand reduction’. 
Still, however, I will argue that the ‘drugs-as-health’ and ‘drug control’ discourses are two parallel discourses, 
which at times are inseparably interwoven, but at times operate quite separately and through different forums. 
How these discourses get increasingly intertwined is a theme of this chapter. However, it should be noted that 
there have been tensions between the UN health institutions such as the WHO and the UNAIDS on the one hand 
and the UN drug control institutions such as the CND and the INCB on the other hand, particularly about harm 
reduction (Jelsma 2004b).  
82 
 
the drug control debate, among other in relation to public opinion and to the character of 
political benefit in section 5.3.3. 
5.3.1 Influencing the international drug control organs 
This section draws heavily on my interviews in accounting for the development in civil 
society participation around the UN drug control organs as well as the changes in discourse 
which the drug law reform movement has contributed to instigate within some of these 
organs. An organizational chart of the UN drug control bodies is presented in appendix 9.2. 
Both Mike Trace and Martin Jelsma (interviews) tell about how the UN drug control organs 
have been unique institutions in the UN system in the sense that they have been reluctant to 
allow for civil society participation – especially participation of critical NGOs. However, they 
both claim that there has been a change regarding civil society participation, especially around 
UNODC and CND, which they identity to have occurred around five years ago:  
“ [...] when I left the UN in 200388, having been somebody from a NGO background and 
having seen political structures from inside, I’m being pretty disgusted about how little weight 
they gave to expert movements, academics, civil society, organizations, NGOs, drug users. 
Basically the policy making culture right up until the last few years has been absolutely 
dismissive of that role. Whether it be national, transnational, whatever. So, one of the reasons 
why I got involved in this after I left the UN was the aim to build up a civil society voice in 
this void. Because all the expertise exists in civil society, all the power exists in the 
governments. Now, in that situation you should have a coming together. In the drugs field, 
you’ve not had as much of a coming together as you should have. And it’s largely because of 
the political polarity of the issue that’s been known for decades. So if you go to any 
government person, you still get it now, but if you go to any government policy maker, five 
years ago, and they say: why do we want civil society involved? Because they would ask us 
difficult questions about legalization and human rights, and we don’t want to hear those 
questions. Whereas the normal response would be; Well, they are the guys with the expertise 
that knows what’s going on out there, so we need to hear more. Well, that culture was just not 
there at all and it’s not been there for decades. It’s really changed a lot the last five years” 
(Mike Trace, IDPC, interview).  
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(UNODC). 
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Martin Jelsma tells how the culture for civil society participation at the annual CND meetings 
in Vienna has changed, as more and more critical NGOs have gotten ECOSOC status
89
: 
“[…] we were one of the first NGOs from a critical perspective to start working during the 
Commission meetings. And there were several incidents where I was thrown out of the 
conference room. And that was the background why the Dutch government included me in the 
government delegation […] There’s the official NGO Committee on narcotic drugs90 that has 
also opened up. Because when we became members the Committee was dominated by quite 
conservative prohibitionist NGOs […] And the last five years it has developed very rapidly so 
now around the CNDs, there’s very active civil society involvement [and] there are parallel 
sessions organized by NGOs […]”(Martin Jelsma, TNI, interview).  
Jelsma (interview) also tells how the movement in itself has become transnationalized, with 
an increased networking and cooperation across national boundaries and across regions. Now 
drug policy reform NGOs from all around the world participate around the annual CND 
meetings, including both Espolea and CUPIHD. 
Mike Trace and Martin Jelsma point to the fact that the civil society participation in the drug 
policy field of the UN has been extremely weak compared to other fields and that the Vienna 
environment has been particularly hostile to NGOs questioning the status quo. As earlier 
noted, this difficulty can be attributed to the securitization of the drugs issue, defining it as a 
national threat. Such a definition delimits policy making to a restricted supra-national level, 
which is almost impossible to influence by civil society
91
. Although the possibilities for civil 
society participation around the UN drug control organs of UNODC and CND have opened 
up (this is not, however, the case for the INCB, a theme in the subsequent chapter), Trace 
notes that the structures for civil society participation are still not very strong:  
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 To be present at the meetings of the CND, NGOs have to apply for a formal NGO status to the Economic and 
Social Counsel of the UN (ECOSOC). However, Cook notes that CND NGO participation is restricted to NGOs 
with ECOSOC consultative status, which only permits them to participate as observers, and which is an unusual 
restriction when looking at the other functional commissions under the ECOSOC (2010: 24). Meaningful 
participation of NGOs at the CND has been achieved through NGO representatives becoming part of some 
government delegations. She also notes that although UNODC has become committed to bring in civil society in 
their work, such participation has often become blocked by the CND, which has to approve of this as its 
governing body (Ibid.).  
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 The Vienna NGO Committee 
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 “Proposal of a model for the debate about new drug policies” by Fredrik Polak, an unpublished document to a 
meeting in the CSF in Brussels, October 2011, which he provided me with. 
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“There was a big battle in the UN Commission on Narcotic Drugs two weeks ago about the 
extent of the role of civil society, and, so there are still a lot of countries who are still nervous 
about civil society in the drug sphere. In general, what was always seen as radical a few 
years ago is actually normal now. Civil society plays a role that UNODC, the heads of 
UNODC, in every speech they make say how important civil society is. They don’t always 
follow up on that, but they say it [...] It’s now normal for people in the international discourse 
to say civil society are crucial partners, [but] the mechanisms for civil society involvement 
are still not particularly strong in this field. If you look at the UNAIDS for example, civil 
society has a very strong role within their structures, whereas still, the drug control structures 
you’re on the outside looking in. But, the discourse has improved an awful lot. Whether it’s 
changed policy, I tend to the view that it has an awful lot” (Mike Trace, IDPC, interview).  
Although the structures for civil society participation are still not very strong around the UN 
drug control organs, Trace claims that the drug policy reform movement has had an impact on 
policy and discourse. He points to the former Executive Director of the UNODC, Antonio 
Maria Costa, who amended the discourse of criminal repression in a war on drugs to saying 
that the problem has been contained
92
, while at the same time recognizing drug users not only 
as criminals but also as patients with health problems
93
. He attributes this change to the power 
of ideas rather than direct confrontation:  
“So he [Antonio Maria Costa] started saying lots of things that you’d hear in this 
conference
94. Human rights, public health principles, these people aren’t criminals, that sort 
of thing. Why did he change? And why did the official documents of all the UN agencies 
change? I’d like to think, this is why I talk about the power of ideas, these were ideas that... 
phrases, these are phrases that you first saw coming from IHRA, coming from the drug users 
union, coming from IDPC. Then they were first produced and we’d send them to people like 
Costa, they’d be: ’oh no you’re all wrong’ and that sort of thing. A couple of years later we’d 
see our own phrases in their documents. So I would say there’s a pretty direct correlation 
there and I do think that, not directly, say someone like me turns up to Fedotov, who now is in 
charge of UNODC, and say: ‘I demand you to change your policy to this’, it won’t have any 
immediate impact. But this power of ideas where you just filter all these things in, and then 
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 Similarly, MacCoun and Reuter claim there was a shift in the New York Times media debate on drug control  
in the 1990’s , among other with the emergence of the position ‘reformed prohibition’, which called for a softer 
kind of prohibition with a larger emphasis on treatment and prevention (MacCoun and Reuter 2001: 45).  
94
 The International Harm Reduction Conference in Beirut 3rd – 7th of April 2011.  
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you convince them there is a political benefit to them to use those ideas, then that’s where the 
big impact is. And in this field, in these last five years, everything that’s good that’s 
happening in policy making at the international level, I can track back, you can absolutely 
track back, that I can say where concepts and ideas that were produced by NGO networks in 
previous years. And I don’t know how they came into government discourse, but somehow 
they have” (Mike Trace, IDPC, interview).  
Through their ideas and argumentation the drug policy reform movement has contributed to 
an indirect influence on the UN drug control organs, leading to a slight amendment of their 
discourse. The next section will deal with another kind of contribution to opening up the 
debate.  
5.3.2 The role of powerful alliances in opening up the debate 
The recent years two sensational statements has been made by groups consisting of ex-
presidents, other former prominent policy-makers and famous authors from a number of 
different countries that have publicly called for a shift in global drug control strategies and 
promoted an informed debate on the issue.   
In 2009 the Latin American Commission on Drugs and Democracy, consisting of Latin 
American ex-presidents, policy makers and authors stated that the war on drugs has not only 
failed in reaching its goals, but has led to enormous human and social costs in Latin America. 
The growth of drug cartels, guerillas and other organized crime groups has lead to 
unacceptable levels of violence, resulting in what they call a ‘criminalization of politics and 
politicization of crime’ as well as corruption in all levels of state apparatuses (Latin American 
Commission on Drugs and Democracy 2009). They propose five initiatives which could bring 
global drug control towards a paradigm shift; 1) Change the status of addicts from criminals 
to patients, cared for by the health system, which is mainly a call to ‘demand countries’ with 
the main aim of making patients out of buyers in an illegal market that finances organized 
crime; 2) evaluate the possibility for decriminalization of possession of cannabis for personal 
consumption on the basis of public health and medical science, where they claim harms are 
mainly caused by prohibition, leading to massive incarceration rates, and which in Latin 
America facilitates an extortion of users by police officials; 3) reduce consumption through 
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education, information and prevention campaigns especially targeting young people
95
, calling 
for innovative approaches and emphasizing the individual’s responsibility; 4) redirect 
repressive strategies at fighting organized crime, which are especially targeting the harmful 
consequences of organized crime, and; 5) reframe the strategies of repression against 
cultivation of illicit drugs, stressing the need for alternative development projects adapted to 
local realities to follow eradication efforts as well as to adjust cultivation to traditional, legal 
use of the coca leaf. Furthermore, they call for drug policy to be based on science and local 
participation, and for the need of alternative strategies to the ‘war on drugs’. 
The Global Commission on Drug Policy is a continuation and expansion of the Latin 
American Commission – now joint by a number of ex policy makers and ex presidents from 
the rest of the world including former UN Secretary-General Kofi Annan – , and it also goes 
much further in its proposals. Its report, “War on Drugs. Report of the Global Commission on 
Drug Policy“ (2011), in addition encourages governments to experiment with models of legal 
regulation of drugs, especially of cannabis. It makes a differentiation between types of 
‘traffickers’ to be repressed, emphasizing that the principles of harm reduction and 
decriminalization should also be applied to farmers, couriers and petty sellers. It also 
emphasizes that repression efforts should be directed at reducing harms of organized crime, 
not drug markets per se. Furthermore, it calls for a transformation of the global prohibition 
regime and a revision of the conventions – especially the substance scheduling –, emphasizing 
that the UN drug control system needs to act in coherence with human rights. 
Both commission reports draw heavily on research, background papers and other literature 
written by the drug policy reform movement. Martin Jelsma and Mike Trace have provided 
background papers for the Commissions and also act like advisors for the Global Commission 
alongside Ethan Nadelmann and Dr. Alex Wodak, other prominent members of the 
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they continue the same debate about responsibility for the problem which for a long time has been going on in 
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movement
96
. Furthermore, both reports are supported by the Open Society Foundations 
(OSF)
97
.  
Luís Astorga (interview) asserts that these Commissions form part of the international level 
plan of the OSF, which is probably one of the most active non-state actors in the field of 
global drug policy. The aim with these Commissions, he claims, is to create a voice that 
powerful that it needs to be heard by the U.S. government, a common feature for the 
Commission members being that they hold a high political legitimacy both in their countries 
and internationally. It was also strategic to start with forming the Latin American 
Commission, as it is common knowledge that Latin America is one of the regions in the world 
most affected by the ‘drug war’ (Astorga, interview). For instance Gaviria faced one of the 
hardest phases in Colombia with Pablo Escobar in his presidential period. Astorga also 
assesses that other politicians, such as Mexican ex-president Vicente Fox, who has also called 
for a shift in global drug control, could not form part of the Commissions as he does not hold 
a high legitimacy among other due to corruption scandals and populist appearances. The 
Commission members thus hold a high degree of legitimacy generally, but also specifically in 
relation to what they are proposing.  
Aram Barra (interview) assesses that the Commissions have not yet had an impact at a 
political level. They have done a lot in opening up the debate and legitimizing it, but he 
claims  
“[…] it’s not yet enough in terms of sitting down and having an informed debate […] I think 
the Global Commission has quite a role to play in professionalizing that debate and bringing 
it up, to have more arguments, to use the correct terms. And attempt to actually debate ideas 
without causing more harm than good” (Aram Barra, interview). 
However, Barra also claims that the Commissions highlight that it’s still illegitimate for 
current politicians to talk about drug law reform - or in Barra’s own terms; “to talk outside of 
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 Open Society Foundations (OSF) was established in 1984 by ‘investor and philanthropist’ George Soros, and 
their aim is to “build vibrant and tolerant democracies whose governments are accountable to their citizens” 
through “shaping public policies assuring greater fairness in political, legal, and economic systems and safeguard 
fundamental rights”, see: http://www.soros.org/about. The OSF Global Drug Policy Program (which is merely 
one of many OSF initiatives), established in 2008, form a very important part of the drug policy reform 
movement – through networking and connecting NGOs in different countries - or in Astroga’s words; “gathering 
the whole critical mass” – but maybe most notably through being one of the main funders of the movement.  
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the box” – as  there are too many interests involved, and too many connections into other 
policy areas on different levels. Most notably, it is not politically beneficial for politicians to 
talk about drug law reform
98
.  
5.3.3 Political benefit and public opinion 
As emphasized by Mike Trace (interview), an important task of the drug law reform 
movement is to create a context where it is politically beneficial for policy-makers to use their 
ideas.  
Barra is highlighting the problem of political benefit and suggests one strategy of overcoming 
this barrier:  
“So, if we want our politicians to talk about a change in drug policy, we need to help them in 
getting there. It need be politically cost-effective to talk about it. [...] If I was a politician 
today I would probably not talk about drug policy in the way in which I talk because I’m in 
civil society, because it wouldn’t be cost-effective, nobody would vote for me. If public 
opinion is not there, it doesn’t matter what I say. I follow the polls and I follow what people 
want me to say. And so we need to change that, which is why we need to work on public 
opinion, why we need to work with the media, why we also need to work with the politicians. 
[...] We’re engaging with young politicians to change that99. We need to give them the tools to 
be able to confront the media and talk about drug policy. And so the media say: ‘You’re being 
a radical because you’re talking about regulating a market’. That the politician is able to say: 
‘No, you’re the radical, because you’re denying the fact that we need to talk about it, that’s 
what’s being radical and irrational, not what I’m proposing’. And we need to give them the 
tools to be able to do that” (Aram Barra, Espolea, interview). 
Barra is thus pointing out the need to work with the media and the public opinion in order to 
make it beneficial for politicians to talk about drug policy change. According to MacCoun & 
Reuter one obstacle for drug law reformers is the decades-long dissemination and 
campaigning about the dangers of drugs, which in the case of cannabis in the U.S. takes form 
of “aggressive promotion of findings of adverse effects in quite limited studies” (2001: 377). 
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 Recently, however, the president of Guatemala, Otto Pérez Molina, has called for a debate about alternative 
drug political approaches due to the security crisis and violence in the region, which he claims current policies 
have been completely ineffective in reducing (Jelsma 2012).  
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 Engaging with young politicians and political youth parties is also a strategy used by the German NGOs.  
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Although the ‘stepping stone hypothesis’ has been scientifically refuted (MacCoun & Reuter 
2001), beliefs about cannabis and other drug use as a gateway to hell for individuals and 
societies, leading to certain death and to an immoral pathway of life, has been internalized and 
are often deeply rooted in the (conscious or non-conscious) perception of the general public. 
My interviewees highlight the need to disseminate information about drugs that is based on 
scientific evidence. Barra points to the problem that this is a long term project which is also 
not personally cost-effective for politicians: 
“It’s a shame in the end that there’s politicians like Gaviria, like Fox, like Clinton after their 
power coming up and say: ‘Well maybe we should try something different?’ […] Well, why 
didn’t you do it while you were in power?  […]Because it’s not cost-effective for me as a 
politician to move on a policy proposal if that’s going to ruin my political career. […] In 
order for me to do that as a politician, I need to convince the electorate, convince society, 
convince people that are in your territory or in your political geographic territory that this is 
a good policy. And that comes again with education and information. Education and 
information in the long run changes preconceptions, prejudgements, cultural understanding 
of an issue. It’s the same with gay rights, it’s the same with abortion, it’s the same with 
women’s rights, it takes time, it takes full generations to change those understandings of what 
society should do with the problem. The problem again is that education is not cost-effective 
in the immediate run. You need to put a lot of money into it, and it shows only like twenty 
years later. And somebody else twenty years later will make the best out of that and will get 
all the credit and not me right now, putting budgets towards that. Still, it’s the right thing to 
do, it’s the moral thing to do. We know politicians are not necessarily moral or ethic, that’s 
the problem, right?” (Aram Barra, Espolea, Astrid Renland’s interview).  
As disseminating scientifically evidence-based information about drugs and their use to the 
general public is not politically cost-effective this task is often left to the movement itself. As 
noted by Barra, this task requires large economic and human resources, which poses specific 
problems for NGOs with limited funds.  
MacCoun & Reuter assess that the arguments posed by ‘decriminalizers’ and ‘legalizers’ have 
had no effect on public opinion
100
 most notably due to the complexity of the arguments – 
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which makes them hard to communicate as well as to accept for the general public (2001: 55). 
These arguments also require what they call ‘tradeoffs among competing values’ (Ibid.), 
especially between the very basic moral view that the public have incorporated towards drugs 
and the pragmatic efficiency principles and more complex consequentialist perspective which 
the movement is advocating. They illustrate this with an example: “If drugs are evil, how can 
it possibly be right to allow them to be sold in legal commerce?” (2001: 51). As prohibitionist 
rhetoric is simple, the rhetoric of the movement will seem counterintuitive and paradoxical 
from a superficial point of view; “how can permitting a socially problematic behavior lessen 
the problem to society?” (MacCoun and Reuter 2001: 54).  
The book “Children of the Drug War” (2011) documents severe harms and human rights 
infringements to children across the world resulting from drug prohibition. In the introduction 
Damon Barrett notes that still, however, the main rhetoric of prohibitionists is to ‘protect our 
children from drugs’, which is “…unhelpful if it obscures reality” (Barrett 2011: 4). He goes 
on to note that: “For policy makers and politicians the simple message is useful. It is more 
easily understood by the general public than some of the counterintuitive, yet evidence-based 
responses available, such as harm reduction” (Ibid.). The complexity of the arguments for 
harm reduction is also pointed out by Aram Barra (interview), who claims it is sometimes 
problematic to reduce the arguments into a minimum so it could fit the limited space and time 
given by the media without the content and meaning of the messages getting lost.   
MacCoun and Reuter remind us that although policy analysis tends towards consequentialist 
positions, most people also hold many deontological beliefs, as deontology and 
consequentialism refer to arguments, not to people (2001:58). They claim it is useful, then, to 
focus on the psychological weight that people give to arguments (Ibid.). 
A weighing of arguments and evidence, as well as their systematization into general themes, 
academic fields, and value- and ideological backgrounds, is just what Frederik Polak 
(interview and briefing note) proposes in order to structure the debate about drug regulation in 
the Civil Society Forum on Drugs (CSF) of the EU
101
. He claims that only through structuring 
the debate by clarifying the background, the evidence and the psychological and scientific 
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content and weight of the arguments, as well as clarifying the problem perceptions and the 
policy objectives and goals, is it possible to make the debate productive
102
. Structuring the 
debate would make it possible to rule out specific areas of high and low levels of 
disagreement (such as for instance moral vs. health), which could lead to bringing opinions 
closer in some areas, and which subsequently could make it possible to draw conclusions in 
areas with low levels of disagreement. As for the current debate “[t]heoretical assumptions, 
moral judgements and statistical data are presented in an unstructured way”103, which makes it 
hard to reach any conclusions. This proposition is, however, targeted at the CSF and aims at a 
professionalization and structuring of the debate among NGOs in the field of drug policy – 
not for the media debate or the debate in the general public. Nevertheless, it could be argued 
that if it would be possible to reach an agreement in certain areas in the CSF, these might 
easier affect the European Commission as well as creating more joint efforts of opposing 
NGOs in influencing public opinion.  
This section has drawn on my interviews to discuss how the drug policy reform movement 
has managed to instigate changes in the global discourse on narcotic drugs, as well as 
different obstacles for further change. This discussion will be continued in the next section, 
where it will be seen in relation to governmental logics, practices and rationalities. 
5.4 Discussion 
In the previous chapter I argued that harm reduction interventions, being in consistency with 
neo-liberal discourses on health and the ‘new’ public health movement, can be seen as 
advanced liberal’ bio-political projects with focus on risk management.  
Firstly, I will show how one of the goals of the movement (or rather the goal of a part of the 
movement), de jure legalization of drugs with government regulation, can be seen as an 
extension of the logic of ‘advanced liberal’ bio-power and governmentality to drug control in 
general in section 5.4.1.  
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 He also proposes a model for how to structure the debate following a division into different phases and areas 
of discussion, which I unfortunately have to leave out due to the space restrictions of this thesis.  However, it 
should be noted that the general themes of the model which should be discussed separately to reach conclusions 
in each field are: legal aspects, health, ethics, economics, cultural and social aspects, education and international 
relations.  
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 “Proposal of a model for the debate about new drug policies” by Fredrik Polak, an unpublished document to a 
meeting in the CSF in Brussels, October 2011, which he provided me with. 
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Secondly, I discuss the current drug control regime in a governmentality perspective, as 
‘authoritarian’ forms of governmentality and as a myriad of agencies and institutions with 
system-internal logics, in section 5.4.2. 
Lastly, I examine the role of the drug policy reform movement in amending the drug control 
discourse of the UN drug control organs, and suggest that also here might there be a tendency 
of governing through civil society organizations, which accordingly downplay their elements 
of opposition, in section 5.4.3. 
5.4.1 ‘Advanced liberal’ drug control 
Following the argumentation in the last chapter of harm reduction as bio-politics, I will argue 
that the models of government regulation presented by Rolles (2009) can be seen as a 
prospect of how global drug control could look like if ‘advanced liberal’ governmental 
rationalities were to be at work in this task. 
One important point in Rolles’ ideas is that solely through an abolition of criminalization of 
drugs and drug activities is it possible to make use of relatively subtle mechanisms which 
regulate and impact on drug users’ behavior. In the following, I will use some examples from 
Rolles’ book to illustrate this, although the space limitations unfortunately force this account 
to be brief.  
A first set of regulatory mechanisms is aimed at influencing a less risky drug user behavior – 
which can be seen as an extension of the ‘risk management’ rationality of harm reduction. 
Rolles notes that the most potent products of the most risky drugs, such as heroine powder, 
amphetamine powder, crack and powder cocaine
104
, should still be object to strict control – 
preferably (at least initially) through prescription and pharmacy models. However, less potent 
products of the same drug, as well as less risky drugs, could be more available and less 
controlled (as for instance light coca beverages, which he compares with legal vodka Red 
Bull). Rolles argue that many recreational users would favor less risky and less potent 
products if available – as a healthy consumer choice. Thus, a large part of non-problematic 
(recreational, experimental and occasional) users would change their use towards less risky 
products and methods of use, which would also lead to less problematic behavior while 
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 Which he notes were brought about precisely due to the prohibition, which promotes high potent drugs as 
well as high potency consumption methods such as injecting.  
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intoxicated due to the potency of the drug. The users which would develop problems would 
be directed into medical models of drug provision or other types of therapy.  
A second set of mechanisms, although also promoting the over all least risky behavior, is 
rather targeting the user’s accountability and knowledge. Examples on such mechanisms are 
the obligation of the supplier
105
 to provide the user with information of the drug; harm 
reduction advices, safer use, and treatment services in case of potentially problematic use 
(Rolles also suggests to make the seller co-accountable for how the drug is used), information 
on product labeling (such as contents, strength/potency, units and health and safety advices) 
as well as volume sales/rationing controls which would restrict excessive use. Three 
additional examples of mechanisms which target the accountability of the user are licensing of 
users, alternatively, or in addition, a membership to a specific ‘users’ club’ (such as the 
Spanish Cannabis Clubs), and order-pick up delay. The first imply that the user would need to 
obtain a license, resembling a driver’s license, which makes sure the user is informed about 
the implications of the use of the drug in order to be able to purchase the drug (Rolles 2009: 
58). This, he claims, would give good opportunities for thorough education
106
. The order-
pick-up delay is aimed at influencing the individual to plan his or her drug use in advance. 
These mechanisms all have as a goal to make the user’s choice an informed one, thus making 
the user (and partly the supplier) accountable.  
The above mentioned mechanisms can thus be divided in having two main groups of 
functions: 1) mechanisms which indirectly direct the (non-conscious) behavior of individuals, 
sub-groups and populations (i.e. patterns of use) and 2) mechanisms which make the 
individual informed, accountable and conscious of his or her choices.  
Rolles do, however, note that there will be need for disciplinary sanctions, for instance in the 
case of breaking the rules of licensing systems – or a more direct and tight control over those 
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 Rolles is discussing different licensing systems; The licensing of seller as well as  licensing of vending 
location (the pharmacy, shop, bar, which would have to obtain a license in order to sell) 
106
 In their examination of legal rationality and deterrence MacCoun & Reuter note that perceived health risks 
might have more influence on the choice to use drugs than legal risks (MacCoun & Reuter 2001: 85). They draw 
here on the evidence from Schelling (1992), who documented the influence of information on the large drop in 
cigarette consumption in the United States, as well as Bachman et al. (1988, 1990) who identified that the 
decline in drug use among high school students was contributed to a rise in health-related concerns (Ibid.). As 
shown in the last chapter, however, this is partly disputed by Rhodes (2002), who claims this presupposes 
rational decision making.  
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who cannot consume responsibly
107
. However, direct sanctions would in such a system be 
reduced to an absolute minimum.    
In Rolles’ propositions the role of the state is to create a regulatory framework through laws 
and regulations as well as to handle the minimum of sanctions which would be needed – it is 
to ‘steer and regulate’ rather to ‘row and provide’ (Rose 2000: 324). The task of carrying out 
the practical functions would be left to pharmacies, shops and ‘clubs’, as well as to harm 
reduction actors
108
. Here it is important to note that Rolles strongly warns against the 
involvement of commercial actors, emphasizing that any kind of marketing strategies should 
be strictly forbidden.   
One could say that the ‘controlling role’ of the state would be reduced to monitor the 
regulatory framework. Rose argues that control in advanced liberal societies is no longer 
centralized but rather dispersed through “networks of open circuits that are rhizomatic” rather 
than hierarchic (2000: 325). Central to circuits of control is individualization of the citizen as 
well as securitization of identity, which means that  
“control is better understood as operating through conditional access to circuits of consumption and 
civility: constant scrutiny of the right of individuals to access certain kinds of flows of consumption 
goods; recurrent switch points to be passed in order to access the benefits of liberty ” (Rose 2000: 326).  
The regulation models which Rolles proposes do not presuppose an abolition of control 
mechanisms but rather a decentralization and individuation of control. 
Another dimension is also crucial in Rolles’ propositions, namely how a transition to 
regulated markets would affect the global market. Central in this regard are price mechanisms, 
which could be placed as one of the main regulatory mechanisms in the first set of 
mechanisms accounted for above. The drug prices would need to be sufficiently high as to 
discourage use at the same time as they would need to be sufficiently low as to displace the 
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 He also emphasizes that the use of drugs would still be illegal for minors, and discusses methods for how 
such use could be prevented. I do unfortunately not have the space for discussing this any further here.   
108
 Similarly Ritter (2010) draws on regulatory theory to examine how drug markets could be regulated through 
strategies of self-regulation or ‘micro governance’ and strategies of market regulation or ‘macro governance’ 
implying economic instruments. In this proposal, she discusses the role of non-state actors, such as 
pharmaceutical industry, chemical manufacturers, retail pharmacies and property owners as partners in 
regulation. Most cleverly, she also discusses how the market could be manipulated through strategic law 
enforcement activities. 
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illegal market
109
. Viewing crime primarily as a function of opportunity, Rolles claims that 
regulating the drug market would eliminate, or at least substantially reduce, drug trade as 
illegal opportunity structure, which specifically would prevent future generations of drug 
producers, traffickers and dealers from a life in crime (2009: 92). There would, however, be 
several aspects that would be needed to take into consideration in a post-prohibition scenario: 
Many marginalized and socially excluded individuals would loose their income and would 
need to be included into social policy discourse; drug crop production would become part of a 
wider development discourse (drawing experiences from Alternative Development) and fair 
trade principles (overseen in a similar fashion as existing medical production by UN 
agencies); and strategies to prevent engagement of profit-driven multinational corporations in 
the trade would need to be established. In producer countries “positive impacts from reduced 
criminal profiteering, conflict and instability would be weighed against the short to medium 
term reduction in economic opportunity and GDP” (Rolles 2009: 89). Furthermore, Rolles 
discusses what might become a major problem, namely the reduction in the level of concern 
and the resources directed towards impoverished drug producers once the eradication 
priorities of current policies dissolve (2009: 90). He proposes what he calls a ‘post-drug war 
Marshall Plan’ to make sure that the economic gains (among other through tax incomes and 
savings in criminal justice expenditures) in consumer countries would also accrue producer 
countries, in helping to build alternative livelihoods, develop good governance and state 
infrastructure (Ibid.).    
The economic benefits from a regulated drug market are also noted by many to be what might 
just move the paradigm: 
 “And my hope is that actually the financial crisis may actually be the thing that says: this is not about 
ideology, this is not about morality, this is about funding. And prohibitionist models are very, very 
expensive and leads [to] growing costs as you do more damage to the health of people who use drugs. 
So I hope that we actually may persuade people that of all times that’s in the middle of a crisis, that you 
go for the best value for money model, which is harm reduction”110.  
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 In his lectures Foucault (2008: 257-59) discusses the (price) elasticity of drug use, noting that the elasticity is 
very low for drug addicts whereas it is high for non-addicts. He thus suggests the drug prices should be low for 
addicts and high for non-addicts. However, I would say that although such a strategy might seem plausible in 
isolation, it is not sufficient if another goal is to undermine the transnational illegal market.   
110
 Mat Southwell, International Network of People who Use Drugs (INPUD) , interview in the documentary 
“The State of Harm Reduction in Europe” (2011) by the Hungarian Civil Liberties Union, see: URL.: 
http://drogriporter.hu/en/eurohrn_marseille [watching date: 01.05.2012] 
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In this section I examined how global drug control could look in the case of an expansion of 
‘advanced liberal’ governmental and bio-political rationalities into this field of policy. In the 
next sections I will examine what kind of rationalities that dominates in the current drug 
control system, and how they might be seen to work both as barriers to and instigators for 
change. 
5.4.2 The current drug control regime 
Although the account above indicates how drug policy could look like in an ‘advanced 
liberal’ form of governmentality, this does not necessarily imply that the current global drug 
policy is not governmentalized. The account above has focused on the liberal techniques of 
control but this does not mean that governmentlity cannot also encompass forms and 
techniques that are ‘illiberal’.  
Keeping the objectives of the Single Convention in mind, the global drug prohibition regime 
aims at maximizing the ‘health and welfare of mankind’. Its justification, one might say, is 
posed in bio-political terms, albeit in a rather traditional and not an ‘advanced liberal’ form of 
bio-politics (this becomes particularly evident by looking at the historical time that gave birth 
to the Single Convention). Its object of protection is the world population as a whole. As 
noted by Dean, however, “…it is remarkable how much of what is done of an illiberal 
character is done with the best of bio-political intentions” (1999: 132). He reminds us that 
liberalism (as the principle of rationalization of governmentality) is made up by specific 
constellations of “…pastoral power that takes the form of a bio-politics of the administration 
of life and a form of sovereignty that deploys the law and rights to limit, to offer guarantees, 
to make safe and, disciplinary practices” (Dean 1999: 132, my emphasis). Some of these 
constellations can give birth to what he calls ‘authoritarian governmentality’.  
In liberal forms of governmentality there has always been those groups regarded as not able 
or willing to govern themselves responsibly. In the previous chapter I noted that these groups, 
seen as impossible to reaffiliate – or in Dean’s (1999) words; those without potential for 
improvement –, are subject to exclusion framed in terms of immorality (Rose 2000). These 
groups are ‘governed through crime’ and subjected to techniques of management and 
neutralization through the criminal justice apparatus (Ibid), or through disciplining and 
sovereign sanctions by ‘authoritarian’ governmental rationalities (Dean 1999) - which also 
serves to denote the boundaries of the ‘new morality’ (Rose 2000). I also showed that the 
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discourse on the ‘non-improvable’ drug users might be in the process of changing with the 
‘advanced liberal’ bio-political techniques and discourse of harm reduction gaining ground.  
However, this does not explain the reluctance of the general ‘drug control discourse’ to 
change towards ‘advanced liberal’ forms of drug regulation (such as Rolles propositions). As 
examined in this chapter, a tendency towards a ‘soft’ control of drug users can be observed 
globally (Jelsma 2009), exemplified in this chapter through the cases of Germany and 
Mexico. However, this tendency is also accompanied by ‘harder’ control as well as a 
‘securitization’ of drug trafficking111 (Jelsma 2009, Böllinger 2004). Moreover, the account 
above does also not explain the initial eager of the drug prohibition regime to internationalize 
itself, which is something I think we have to examine in order to comprehend the process of 
securitization. 
In the 1960s drug use was framed as a ‘national threat’ to Northern/Western countries where 
drug addiction was seen as a growing problem. As noted in the introduction chapter, 
international drug prohibition was created through pressure from the U.S., which has also 
been the driving force behind its strict enforcement (Nadelmann & Andreas 2006). The reason 
for the internationalization of prohibition was mainly to fight the new ‘threat’ in terms of 
supply (Boister 2001), and the pressure was mainly put on the drug producing countries 
defined as a risk to the U.S. (and Europe, it could be added)
112
 (Astorga, interview). 
According to Kushlick (2011) drug policy has undergone a twofold securitization process, 
with a second securitization being that of organized crime due to drug trafficking in the 
1980s, resulting from the prohibition regime
113
.  
The rhetoric of ‘war’ on drugs which defines drugs as a ‘threat’ to security has, in many 
countries, allowed for extensive militarization. It has also allowed for an expansion of 
coercive measures and techniques available to police and intelligence agencies, as well as an 
expansion of these agencies themselves. Nadelmann & Andreas (2006) examine international 
police cooperation and find that it has become increasingly professionalized and depoliticized, 
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 In Stanley Cohen’s (1994) terms, one might observe a bifurcation in a ‘soft’ and ‘hard’ end in global drug 
control. 
112
 Which has also allowed for the U.S. to exert control over other countries (some more than others) even after 
the Cold War era.  
113
 Many have also noted that the ‘threat of drugs’ as well as the ‘threat of organized crime’ to be rhetorically 
mixed with the ‘terrorist threat’, the latter particularly after September 11th (see among other Jelsma 2004b). 
However, I will not discuss this link any further in this thesis.  
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just as the definition of drug trafficking as a matter of ‘national security’ has depoliticized this 
matter at the level of governments. 
I think that if we want to understand the barriers to change, it is insufficient to examine 
change in general terms of governmental rationalities as each and one of the agencies, 
departments and institutions devoted to fighting drug trafficking follow their own system-
internal logic and rationality with their own system-internal goals, objectives and 
techniques
114
. These types of barriers might most properly be called ‘institutional barriers’. 
The logic of these agencies and institutions will most likely primarily aim at self-survival (just 
as politicians follow a logic of self-survival, which we saw in the last section), which in many 
cases constitutes significant and powerful barriers to change. Due to the scope of this thesis I 
cannot examine these plentiful system-internal logics and rationalities in detail. However, in 
the next section I will show how one such system-internal logic of self-survival might just 
have been what has allowed for an amendment of the global discourse on narcotic drugs.  
5.4.3 Amendment of the drug control discourse and the role of civil society 
organizations  
The prevailing international drug political objective has been to eliminate, or at least 
substantially reduce, the prevalence of drug consumption. This has mainly been done through 
efforts aimed at suppressing drug supply. With harm reduction gaining ground, another drug 
political objective emerges with it, namely to reduce the net sum of harms related to drugs 
rather than consumption prevalence. MacCoun & Reuter (2001) note that these two goals are 
not necessarily compatible
115
. For instance a regime of de jure legalization might witness an 
increase in consumption prevalence although it would most probably lead to a substantial 
reduction in net harms. They claim that the most crucial barrier to change is “the 
unwillingness to consider tolerating increases in drug use to achieve reductions in drug-
related harm” (2001: 371). However, in the last chapter I argued that one of these harms, 
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 For instance Feeley & Simon (1998) claim that the U.S. criminal justice system has adopted an actuarial 
rationality leading the system to operate with its own, system-internal logic of ‘risk management’ which does not 
take any societal consequences into regard. Cohen (1994) rather claim that the ‘soft end’ of the criminal justice 
system has given birth to a myriad of different interventions from community service to halfway houses, which 
all create their own internal logics, professions and objectives. Christie (2000) accounts for how (especially U.S.) 
crime-control can be seen as a profit-driven industry with a logic of profit maximization. Many have also noted 
that police agencies operate with the aim of producing statistics (see for example Barrett et al. 2008).  
115
 They argue that harm reduction currently seems limited, and that it should incorporate a strategy of quantity 
reduction – focusing on consumption levels rather than prevalence rates – which thus would serve both the ends 
of use reduction and harm reduction (MacCoun & Reuter 2001: 372).  
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namely the HIV-epidemic, has been framed as a serious threat to security (in bio-political 
terms), which has elevated the drug political goal of harm reduction into official political 
discourse. Furthermore, Rolles claims that the two new drug policy trends which have 
emerged, namely harm reduction and decriminalization, pose an intellectual threat to 
prohibition in that they have demonstrated effectiveness (Rolles 2011: 61). Most notably, the 
evidence from countries that have decriminalized use and possession for personal use 
undermines the fatalistic argument of the prohibitionists that an abolition of prohibition will 
automatically lead to increased use
116
, which is one of the key points of contention in the drug 
control debate (MacCoun & Reuter 2001: 72). 
The UN drug control organs seem to have managed this intellectual threat through partly 
incorporating the ideas and rhetoric of harm reduction and decriminalization; to hold a stance 
of what MacCoun & Reuter (2001) call ‘reformed prohibition’. This is an amendment of the 
drug control discourse which the drug policy reform movement has helped to produce:  
“[...] I think what we’ve created now is we’ve civilized an unsustainable system. So, we’ve 
given people like Fedotov
117, we’ve given them a discourse which allows them to stay a friend 
of health as well as a friend of police. Now, Marxist analysis of that would say; every time 
you allow a paradigm to civilize itself, you extend its life. So there would be some, for 
example legalization campaigners, who’d say: Why are you helping them to find this new 
discourse?  What you should do is allow them to break themselves and become irrelevant [...] 
Or wait until the system absolutely breaks and there’s a paradigm shift. What’s happening at 
the moment is incremental moderation of a bad policy. Which for me as a policy maker, that’s 
what should happen. Step by step you make things better. There’s another theory that says: 
Well actually you should allow…because it’s fundamentally a wrong paradigm, you should 
allow it to eat itself, and then you replace it with a different paradigm. I don’t see how that 
works politically in the current world” (Mike Trace, IDPC, interview).  
Trace is thus indicating that the UN drug control organs needed to reform themselves and 
amend their discourse in order for the prohibition paradigm to sustain. This is something that 
the drug policy reform movement has helped them in doing by giving them arguments and 
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 He points out that the decline in use seen in Portugal and other European countries can not be causally linked 
to the decriminalization of drug use and possession as there are many other variables at play. However, he does 
also note that there has not been an increase in use, as predicted by prohibitionists (Rolles 2011: 61).  
117
 Yury Fedotov is the current Executive Director of the UN Office on Drugs and Crime (UNODC) and 
Director-General of the United Nations office in Vienna (UNOV). He replaced Antonio Maria Costa in 2010.  
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ideas. As previously noted, the amendment of discourse coincided with an opening up of the 
structures for civil society participation. 
In the previous chapter I argued that there is an increasing tendency for states and IOs to 
outsource the responsibility for the health and welfare of drug users to harm reduction NGOs. 
In relation to the UN drug control organs there could not be said to be a similar outsourcing. 
However, I will suggest that these UN organs might have used the drug policy reform 
movement to “create space for political agency” (Neumann & Sending 2010: 127), or rather 
harnessed them in order to reform themselves – which was necessary for their self-survival 
and for a sustainment of the paradigm. It should be noted that this is not necessarily a 
strategic, conscious action as it may seem here, and it is probably also an outcome of the more 
general anticipation and tendency of UN organs to involve civil society. But it might be 
argued, then, that this change is in line with a broader change in governmental rationality 
implying a governing through civil society. 
Neumann & Sending note that this increase in governing through NGOs has generated a new 
type of NGOs as well as new action-orientation among existing ones, as these actor “have 
resumed responsible, effective and diplomatic attitudes” (2010: 129). Furthermore, they claim 
that “[i]t is their ability to act as responsible vehicles for political will-formation and as 
sources for expertise that renders them central actors [in important governmental tasks in 
international settings]” (2010: 130). Della Porta et al. (2006) similarly note that many social 
movements transformed in the nineties to be more ‘civilized’ by adopting more inclusive 
strategies: 
“Especially after the decline of a broad wave of peace protests of the early eighties, scholars of social 
movements noted a tendency toward institutionalization of the movements’ organizational structures 
with the creation of formalized (and often rich) associations, their specialization on single issues with a 
certain degree of pragmatism, and a declining emphasis on protests as well as preference for less visible 
lobbying strategies or voluntary action” (della Porta et al. 2006: 22). 
Mike Trace (interview) assesses that one of the changes that has occurred within the drug 
policy reform movement the last decades, which has contributed to their success in terms of 
advocacy, is that they got a better understanding of how to work with the system.  
One example at the international level is the work of the Transnational Institute. Martin 
Jelsma (interview) tells me that their work involves bringing in their expertise on the UN drug 
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treaty system to governments which are open to drug law reform. Through making 
comparisons between reform experiences in different countries, they advise on changes that 
can be made within the UN treaty framework
118
. They offer direct counseling services, 
providing governments and parliamentarians with concrete policy recommendations and 
comment on and draft legislative proposals (also involving local experts on national drug 
laws), as well as creating spaces for more informal dialogues where they invite government 
officials from different countries who are looking for reform possibilities.  
At the national level of Germany, the change towards working with the system is also brought 
up by Dirk Schäffer:  
“Ten years ago the JES Network was the fundamental opposition. We are against many things 
and that is the way we like, but it is not the way to get in contact with the politicians on a 
national level in Germany. In my view it is important to take seat in the different working 
groups. We have a working group to change the national law for substitution treatment and 
the paragraphs for the substitution treatment. And our work and my work is to get in contact 
with the politicians who are involved there and try to get a chance to take a seat there, or that 
I’m seen as an expert or that I could make some notes of what’s my view and what the view of 
other people is. And that is more effective than being in fundamental opposition. But this is 
our role too, to be a fundamental opposition, a radical opposition to many things, but we do 
not make many efforts with this” (Dirk Schäffer, Deutsche AIDS-Hilfe, JES, interview).  
With this, Schäffer touches upon a point that according to Neumann & Sending (2010) is 
crucial for the possibility of governing through NGOs. Although the drug policy reform 
movement has become much better at working with the system, they are still in fundamental 
opposition. It is the element of opposition which makes them autonomous subjects to be 
governed through, rather than objects to be governed upon.  
Some elements of opposition can often, however, be downplayed in the process of working 
with the system. For instance both Schäffer and Stöver (interviews) tell me how their long-
term goal is to have government regulation of drugs similar to the models proposed by Rolles 
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 The TNI has advised on drug law reforms in many countries, among others in Ecuador, Thailand, Uruguay 
and Bolivia. 
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(2009). However, in their advocacy they primarily emphasize the (short-term) need to 
decriminalize drug users
119
: 
“Our main goal is decriminalization. Our main goal is that drug use is not a criminal thing 
and that is our main goal that drug users, if they want to use drugs they could live with drugs 
if they want, and that they don’t go to jail […] We have a model, and only on the paper, for 
drug shops, it’s called drug shops in Germany120 […] But in my view it is not a success to 
present the politicians with these things.  I think it is more important to go one step after 
another. Because if we told them: ‘Make shops where you can buy drugs’, they’d say: ‘You’re 
crazy, go away’. It is not the way” (Dirk Schäffer, Deutsche AIDS-Hilfe, JES, interview).  
Akzept is also primarily fighting for the decriminalization of drug users. Simultaneously, 
however, Stöver (interview) tells me that they are translating Rolles’ “Blueprint for 
Regulation” to German, printing it thousand fold, and are distributing it to the right people 
who could change things. He claims that with the increase in violence due to drug prohibition, 
covered by media internationally, it is now a point where they need to have clear strategies 
and alternatives for the future.  
5.5 Conclusion 
In this chapter I first presented the ‘problem construction’ underpinning the prevailing drug 
policies, the current legal framework of drug prohibition, the increasing tendency or ‘trend 
towards decriminalization’ taking place within the room for maneuver under the UN drug 
conventions, as well as models for de jure legalization and government regulation proposed 
by one NGO in the movement.  
Second, I presented what I perceive to be the movement’s main argument for drug law 
reform, namely to stem the harms and costs of drug prohibition. I also exemplified, through 
the cases of Germany and Mexico, how drug law reforms having occurred are seen as 
insufficient by the movement, and how their explicit goals are complete decriminalization of 
drug users as well as introduction of the debate about alternative regulation of drugs.  
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 This is also particularly interesting in relation to Thomas Mathiesen’s (1974) theories on action research and 
social movements, where he claims movements should never choose between their short term ‘ reformist’ goal or 
their long term ‘revolutionary’ in order to neither be co-opted and neutralized nor to be defined out as 
illegitimate. 
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Third, I accounted for how the movement tries to influence a change in the global drug 
control discourse, particularly the discourse of the UN drug control organs, how this discourse 
has been amended, and how the structures for civil society participation have opened up. I 
also discussed the roles of the Latin American Commission on Drugs and Democracy and of 
the Global Commission on Drug Policy in opening up the debate, as well as the particular 
barriers of political benefit and public opinion in this task.  
Lastly, I examined de jure legalization of drugs and the prevailing drug control regime in a 
governmentality perspective. I argued that whereas legalization could be seen as a prospect 
for how ‘advanced liberal’ drug policies could look like, the current policies are dominated by 
‘authoritarian’ governmental rationalities, where a myriad of system-internal logics act as 
institutional barriers to change. I also argued that the UN drug control institutions are 
governing through the drug policy movement in order to sustain themselves and the 
prohibition paradigm, and that the movement accordingly has downplayed its elements of 
oppositions to work more efficiently with the system. The NGOs are still, however, in 
fundamental opposition, which makes them autonomous subjects to be governed through.  
Despite cracks in the transnational moral consensus, the global prohibition regime still stands 
firm and constitutes legal and moral boundaries which signalize norms for appropriate 
behavior – also of states. The moral aspects of drug prohibition and their internalization into 
public opinion seem to be some of the strongest barriers even to informed debate. The 
polarization of the positions of the parties in the debate into the dualistic construction of 
‘prohibitionists’ and ‘legalizers’, as well as a moral stigmatization of the latter position, blurs 
the drug political complexity and hampers the debate.    
In the next chapter I will examine an evolving framing strategy used by the movement which 
helps to break up the dichotomized debate at the same time as it draws on an internationally 
recognized normative framework, namely the human rights discourse.   
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6 Human Rights 
The two previous chapters examined how the drug policy reform movement argues that drug 
political issues should be regarded as matters of public health, social policy and development 
policy as well as how they argue for the abolishment of the criminalization of drug users – 
and/or of the entire drug prohibition paradigm.  
This chapter is dedicated to examine one specific advocacy strategy used by the movement, 
which has quite recently emerged, and which might have a very influential potential when 
looking at the broader development of global, and specifically international, policies at large, 
namely human rights advocacy.  
In section 6.1 I account for how the movement argues that many of the harms and costs 
created by drug prohibition, which were examined in the last chapter, are also violations of 
human rights law.  
In section 6.2 I elaborate on how the NGOs in Mexico and Germany draw on rights 
discourses in their argumentation and advocacy. This section outlines once more a 
fundamental similarity between the NGOs, namely their primacy of advocating drug users’ 
rights. However, the section also examines differences in strategies in relation to the legal, 
cultural, social and political context of their advocacy as well as being a basis for a larger 
discussion of the ‘deontological liberal’ argument of the (human) right to use drugs.  
In section 6.3 I go on to examine the (political) benefits of arguing within a (human) rights 
discourse. First, I elucidate the benefits of bringing the debate from the legislative to the 
judicial power, by looking at a ‘trend’ of countries in certain regions of trying the 
constitutionality of drug offences (in section 6.3.1.). Second, I examine the development of 
the human rights legal framework, its institutions and mechanisms in relation to how this 
development affects the effectiveness and advocacy possibilities of the drug policy reform 
movement (in section 6.3.2.). Third, I account for what is called the ‘system-wide coherence 
argument’, which seems to be a specifically forceful critique of the UN drug control organs, 
targeting the incoherence and disparity between the UN drug control organs and the rest of 
the UN system in relation to human rights (in section 6.3.3.).  
In section 6.4 I discuss the broader societal and political significance of the human rights 
paradigm as a ‘normative master discourse’ or a ‘standard’ and ‘norm’ for measuring the 
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behavior of states, IOs and non-state actors. I argue that this ‘new’ norm contests and 
restructures the boundaries of the circuits of inclusion at an international level in a similar 
manner as does the harm reduction discourse. I also examine the role of transnational 
advocacy networks in enforcing this norm. Moreover, I argue that the human rights norms and 
discourse stand in opposition to several domestic, and international, crimes – specifically 
what could be called ‘criminalization of poverty’ – and that it can be a basis for 
deconstructing these crimes at the same time as it reconstructs perceived criminals as human 
beings with dignity and inherent rights.  
6.1 Drug policy and human rights violations 
The previous chapter examined the harms that stem from prohibition as one of the 
movement’s main arguments for drug law change. In this section I will show how the drug 
policy reform movement draws on international human rights legal framework to state that 
some of these harms are not merely harmful consequences but also violations of international 
law
121
. This section is a broad and brief examination of the movement’s (juridical) 
argumentation of how specific human rights are being violated by the enforcement of 
prohibition. 
First, I account for how the movement argues that current global drug policies systematically 
violate three fundamental human rights principles (in section 6.1.1). Second, I examine how 
supply reduction measures for a long time have been criticized by the movement in terms of 
severe human rights violations (in section 6.1.2.). Third, I elucidate how human rights are 
used in the argumentation for harm reduction policies and interventions, specifically focusing 
on the right to the highest attainable standard of physical and mental health (in section 6.1.3.), 
also in prison facilities. Fourth, I account for specifically grave human rights violations in the 
name of drug control, in relation to arbitrary detention and torture (in section 6.1.4.), 
extrajudicial executions (in section 6.1.5.) and death penalty (in section 6.1.6.).  
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 This section draws heavily upon literature written by members of the movement specifically dedicated to the 
human rights issue, some of which founded the International Centre on Human Rights and Drug Policy in 2011, 
evolving from the Human Rights and Harm Reduction program, or the “HR2” (founded in 2007) of Harm 
Reduction International (HRI). It also draws on specific projects such as the HRI ‘Death Penalty Project’ and the 
transnational campaign ‘Stop Torture in Healthcare’.  
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6.1.1 Violations of fundamental human rights principles 
Barrett et al. (2008) emphasize three crucial human rights principles that have their basis in 
the Charter of the United Nations and the Universal Declaration of Human Rights and run 
throughout all the human rights treaties, which are systematically violated by drug policy 
globally, namely the principle of non-discrimination, the principle of protecting the most 
vulnerable and the principle of empowerment. The principle of non-discrimination places both 
a negative and a positive obligation on the States Parties. The negative obligation is to avoid 
discrimination against “…certain individuals and groups on a variety of explicitly enumerated 
grounds (e.g. race, colour, sex, religion, etc.), or on the basis of ‘other status’, which have 
been interpreted as including health status (including HIV status)” (Barrett et al. 2008: 20), 
whereas the positive obligation is to “…actively identify those individuals and groups in need 
of special measures and to take measures in order to diminish or eliminate conditions that 
cause discrimination” (Ibid.). Barrett et al. (2008) note that in practice drug policy often 
hampers access to health services (which will be dealt with in more detail under) as well as 
creating systematic discrimination through law enforcement and criminal justice systems 
where ethnic-racial minorities, indigenous people and people living in poverty are 
disproportionately punished
122
. Both local farmers producing drug crops, as well as drug 
users, are vulnerable groups. In the case of the first these are people living in poverty 
constantly threatened by reprisals either from drug cartels or supply-side suppression efforts, 
and in the case of the latter, drug users are one of the most marginalized and stigmatized 
groups in their countries. Barrett et al. (2008) note that these marginalized groups and 
communities “… have not, in practice, been a priority, and have instead been overshadowed, 
and often badly damaged, by the pursuit of a drug-free world” (Barrett et al. 2008: 21). The 
principle of empowerment “…is reflected in such matters as the right to self-determination of 
peoples, to the right to freedom of expression, religion, privacy and association, the right to 
political participation, the right of the child to be heard, the right to vote, and the right to 
engage in cultural activities” (Barrett et al. 2008: 21). This principle, they claim, is 
systematically violated through the reluctance to engage people who use drugs or 
communities that are directly affected by drug suppression policies. 
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 Many have for example harshly criticized the overrepresentation of African Americans in U.S. prisons (see 
for example Polak 2012, MacCoun & Reuter 2001, Christie 2000). 
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6.1.2 Supply reduction 
This section will briefly deal with how different human rights are violated through law 
enforcement efforts of suppressing supply, an argumentation which for a long time has been 
invoked by the movement specifically in relation to drug crop producing farmers (Martin 
Jelsma, interview).   
Forced crop eradication efforts have often targeted the crops upon which farmers and local 
communities depend to earn their living, or these farmers themselves, as they make easier 
targets than drug traffickers. Barrett et al. note that eradication of coca and poppy crops prior 
to an establishment of alternative livelihood directly conflicts with objectives of the UN 
Development Program (UNDP) and the World Bank, as it pushes the farmers into deeper 
poverty (Barrett et al. 2008: 31). They draw on examples from Myanmar (Burma) and from 
Peru to show that forced crop eradication was followed by a large drop in school enrolment, a 
decrease in quality of life of the farmers as well as medical practitioners and pharmacies 
shutting down (Ibid.). The book “Children of the Drug War” (2011) documents how children 
of coca growing farmers in Colombia join guerilla groups (Hunter-Bowman 2011) and how 
young girls in Afghanistan are married away to drug traffickers in order for the farmers to pay 
back their debts after their crops have been eradicated (Ahmadzai & Kuonqui 2011), which 
violates these children’s rights. Martin Jelsma (interview) also notes that opium bans in 
Southeast Asia, instigated by the UN drug control agencies, have led to humanitarian crises, 
where other UN agencies had to step in to prevent hunger catastrophes from developing. 
In addition to forced eradication efforts by police or military forces, leading to killings, abuse, 
violence, arbitrary detentions and social and political conflict, aerial fumigation with 
herbicide have led to documented negative health effects and damage of legal food crops.  
The illicit crop spraying have been reported both by the Special Rapporteur on the right to 
highest attainable standard of physical and mental health for its health implications and by the 
Working Group on the use of mercenaries for the engagement of private companies in this 
activity (Barrett et al. 2008: 15). Concerns were also raised by the Committee on the Rights of 
the Child in their report on Colombia in 2006 (Ibid.).  
The next sections will deal with how human rights are being increasingly invoked also in the 
case of drug users, starting with the right to health, which is the most frequent right drawn 
upon by the drug policy reform movement and especially by the harm reduction movement. 
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6.1.3 Harm reduction and human rights 
In chapter 4 on harm reduction I noted that the harm reduction discourse to a large degree is 
concerned with the risk for HIV/AIDS and other diseases, primarily for injecting drug users, 
which is also one of the most important and powerful arguments. What makes the argument 
even more powerful is the explicit legal obligation to States Parties in Article 12 of 
International Covenant on Economic, Social and Cultural Rights, 1966 (ICESCR), which 
requires them to take active steps for “(c) The prevention, treatment and control of epidemic, 
endemic, occupational and other diseases and (d) The creation of conditions which would 
assure to all medical service and medical attention in the event of sickness”123.  
Hence, the obligation of States Parties is not only to provide access to and best possible 
treatment of HIV for drug users (such as antiretroviral therapy) as well as other diseases such 
as hepatitis and tuberculosis, but also to actively prevent these diseases. Put in Ezard’s (2001) 
terms, the obligation of states is not solely that of harm reduction, but also that of risk 
reduction. In also complying with human rights in general, through adequate standards of 
living, non-discrimination etc. as well as equal fulfillment of these rights, at all levels and for 
all groups in society, states will also reduce the vulnerability which predisposes for drug-
related risk (Ezard 2001).  
Barrett et al. (2008) emphasize that the illegal status of drugs does not remove the obligation 
of States Parties to provide measures and to take active steps to ensure that the right to highest 
attainable standard of health is fulfilled for people who use drugs. However, they claim that 
“…[d]espite the obligation in international law, the rhetoric of drug control has often been 
used to undermine the right to health, particularly in the area of the prevention of blood-borne 
diseases such as HIV and hepatitis C virus (HCV)…” (2008: 32). Harsh criminal laws and 
zero tolerance policies in many countries even criminalize (or have criminalized) harm 
reduction measures such as needle exchange and methadone treatment, which are necessary 
measures for the right to health to be met. Furthermore, the fear of arrest and criminal 
sanctions, specifically caused by aggressive law enforcement efforts, often leads to the 
obstruction of harm reduction measures – even in high income countries with comprehensive 
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 Article 12 of the ICESCR is a twofold obligation which first obliges the States Parties to recognize “…the 
right of everyone to the enjoyment of the highest attainable standard of physical and mental health” in paragraph 
one, whereas paragraph two obliges the active involvement of the States Parties to make sure that the right is 
achieved. 
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harm reduction measures (as we saw in relation to Germany in the last chapter). Barrett et al. 
(2008) identify this to be a common problem throughout the world
124
. Jürgens et al. (2010) 
emphasize that under the obligation of the right to health in Art 12., it is not enough for States 
Parties to provide comprehensive harm reduction measures, but that they also need to ensure 
that these measures are accessible. Thus, the active obligation of states includes active efforts 
to ensure that the function of harm reduction measures is not obstructed by law enforcement 
practices.  
Barrett et al. (2008) note that the human rights institutions have not been very concerned 
neither with drug users as a group nor with harm reduction. This is, however, in the process of 
changing as “[i]ncreasingly, UN human rights monitors have begun to interpret the provision 
of harm reduction interventions as necessary for states to be compliant with the right to health 
under Article 12 of the International Covenant on Economic, Social and Cultural Rights” 
(Barrett et al. 2008: 33, emphasis in original). They go on to note that the strongest statement 
on harm reduction has been made by the UN Special Rapporteur on Health, professor Paul 
Hunt:  
“In his report on Sweden’s compliance with its obligations under Article 12, the Special Rapporteur 
stated that harm reduction is not only an essential public health intervention, but that it ‘enhances the 
right to health’ of people who inject drugs. Stating that the provision of harm reduction programmes 
was ‘an important human rights issue’” (Barrett et al. 2008: 34).  
Furthermore, several states have been criticized for insufficient harm reduction measures, 
examples being the WHO, UNODC and UNAIDS criticism of Ukraine in 2005 and the UN 
Committee on Economic, Social and Cultural Rights’ criticism of Tajikistan in 2006 (Barrett 
et al. 2008: 34).  
The jurisprudence and statements of the human rights monitors thus specifically recognize 
harm reduction measures and their accessibility as a necessity for states to be compliant with 
the right to highest attainable standard of health. As we shall see subsequently, this necessity 
also applies to custodial settings.  
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 And they also present similar examples from Thailand, China, Viet Nam, Russia and Ukraine.  
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Harm reduction in prison facilities 
As noted in the previous chapter, harm reduction services and other health services for drug 
users in prisons are rare or insufficient, even in high-income countries. This, the movement 
argues, infringes on several human rights.  
Barrett et al. (2008) paraphrases the Human Rights Committee, assuring that “…[p]ersons 
deprived of their liberty enjoy all the rights set forth in the [ICCPR] , subject to the 
restrictions that are unavoidable in a closed environment” (Human Rights Committee, 
General Comment No. 21 in Barrett et al. 2008: 35). Restrictions on rights must thus be 
justified in well-founded security considerations (Ibid.), which means that prisoners are 
assigned the same rights as non-prisoners (with deprivation of liberty being the exception), 
including the right to highest attainable standard of health. Furthermore, the negative 
obligation of tolerance of torture and ill-treatment in the Convention Against Torture and 
Other Cruel and Degrading Treatment and Punishment (CAT) of 1984, give rise to a positive 
duty of care “…which have been interpreted to include effective methods of prevention, 
screening and treatment for life-threatening diseases” (Barrett et al. 2008:36). Following from 
this, prison authorities are obliged to take active steps to prevent HIV transmission in prison 
facilities. Barrett et al. also note that states have a special responsibility for ensuring 
prisoners’ rights as they by holding people in custody are directly responsible for their lives 
and well-being. Furthermore, this responsibility might even oblige states to provide prisoners 
with better health services than what they have access to outside of prison (Barrett et al. 2008: 
36). The absence or insufficiency of harm reduction measures in prisons not only infringes on 
the right to highest attainable standard of health, but according to Barrett et al. it also 
threatens the right to life
125
 “…by putting prisoners at risk of premature death by overdose, 
and HIV/AIDS and other life-threatening illnesses” (2008: 36).  
The next section will go on to account for human rights violations experienced by people who 
use drugs in other custodial settings other than prison.  
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 International Covenant on Civil and Political Rights, Art. 6.  
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6.1.4 Arbitrary detention, torture and other cruel, inhumane or degrading treatment 
and punishment 
In the previous section I noted the infringement of the Convention Against Torture and Other 
Cruel and Degrading Treatment and Punishment (CAT) in relation to health services in 
prisons. This convention is especially relevant in the relation to drug users around the world 
as they are often targeted by law enforcement officials. They are also often subjected to 
forced custody either in prison facilities or in ‘treatment’ facilities, where abuses of drug users 
are facilitated by their universal stigmatization and discrimination.   
Barrett et al. note that drug users are specifically easy targets for police needing to fulfill 
arrest quotas or achieve convictions (2008: 26). Findings from several countries
126
 show that 
drug users often are physically and mentally ill-treated by police officials, both in the process 
of arrest, while in custody and in interrogation. For instance they account for how withdrawal 
is used as a common tool for extracting confessions from drug users in Ukraine, and how 
medical assistance is denied in such situations (Ibid.). They note that abusive law enforcement 
practices have been heavily criticized and condemned by the UN human rights institutions, 
but also that such critique has not been posed by the UN drug control organs (Ibid.).  
Detention of drug users without trial has also been documented in many countries, although 
this violates a basic principle of human rights law and more specifically Art. 9 and 14 of the 
ICCPR (Barrett et al. 2008: 29). Furthermore, the Human Rights Committee has interpreted 
‘deprivation of liberty’ to also encompass custody other than in criminal cases, such as mental 
illness, vagrancy, drug addiction, immigration control etc. (Ibid.). The UN body of Principles 
for the Protection of All Persons Under Any form of Detention has stressed that persons can 
“not be kept in detention without being given effective opportunity to be heard promptly by a 
judicial or other authority. A detained person shall have the right to defend himself or to be 
assisted by counsel as prescribed by law” (Barrett et al. 2008: 29). Thus, these rights also 
extend to settings of retention in forced treatment facilities.  
Through the transnational campaign “Stop Torture in Health Care”127 awareness is raised by 
an alliance of drug policy reform NGOs and human rights NGOs, led by the Open Society 
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 Barrett et al. draw on reports from Human Rights Watch and the European Committee for the Prevention of 
Torture and Inhuman or Degrading Treatment and Punishment (CPT) about Russia, Kazakhstan and Ukraine 
(2008: 26). However, there is reason to believe that the practices they describe are not limited to these three 
countries.  
127
 http://www.stoptortureinhealthcare.org/ 
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Foundation (OSF), about the abuse of drug users in drug detention centers around the world. 
Particularly in Asia drug users have been coercively detained under the justification of 
rehabilitation in centers where they have been subjected to systematic torture, sexual assaults 
and forced labor
128
. A documentary made by the Hungarian Civil Liberties Union
129
 reveals 
that people can be detained in these centers for up to five years, often based upon positive 
urine tests or allegations by neighbors, without trial, the possibility of appeal or medical 
evaluation. Some of these centers have been funded by UNICEF, the Global Fund and the 
United States, but have been closed down after NGOs documenting and raising awareness 
around them. Still, however, there are many such centers around the world.  
These accounts are merely some examples of how the stigmatized and degraded status of 
people who use drugs facilitate human rights abuses against them, such as arbitrary detention, 
torture and inhuman treatment and punishment in the name of drug control. The next two 
sections will show practices which violate drug users’ right to life.  
6.1.5 Extrajudicial Executions 
In the prveious chapter I argued that the rhetoric of ‘drug war’ and the framing of drug use 
and trafficking at ‘threats’ have legitimized military intervention and an expansion in 
measures and techniques available to police forces. Still, however, international law strictly 
limits the use of lethal force in police operations through the UN Basic Principles on the Use 
of Force and Firearms for Law Enforcement Officials and Code of Conduct for Law 
Enforcement Officials (Barrett et al. 2008: 26). Use of force can only be lawful when 
“…use of force is unavoidable, it should be used in proportion to the seriousness of the offence and the 
legitimate objective to be achieved, and shall minimize damage and injury. In any event, the 
international use of lethal force by law enforcement is permissible only when strictly unavoidable to 
protect life” (Barrett et al. 2008: 26). 
Barrett et al. present two examples from the ‘drug war’ which have been particularly brutal, 
and where several people have been summary executed. One example is from Thailand, 
where 2275 extrajudicial killings,  in addition to a number of arbitrary detentions, 
intimidations of human rights defenders and coerced drug treatment, found place in a three-
month period in 2003 in an intensive governmental effort to be ‘tough on drugs’ (Barrett et al. 
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 It’s estimated that 400 000 people are detained in such centers in China, Viet Nam and Cambodia alone.  
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 http://www.stoptortureinhealthcare.org/real-voices/detention-treatment/abuse-name-treatment 
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2008: 25). The other example is from Brazil, where the police engage in a continuous war 
with drug gangs in the favelas, which are densely populated, leading casualties in shootouts to 
be large. Extrajudicial executions are rarely investigated and proceedings are seldom 
instigated against perpetrators within police forces.  
The next section will go on to account for executions of drug offenders which are lawful in 
domestic jurisdictions, but which violate international law. 
6.1.6 Death Penalty 
The drug policy INGO Harm Reduction International (HRI) launched a global project in 2007 
with the aim of bringing attention to practices of death penalty for drug offences world wide.  
Although death penalty is not forbidden per se under international law, its use is severely 
restricted. Most notably, the International Covenant on Economic, Social and Cultural Rights 
delimits capital punishment to “most serious crimes” in Article 6 (2). This restriction has been 
interpreted as not encompassing drug offences by jurisprudence of independent expert bodies, 
as well as explicitly stated by the UN Human Rights Committee and several Special 
Rapporteurs (Gallahue & Lines 2010). Thus, capital punishment for drug offences clearly 
violates international human rights law.  
Still, however, the global overview (Gallahue & Lines 2010) shows that the jurisdiction of 32 
countries world wide retain death penalty for drug offences
130
. Although five of these 
countries are ‘abolitionist in practice’, at least twelve of them have carried out executions in 
the last three years (2010: 7). A HRI report on death penalty for drug offences from 2007 
showed that although there has been a global trend towards the general abolishment of capital 
punishment, such punishment for drug offences seemed to be rising, thus implying capital 
punishment for drug offences to be a growing share of all executions. However, the report 
from 2010 (Gallahue & Lines 2010) shows that this trend seems to have reversed the 
following three years. Still, some countries such as China
131
, Iran, Saudi Arabia, Viet Nam 
and Malaysia execute large numbers of drug law offenders. In some countries these numbers 
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 Bahrain, Bangladesh, Burnei-Darussalam, China, Cuba, Egypt, Gaza (Occupied Palestinian Territories), 
India, Indonesia, Iran, Iraq, Kuwait, Lao PDR, Libya, Malaysia, Myanmar, North Korea, Oman, Pakistan, Qatar, 
Saudi Arabia, Singapore, South Korea, Sri Lanka, Sudan, Syria, Taiwan, Thailand, United Arab Emirates, 
United States of America, Viet Nam and Yemen (Gallahue & Lines 2010: 11).   
131
 China has even been reported to have large public executions of drug law offenders on the UN International 
Day Against Drug Abuse, the 26
th
 of June (Gallahue & Lines 2010: 21).  
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even seem to be increasing, although numbers can be hard to obtain and hold high uncertainty 
(Ibid.).  
6.1.7 Concluding remarks 
The accounts in these sections have shown that human rights violations happen on a massive 
scale in relation to drug control policies. One specific development of the drug policy reform 
movement is to document these human rights violations, and to bring attention to them at a 
global level and specifically to the UN. In this regard they increasingly cooperate with 
international human rights organizations such as Human Rights Watch and Amnesty 
International.  
This development has been made possible also due to the transnationalization of the 
movement, where the international NGOs, such as IDPC, HRI, Youth RISE and TNI, as well 
as the OSF, has done a lot to connect domestic and regional NGOs together into a 
transnational network. Sikkink (1993) and Keck & Sikkink (1998) stress the importance for 
international NGOs to have dense contact with domestic NGOs, which can provide 
information about local situations and local human rights violations that the international 
NGOs do not have the resources, capacity or local knowledge to uncover themselves. The 
international NGOs, on the other hand, provide their expertise and contacts in lobbying 
international organizations and governments. For domestic NGOs it is sometimes necessary to 
bring their issues to international forums and for an external pressure to be put on their 
countries in order for changes to be made. 
In the next section I will account more specifically for how the domestic NGOs of Mexico 
and Germany draw on rights discourses in their advocacy.  
6.2 Arguing within a (human) rights discourse 
The previous section accounted for how the movement argues that the negative consequences 
which are caused by prohibition and law enforcement are (often severe) human rights 
violations. This section will show examples of how my interviewees from Mexico (section 
2.1.) and Germany (section 2.2.) argue within rights discourses in their advocacy.  
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6.2.1 The case of Mexico 
Mexico is one of the countries in the world experiencing the highest levels of violence and 
abuses in the rhetorical ‘war on drugs’132 between drug cartels and between government 
military and police and drug cartels. Since the military was set in to combat organized crime 
in 2006, which escalated violence, nearly 50 000 people has been killed
133
.  
Apart from horrendous human rights violations on the part of drug cartels, a Human Rights 
Watch report on Mexico, “Neither Rights Nor Security” (2011) found violations also to be 
frequent on the part of police, armed forces and the criminal justice system. Their evidence 
supported the systematic use of torture by security forces as a means of extracting 
confessions, in addition to engagement in disappearances, extrajudicial executions and other 
abuses. Complaints about violations systematically failed to be investigated and prosecuted, 
leading to a state of impunity.  
However, the goal of Espolea and CUPIHD is to separate drug policy from security policy to 
make it a policy of its own - based upon principles of public health and human rights: 
 “The first thing is; it’s about drugs, and that’s very important because otherwise you mess 
with the interest of organized crime in Mexico. Because I am defending first public health, 
individual rights, as well as a much better health approach to the problem of drugs in Mexico. 
And the main objective of that is that and not to combat organized crime” (Jorge Hernández 
Tinajero, CUPIHD, interview).  
Aram Barra (interview) notes that it is wrong to characterize Mexico merely as a transit 
country as it is also (apart from also being a producer country) home to an increasingly 
growing number of drug users. As in the rest of the world, drug users in Mexico are subject to 
systematic stigmatization and discrimination, a situation which is not improved by the 
government’s zero-tolerance approach to drug use (Barra & Joloy 2011). Luís Astorga 
(interview) notes that drug users are regarded as trash, as criminals, to which anything can be 
done because they are regarded to be completely without any rights. Barra & Joloy point out 
that “Article 4 of the Mexican Constitution provides for universal access to health services, 
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 Gallahue (2011) analyses the situation of violence in Mexico to see if it could be classified as an ‘armed 
conflict’, hence subjecting it to International Humanitarian Law. However, he finds that it cannot be classified as 
such among other due to the lack of organization on the part of drug cartels, which rather makes the situation a 
‘rhetorical war’ rather than an armed conflict.  
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 http://www.guardian.co.uk/world/2012/may/01/mexico-law-compensate-crime-victims1?INTCMP=SRCH 
[Date of last access: 02.05.2012] 
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but this is far from the case for people who use drugs” (2011: 34). Treatment options and 
harm reduction services are “…scarce and hampered by a lack of security, criminal laws, and 
drug-related stigma” (Ibid.). They go on to note that the criminalization and public 
stigmatization of drug users drives them away and hampers them from accessing the 
insufficient treatment options that do exist.  
Furthermore, they highlight that drug users in Mexico are subject to severe human rights 
violations, such as violence, kidnappings and killings by drug cartels which can be seen as a 
form of ‘social cleansing’ (Barra & Joloy 2011: 35). There have also been several attacks on 
rehabilitation centers as well as massacres of drug users. The government responses to such 
killings and abuses, however, is that drug users are part of organized crime and belong to one 
group or another, as “…widespread stigma and negative public attitudes toward drug users 
combined with the drug war have made violence against this particular community a valid 
political statement” (2011: 34). The government rhetoric has been criticized by a local 
Commission on Human Rights and is also strongly criticized by Espolea
134
. Espolea has also 
pointed out that many drug users are young people, and abuses against them also specifically 
violate the Convention on the Rights of the Child. 
The Latin American Commission on Drugs and Democracy has stated that the criminalization 
of drug users in Latin America facilitates the extortion of drug users by law enforcement 
officials. Tinajero (interview) tells me that CUPIHD give out a little pocket-sized booklet in 
the streets informing drug users about their legal rights according to the new drug law as well 
as their procedural rights if arrested
135
. They also try to bring awareness around traditional 
and cultural drug use, which has long historical roots in Mexico and in the whole of Latin 
America, and is protected by indigenous rights both in international and in national laws. 
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 It is peculiar for instance that the Human Right Watch Report on Mexico’s ‘drug war’, “Neither Rights Nor 
Security” (2011) does not mention any human rights violations done to drug users. The only mention of drug 
users in the report is when alleged killings by law enforcement officials or military personnel of non-drug using 
civilians have been manipulated through planting drugs on the victim to make the victim look like he was part of 
organized crime. It is then the manipulation of the crime scene that is criticized by HRW, not the point that it 
would be regarded legitimate to kill the person if the person was a drug user. 
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 In earlier conversations with Aram Barra (in 2010) I got to know that the new drug law is very badly 
communicated to people. He thought very few drug users knew about it and to an even lesser degree its 
substantial content. This corresponded with the experience I had from talking to drug users in Mexico (on a trip 
in 2010), who told me that 1) they didn’t know about the new law and 2) they thought that the police didn’t 
know either, and if they did, they wouldn’t change their behavior in accordance with the law as they often 
arrested drug users for the mere aim of extortion. 
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The Mexican NGOs also have a large job to do in changing the attitudes of law enforcement 
officials and government officials. Astorga (interview) talks about using the human rights 
discourse as advocacy strategy in terms of a pedagogic approach. He says that their task is to 
make people understand that human rights are international laws that need to be respected and 
that these rights also apply to people who use drugs.  
6.2.2 The case of Germany 
In Germany too the main concern of the drug policy reform movement are drug users’ rights. 
However, Dirk Schäffer (interview) informs me that they do not draw much on human rights 
in their advocacy. They have a large focus on the best possible treatment for drug users, but 
they rather draw on health rights according to national law in their argumentation.  
Jürgens et al. note that the right to health in international human rights law is interpreted to 
require all countries to have “…effective, national, comprehensive harm reduction policy and 
plan, delivering essential services”, but also that high-income countries are expected to 
deliver more than these essential services (2010: 1 and 6).  
This can mean that the national laws of many high income countries are not only presumed to 
be in accordance with human rights law, but that they also set higher standards than required 
by international law. National rights in high income countries might have a strong level of 
institutionalization as well as elaborated domestic mechanisms monitoring their compliance 
and processing complaints. This, then, makes it more strategic for advocates to draw on rights 
according to national law. In relation to harm reduction, however, I assume that the content 
and the interpretation of health rights might vary according to the political climate for harm 
reduction. In cases where domestic interpretation of health rights does not encompass harm 
reduction measures, it might be necessary to draw on international human rights law and 
international jurisprudence. Sweden has for instance been specifically criticized by the 
Special Rapporteur on the highest attainable standard of physical and mental health for its 
failure to provide harm reduction measures on human rights grounds (Barrett et al. 2008: 34).   
There is, however, also another way that the German movement draws upon human rights. 
Heino Stöver says human rights are one of the key arguments they are using when it comes to 
political change:  
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“That finally it’s a human right to use drugs and from a human rights perspective we have to 
support the users’ views. And that’s, I think, the common ground [for the five German drug 
political organizations working together with Akzept]” (Heino Stöver, Akzept, interview).  
Stöver thus argues from the position which MacCoun & Reuter (2001) call the ‘deontological 
liberal’ position, which is, as I will discuss in greater detail in the next section, specifically 
interesting in relation to Germany as such an argumentation was partly what lead the German 
Federal Constitutional Court to open for depenalization of drug possession. Stöver’s quote is 
also specifically interesting in that it highlights the close relation of the underlying humanistic 
principles of harm reduction and human rights.   
Neil Hunt (2004) argues that one can identify two philosophies of harm reduction as a rights 
based movement; one version which emphasizes public health and one version which 
prioritizes human rights before public health. These two versions of harm reduction, he 
claims, can lead to different forms of ‘right action’ (Hunt 2004: 231). He calls the two 
versions ‘weak rights’ and ‘strong rights’ versions based on John Stuart Mills’ philosophy on 
the sovereignty over the body (Hunt 2004: 232). The strong rights version recognizes a right 
to use drugs to the extent that it does not harm others; the right to sovereignty over the body is 
prioritized, which “…limits the means by which we may promote health to those approaches 
that are essentially persuasive”136 (Hunt 2004: 232).  The weak rights version may put more 
limitations on sovereignty with the goal of optimizing the health of the population. Liberty is 
thus subordinated to the aim of optimized public health - which implies supporting the regime 
which produces least harms
137
. However, Hunt does also notes that these positions are styled 
for the purpose of analysis and that many individuals would normally hold a position in 
between these versions.  
Van Ree (1999) claims that in countries where drug use and possession is not a punishable 
offence, there already exists a ‘weak’ right to use drugs - in the negative sense that it is not 
punishable. However, he argues that the perception of freedom in the Universal Declaration of 
Human Rights is closely linked to the inherent dignity of a human being. Thus, as many 
people use drugs, there is a need for a strong right to use drugs which recognizes them and 
their dignity as long as they do not infringe on the rights of others (in the Millean sense). Hunt 
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 This version especially supports the regulation model presented by Rolles (see last chapter).  
137
 When claiming that harm reduction is indifferent to the question of legality of drugs (as I did in the two last 
chapters), this is necessarily in relation to the weak rights version. 
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(2004) claims that the inclusion drug use as a human right in the Universal Declaration of 
Human Rights is highly unlikely. However, he argues that practically this right could most 
likely arise from legal interpretation of the exiting rights to privacy (Hunt 2004: 234), like for 
example the Article 12 of the Universal Declaration, which guarantees the ‘privacy’ of the 
citizen, or the Article 18, which gives the citizen the right to manifest his ‘belief’ through a 
‘practice of choice’ (van Ree 1999: 92). As we shall see in the next section, a similar 
interpretation has been made in many countries where the constitutionality of simple drug 
possession has been tried.  
6.2.3 Concluding remarks 
In this section I have shown how the drug policy reform NGOs in Mexico and Germany draw 
on rights discourses in their argumentation. Again it outlines a fundamental similarity 
between the NGOs, which are first and foremost concerned with the rights of people who use 
drugs – be it in relation to their rights to health and best possible treatment or their right to 
freedom from stigma and discrimination. The variation between the NGOs is rather evident in 
relation to the legal framework of rights upon which they draw as well as the political, social 
and cultural contexts in which they are situated. The argument about traditional and cultural 
use might more specifically apply to the Latin American context. Still, however, Böllinger 
claims that the process of globalization and mobility of peoples “…has fostered the 
elimination of the traditional delineation of culturally integrated and nonintegrated drugs” 
(2004: 498), leading patterns of use which before were limited to certain cultures and 
hemispheres to be exported and generalized (Ibid.). 
The next section will continue discussing some of the themes touched upon in this section in 
relation to the (political) benefits of moving the debate about legality of drugs from the 
legislative power to the judicial power.  
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6.3 (Political) benefits of arguing within a (human) rights discourse 
This section discusses different benefits of arguing within rights based discourses to change 
drug policy. First I present the benefits of bringing the debate from the legislative to the 
judicial power (in section 6.3.1.). This section accounts for a process which could not be said 
to be influential on the part of the drug policy reform movement, but which nevertheless is 
important for awareness around and acknowledgement of drug users’ civil rights. It might 
also be significant in relation to a change in the global discourse on drug control. Second, I 
account for how the development of the human rights legal framework and its 
institutionalization has enhanced the advocacy possibilities of the drug policy reform 
movement (in section 6.3.2.). Third, I present what I perceive as a particularly powerful 
argument posed by the movement, namely in relation the human rights commitments of the 
UN drug control organs and their disparity to the rest of the UN system (in section 6.3.3.).  
6.3.1 Benefits of bringing the discussion from the legislative power to the judicial 
power 
In the previous section I outlined the argumentation from a ‘deontological liberal’ position 
which recognizes a person’s right to use drugs to the extent that it does not infringe on the 
rights of others. As will be shown in this section, such a right can currently be derived in 
many countries whose constitutions guarantee their citizens strong civil rights including the 
‘freedom to hurt oneself’ or the ‘freedom to express one’s personality’.  
As mentioned in the previous chapter, such a constitutional civil right is just the reason why 
drug use per se is not a criminal action in German law. The process which led the German 
Federal Constitutional Court to rule out the principle of nolle prosequi in cases of simple 
cannabis possession was instigated by the Lübeck Court, which, instead of condemning a 
woman for simple cannabis possession, chose to try the constitutionality of the crime 
(Papendorf 2002). One of the main arguments of the Lübeck Court was that criminalization of 
cannabis possession conflicts with Article 2 part 1 of the German Constitution, which 
guarantees the free expression of the personality (2002: 109). An intervention could thus only 
be justified through the principle of proportionality. The Court did not consider penal 
sanctions proportionate to the crime. Although the Federal Constitutional Court disputed this 
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interpretation
138
, it still decided to rule out the principle of nolle prosequi in cases of simple 
possession with low degree of public interest and of personal guilt (Ibid.).  
Aram Barra (interview) talks about a similar process taking place in many Latin American 
countries. As Latin American countries all got their independence from Spain around the 
same time, they also have very similar constitutions, inspired strongly by the civil rights bill 
in France which was passed just prior to the independences.  
“And that is very interesting because that allows for the judicial system, particularly for 
courts, for judges, for people who practice law, to defend different positions around drugs, 
which is for instance what we saw in Argentina, the current debate in Colombia, the debate in 
Mexico as well, which is: It is unconstitutional detaining someone for possessing drugs, they 
say, even if drugs are an illegal product. And that has to do with that; the recognition of 
individual rights, of civil rights and thus that an individual can do whatever the individual 
wants to do if it doesn’t affect a third person or a third party. And that is interesting in terms 
of the debate which doesn’t happen in other regions of the world, it doesn’t happen in general 
in Africa, it doesn’t happen in general in Asia. Which question a lot of punitive laws [...]” 
(Aram Barra, Espolea, interview). 
According to Barra constitutional civil rights are thus important tools for defending a change 
of the punitive paradigm.  
In June 2011 Bolivia shocked the world by being the first country ever to withdraw from the 
Single Convention on Narcotic Drugs precisely due to constitutional civil rights recognizing 
traditional use of the coca leaf
139
. Due to the unconstitutionality of the coca leaf ban in the 
Single Convention, Bolivia had asked for a rescheduling of the coca leaf without success. 
Thus, it had no other choice than withdraw from the convention, into which it will re-accede 
with a reservation on the coca leaf and traditional uses (Bolivia Withdraws from the UN 
Single Convention on Narcotic Drugs 2011). In the TNI/WOLA press release Martin Jelsma 
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 The Federal Constitutional Court refuted this assessment due to the possibility of uncontrolled distribution to 
a third party and the stimulation of the demand for drugs (Papendorf 2002: 112) 
139
 The new Bolivian constitution from 2009 Article 384 recognizes that “…The State shall protect native and 
ancestral coca as cultural patrimony, a renewable natural resource of Bolivia’s biodiversity, and as a factor of 
social cohesion; in its natural state it is not a narcotic. It’s revaluing, production, commercialization and 
industrialization shall be regulated by law”(Bolivia Withdraws from the UN Single Convention on Narcotic 
Drugs 2011). 
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notes that the restrictions which the Single Convention places on the coca leaf and its 
traditional users are violations of indigenous rights (Ibid.).  
This brief section served the purpose of showing that bringing the discussion about the 
legality of drugs to the judicial power can lead to amendment of drug laws in one way or 
another, especially in countries with constitutions recognizing strong civil liberties, right to 
privacy and free expression of the personality. As noted by Barra, this might also question the 
legitimacy of punitive drug laws in other countries as well as the legitimacy of the UN drug 
conventions.  
The next section will go on to discuss how the recognition of individual rights and their 
institutionalization in international human rights law and mechanisms has affected the 
advocacy possibilities of the drug policy reform movement.  
6.3.2 The development of human rights and their effectiveness as advocacy tools 
The concept of human rights is historically recent, dating back to the era after World War II. 
However, Sikkink notes that although the human rights norms emerged in the aftermath of the 
Holocaust, their development was not fuelled before the 1970s due to their subordination to 
anti-communism during the Cold War
140
 (1993: 418). It was first after the Cold War that 
human rights came to be nearly universally acknowledged (Manokha 2009).  
Many human rights scholars have emphasized the crucial role of transnational advocacy 
networks or ‘global civil society’ in the task of institutionalizing and globalizing the human 
rights norms, monitoring state compliance, as well as contributing to the process of the 
development of the human rights legal framework, institutions and mechanisms (Sikkink 
1993, Savelsberg 2010, Bianchi 1997).  
Sikkink (1993) notes that what bind the human rights networks together are their shared 
values and principled ideas, which are embodied in the international human rights law. Barrett 
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 The fundamental human rights were codified in the Universal Declaration of Human Rights (UDHR) in 
1948, later to be strengthened in the International Covenant on Civil and Political Rights (ICCPR) and the 
International Covenant on Economic, Social and Cultural Rights (ICESCR), both from 1966. The specific 
human rights treaties are even more recent, as the one for protection of women’s rights from 1979, children’s 
rights from 1990, indigenous peoples’ rights from 1991 and also the convention against torture from 1987 
(Savelsberg 2010: 28). 
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& Gallahue (2011) point out that harm reduction (and drug political issues) has been generally 
unfamiliar to the human rights field. Still, they embody similar principles, such as dignity, 
universality, transparency, accountability and participation as well as the aim of “challenging 
policies and practices that maximise harms” (Barrett & Gallahue 2011: 188). Whereas issues 
of crop producing farmers and eradication efforts for a long time have been framed in terms 
of human rights violations, it is just recently that the drug policy reform movement has also 
framed their arguments about drug users’ rights within the human rights discourse:  
“It’s more recent to try to really enforce the debates more general about the whole drug 
policy, framing it in human rights terms and using it as very powerful arguments, which also 
has become more useful because of the developments of the human rights instruments 
themselves. The right to health has of course become a powerful tool in this context and 
indigenous rights have also become only recently formally recognized as a human right” 
(Martin Jelsma, TNI, interview). 
The development of the human rights treaty system, but also of the human rights institutions 
and mechanisms, have thus allowed the drug policy reform movement to expand their 
arguments – and making them more powerful as they are grounded in an internationally 
recognized normative framework. Sikkink notes that for human rights networks “[t]he body 
of law serves to justify actions and provide a common language to make arguments and 
procedures to make claims” (1993: 416). Bianchi (1997), too, observes that grounding 
advocacy in normative frameworks makes NGO activism much more effective.   
Furthermore, transnational advocacy networks contribute to creating “…global cognitive 
scripts (or models) and norms, which, once produced, unfold considerable force” (Savelsberg 
2010: 32). Bianchi also notes that transnational networks “…create transnational solidarities 
and gather consensus on human rights values regardless of whether they are embodied in 
formal rules” (1997: 190). In this manner they contribute to a ‘communicative process’ where 
state behavior is assessed in relation to whether it is consistent with fundamental human 
values (Ibid.).  
The development of the human rights institutions and mechanisms themselves has also 
allowed the drug policy reform movement to target other arenas in their advocacy than those 
directly concerned with drug policy, such as drug control or health institutions. Martin Jelsma 
(interview) emphasizes the important role of the Special Rapporteurs which have brought 
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attention to the issues of proportionality of sentences, prison conditions, torture and inhumane 
treatment and health in relation to drug policy. He also stresses the importance of the 
independency of the Special Rapporteurs, who work directly under the Secretary-General and 
who report directly to the General Assembly, which allows them to go beyond the level of the 
CND
141
. It also allows for a new strategy for the movement, of bringing the drug issues out of 
the narrow Vienna NGO Forum and to arenas such as the Human Rights Council and the 
World Health Assembly (Jelsma, interview). The Human Rights Council is now issuing drug 
policy for the first time
142
. Aram Barra (interview) tells me that the movement is also 
increasingly engaging with the agencies protecting the special human rights treaties, such as 
the Committee on the Rights of the Child (CRC) and the UNICEF, as there are many children 
either using drugs or directly affected by current drug policies. The same strategy applies to 
women and indigenous people. In this manner, they try to bring awareness, to both human 
rights agencies and other non-state actors working on human rights issues, around an area of 
human rights violations that has previously been neglected.  They seek to expand the global 
cognitive and normative scripts to encompass the rights of people who use drugs and of 
people who are negatively affected by drug policy, to create a transnational solidarity on this 
issue, and, ultimately, to change the behavior of states – and, as we shall see in the next 
section, the behavior of other UN agencies.   
6.3.3 The ‘System-wide Coherence Argument’ 
This section will deal with how the drug policy reform movement draws on international 
human rights legal framework, institutions and mechanisms to influence the UN drug control 
organs to act in coherence with human rights norms.  
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 Many have noted that one particular problem with the CND is that it has chosen to pose resolutions solely 
based upon consensus, which means that the countries have to negotiate the lowest common denominator and 
that any of the fifty-three member countries can block a resolution – often leading wording to be vague (Jelsma 
2004: 5, Barrett et al. 2008). Going beyond the level of the CND thus allows the movement for bringing up 
issues which could never have made it into a CND resolution.  
142
 Barrett et al. (2008) emphasize the enhanced and reinforced position of human rights in the UN system. In 
2006 the Human Rights Commission, which was a Functional Commission under the ECOSOC (just as the 
CND), was replaced by the Human Rights Council, which is a ‘standing body’ elected by and reporting directly 
to the General Assembly (2008: 15). The Human Rights Council now sits alongside the Economic and Social 
Council and the Security Council as the main bodies for the three pillars of the UN (human rights, peace and 
security) (2008: 22). This change was instigated by the former Secretary-General Kofi Annan to emphasize the 
authority and primacy of human rights in the UN Charter (Ibid.).  
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Martin Jelsma (interview) notes that the drug control discourse at the international level has 
been concentrated within the triangle of the CND, the INCB and the UNODC, where the rest 
of the UN system simply has been cut out.  
“And the human rights argument is one of the ways to force all the UN agencies to look at the 
issue and to look at it also from the system-wide coherence argument. System-wide 
coherence, that’s an UN term, that the Secretary-General has to try, that on key issues like 
the Millennium Development Goals, that the different UN branches act in coherent moves. 
And the drug policy issue is a clear example where there is incoherence” (Martin Jelsma, 
TNI, interview) 
This incoherence and disparity between the UN drug control organs and the rest of the UN 
system is an issue that is increasingly emphasized by the drug policy reform movement.   
Barrett et al. (2008) note that although both the drug conventions and the UN institutional 
framework which they enact are similar in structure to the human rights legal framework and 
the rest of the UN institutions (albeit smaller), there are some significant differences. Namely, 
the methods they adopt, and the principles and the ideology which they enshrine are of a very 
different kind. 
First, the UN Drug Conventions are based on very different ideological grounds than the 
human rights treaty system. Rather than promoting and protecting a set of universal rights 
with the aim to attain higher standard of living and peaceful solutions to problems, which is 
the purpose of the Charter of the United Nations and the Universal Declaration of Human 
Rights, the Single Convention establishes the duty to ”combat the evil” which drugs 
represent, through encouragement and sometimes direct obligations to establish criminal 
sanctions.   
Second, Barrett et al. (2008) note that although the preparations for the Single Convention 
were made in the same time as the Universal Declaration of Human Rights was ratified, it 
bares no traces of it. The drug conventions hardly mention human rights at all
143
.The focus of 
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 Article 14(2) of the 1988 Convention mentions human rights in that measures adopted to prevent illicit 
cultivation shall respect fundamental human rights and traditional licit use.    
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the conventions is punitive and there are no but a few provisions about the treatment of 
addiction in the 1961 and 1971 conventions
144
 (Barrett et al. 2008: 19). 
Third, there has been a lack of human rights guidance from the CND, which is the central 
political body on drugs in the UN system (Barrett et al. 2008: 15). This is of special concern 
as the protection of human rights is the purpose of the UN, an obligation in the Charter of the 
United Nations, as well as a responsibility of the CND. The INCB (which monitors the 
implementation of the drug conventions) has even directly stated that it will not discuss 
human rights (Barrett et al. 2008: 12).   
Fourth, the UN drug control organs have been practically closed for civil society 
participation. In the rest of the UN system NGOs have a crucial role as partners - in revealing 
human rights abuses as well as ensuring an open dialogue and transparency. Civil society 
participation has increased in UNODC and slightly for the CND, as we saw in the last 
chapter, whereas the INCB have publicly stated that it will not engage with civil society
145
 
(Barrett et al. 2008: 19). The conventions and the attitudes of its governing organs are thus 
undermining the principle of empowerment mentioned in section 6.1.1. 
Lastly, there has been very little concern about human rights abuses in relation to drug policy 
neither from other UN bodies nor human rights NGOs. As I have shown in this chapter this is, 
however, also changing as Special Rapporteurs in several fields have noted human rights 
violations against drug users and farmers and human rights NGOs, such as Human Rights 
Watch and Amnesty International, have increasingly raised their interests for human rights 
violations in relation to drug policy.  
After a thorough discussion of the hierarchy of human rights and drug control in the UN legal 
framework and of the UN institutions, Barrett et al. (2008) clearly find human rights to have 
precedence. Nevertheless, they state that:  
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 These conventions also specifically open for forced treatment of drug users. Barrett et al. notes that forced 
treatment or ’rehabilitation’, apart from having a very large relapse probability, ”…can and does result in 
significant human rights violations” (2008: 29). 
145
 However, Cook (2010) notes that the CND is mandated to engage with civil society as a functional ECOSOC 
commission, under Art. 71 of the UN Charter, and that this is also the case for INCB, as the 1972 Protocol of the 
Single Convention explicitly states that INCB should draw on civil society as a source of information. On a 
detailed account and critique of the uniqueness of the INCB in the UN system, see “Unique in International 
Relations?” by Damon Barrett (2008).  
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“Instead, notwithstanding the de jure precedence of human rights obligations over drug control, de facto 
drug control is prioritised over human rights. This raises a serious concern for UN system coherence 
and the commitment of the Organisation, and of member states, to the protection and promotion of 
human rights and the aims of the UN Charter” (Barrett et al. 2008: 23).  
Martin Jelsma (interview) tells about a new task force that has been put down by Secretary-
General Ban Ki-moon to make sure that the UN agencies act in coherent, coordinated moves 
in special crisis situations. A special task force is now also put in place jointly coordinated by 
the UNODC and the UN Department of Political Affairs (DPA) to look at the contradictions 
between repressive drug policy and the Millennium Development Goals, which has especially 
been triggered by the situation of violence in Mexico (Jelsma, interview).   
Furthermore, on December the 12
th
 2011, Yury Fedotov, Executive Director of the UNODC, 
announced the creation of a new senior advisory team within the UNODC on human rights, 
with the aim to make sure that human rights are integrated into UNODC program design and 
planning, policies and evaluation.  Harm Reduction International (HRI) notes that the creation 
of this team occurs after Human Rights Watch issued a report on UNODC’s involvement in 
drug detention centers in Viet Nam, and after HRI documented and revealed the involvement 
of UNODC supported and sponsored programs in the application of death penalty and 
executions for drug offences
146
.  
This section has shown how the human rights discourse has allowed the drug policy reform 
movement to pose a particularly forceful critique of the UN drug control organs through what 
Keck & Sikkink (1998) call information politics, accountability politics and leverage politics. 
The critique forces the drug control organs to put human rights on their agendas as well as it 
forces the UN human rights organs to put drug policy on their agendas.  
In the last section the human rights discourse will be examined in a broader theoretical 
context, as well as in relation to how it can form a ‘counter-weight’ and an opposition to the 
criminalization of poverty in general and of drug use and production in particular.  
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 http://www.ihra.net/contents/1151?utm_source=dlvr.it&utm_medium=twitter [Date of last access: 
06.05.2012]. 
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6.4 Discussion 
In this section I will first account for how scholars have argued that human rights is the new 
hegemonic discourse in international relations, before I go on to discuss the significance of 
transnational advocacy networks in enforcing a ‘universal citizenship of rights’, and, lastly, 
discuss how human rights can be a basis for the deconstruction of certain national and 
international crimes.  
Human rights have been referred to as a ‘normative master discourse’ for the post Cold War 
period (Neumann & Sending 2010), by some claimed to be hegemonic (Evens in Manokha 
2009). Drawing on Foucault’s conceptions of power, Manokha (2009) states that the global 
human rights discourse can be seen as having become a global standard or norm with 
reference to which agents are evaluated and evaluate themselves. Actors conform to this norm 
even in absence of external coercion. Power is productive in that it produces behavior through 
mediating the dominant view, but is also exercised more directly on those actors who do not 
conform to the norm
147
. As critiques of human rights have demised and the concept has got a 
nearly universal acknowledgement as a self-evident phenomenon, the global human rights 
discourse has become a ‘discourse with a truth function’, constituting a set of structures in 
which “…the subject transforms himself into an object of power and adopts ‘willingly’ forms 
of behaviour that are expected by the prevailing discourse and truth configurations” 
(Manokha 2009: 435). Interestingly, Manokha also notes that within the human rights 
discourse, which accelerated after the demise of the socialistic states, it is by far the political 
and civil rights which are prevailing – the individually centered rights148. As has been argued 
several times, the values which the drug policy reform movement advocates – with a focus on 
individual rights, social equality and liberation of the oppressed – do very much resemble the 
moral values of the human rights paradigm. 
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 Examples of direct exercise of power are the number for humanitarian interventions set in to prevent massive 
human rights violations.  
148
 Manokha argues that the human rights paradigm should be seen in relation to the development of means of 
production and especially in relation to the central role of the market from the 17
th
 century onwards and to the 
shift towards viewing labor as a commodity – the very commodity which makes capitalism possible. The 
redundancy of political coercion renders civil liberties and equality of individuals possible – which are 
“increasingly seen as the liberty and the equality, while the fact that exploitation and inequality exist in the 
market is taken for granted and objectified” (2009: 447). Global capitalism rendered a particular form of 
democracy possible, where fundamental elements of the market – individual rights – were codified. It “rendered 
possible the development of the human rights discourse” (2009: 448). 
129 
 
I will argue that the human rights discourse may be seen as an attempt to create a ‘universal 
rights-based citizenship’ which is meant to include groups that are marginalized and 
excluded, as human rights law stresses the rights of vulnerable groups to be of special concern 
through imposing positive obligations on signatory states. In this manner the human rights 
discourse contrasts to the projects which attempted to forge a ‘universal citizenship’ in the last 
decades of the nineteenth century and the first half of the twentieth described by Rose, in 
which he argues not all were seen as includable, such as “…the mad, the criminal, those who 
refused the bonds of regular labor, but also, in different ways and in different times, the child, 
the African, the woman and the Jew” (2000: 330). I will argue that the human rights 
discourse, in the same manner as the harm reduction discourse, seek to break up the 
boundaries of the circuits of inclusion through obliging states to include and protect the 
‘underclass’, the marginalized, the truly disadvantaged, and, even, the criminals. It thus 
creates a new boundary or standard by which individuals, states and non-state actors are to be 
included or excluded, namely the standard of ‘universal’ humanistic values. Those who do not 
change their behavior according to the humanistic values of the human rights are pressured, 
‘blamed and shamed’, intervened upon, sanctioned, and sometimes even punished. 
However, this process is not necessarily automatic and there are lots of other interests at play 
in the international community. The novelty of the human rights concept, system, and its 
globalization is evident in its process of constant change, new institutionalization and 
reflexive development (specifically in relation to civil society).  
Although all human beings and their rights are meant to be protected through the human 
rights normative framework acknowledged by practically all states, ‘global civil society’ has a 
crucial role in enforcing this normative framework through their constant scrutiny and 
advocacy (Sikkink 1993, Savelsberg 2010, Bianchi 1997). This means that whose rights 
actually come to be protected may largely depend on the existence of an advocacy group or 
network or on the effectiveness of such an advocacy group or network.  
Keck & Sikkink note that transnational advocacy networks have been most successful on two 
types of issues; 1) issues involving bodily harm to vulnerable individuals – with a short causal 
chain assigning responsibility and 2) issues involving legal equality and opportunity (1998: 
27). However, they go on to note that their success also depends on who is regarded a 
vulnerable group. As noted by Luís Astorga, drug users have commonly been regarded as 
criminals and trash, or as ‘the others’, which makes the task of attracting sympathy and 
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support in rights advocacy a much more difficult one. This thesis is a documentation of how 
the drug policy reform movement tries to change this common regard. 
In the chapter on harm reduction I showed how the movement is trying to differentiate the 
view on drug use through separating the phenomenon of drug use from the problem of drug 
use, while emphasizing that the problematic users are a vulnerable group in need of support 
on their own premises. The last chapter showed how the movement aims at deconstructing 
drug use and acts related to drugs as crimes. This chapter has shown how the movement tries 
to reconstruct the drug user as an equal human being with inherent rights. Through assessing 
state and IO behavior to the human rights global standard, the movement tries to bring 
awareness about neglected vulnerable groups of people who use drugs and people negatively 
affected by drug policy, to ‘blame and shame’ actors who violate human rights norms in 
relation to these specific groups, to hold individuals, states and IOs accountable, and to 
influence them to change their behavior.  
However, the drug policy reform movement does not take on an emotional, punitive rhetoric 
of punishing the perpetrators of the human rights violations, of reinforcing justice and ending 
impunity, such as some human rights organizations have been criticized for doing (Lohne 
2009). For the movement, the perpetrator is rather the drug prohibition paradigm itself and the 
structures which it enacts. The drug policy reform movement calls for a structural change and 
for amendment of a legal framework and a system which produces inequality and 
discrimination. And the human rights might just to be a specifically forceful basis for such a 
restructuring.  
In a report to the United Nations General Assembly (2011)
149
, the Special Rapporteur on 
Extreme Poverty and Human Rights, Magdalena Sepúlveda Carmona, strongly criticizes a 
number of laws and regulations world wide which in different ways criminalize poverty. The 
laws in question range from regulation laws which facilitate privatization and gentrification, 
to laws which directly penalize actions of people living in poverty, such as vagrancy, begging 
and street vending, as well as laws which restrict access to and behavior in public spaces. 
None of the examined laws could be justified through legal restrictions on human rights, such 
as the interests of public security, safety or order, public health or the protection of the rights 
                                                 
149
 United Nations General Assembly A/66/265 (2011): Extreme poverty and human rights. Report by the 
Secretary-General to the sixty-sixth session.  
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and freedoms of others. Rather, their justifications were cosmetic and highly insufficient. 
Many of these laws, she states, severely violate principles of human rights, and, thus, conflict 
with international law.  
She does not mention drug use, which is probably because she finds this activity to be legally 
restricted 
150
. Still, many scholars have emphasized that the criminalization of drug related 
activities is in reality a criminalization of poverty and of marginalized segments of society 
(see for example Christie & Bruun 2003, Feeley & Simon 1998), which, as I have shown 
throughout this thesis, is something that is being increasingly disputed in several countries. 
What her critique shows, however, is how human rights law can be used, as a strong 
normative counterweight, to question – not only the legitimacy but also the lawfulness – of 
punitive responses to social problems. Not only can it be used to deconstruct domestic 
criminalizations of poverty, but it can also, as the efforts of the drug policy reform movement 
shows, be used to deconstruct international criminal law such as the punitive paradigm of 
drug prohibition.  
6.5 Conclusion 
In this chapter I first elaborated on the (juridical) argumentation of the drug policy reform 
movement in stating that many of the harms and costs stemming from prohibition are also 
violations of international human rights law.  
Second, I showed how the primary task of the NGOs in Mexico and Germany is to advocate 
drug users’ rights, however, drawing on different legal frameworks in their argumentation. 
The claim for a human right to use drugs was also discussed in relation to different forms of 
‘right action’ which can spring out from harm reduction.  
Third, I discussed different (political) benefits of grounding advocacy within a (human) 
rights-based discourse. First, I elaborated on the tendency in certain regions of Constitutional 
Courts to deem simple drug-related crimes unconstitutional, which questions punitive laws 
and which might ultimately undermine the legitimacy of the UN drug conventions. Second, I 
examined the development of the human rights legal framework and its mechanisms in 
relation to how it has enhanced the advocacy possibilities of the drug law reform movement. 
                                                 
150
 Why she does not mention drug use at all is still particularly interesting, and might even add up to the critique 
which the movement poses of the negligence of UN agencies to address this issue. Unfortunately, it would be 
beyond the scope of this thesis to discuss this matter any further.  
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Lastly, I accounted for what I perceive to be a particularly powerful argument, namely the 
‘system-wide coherence argument’, which questions the reluctance of the UN drug control 
organs to evaluate their policy in relation to human rights as well as their disparity to the rest 
of the UN system.  
Fourth, I discussed the broader political and social implications of the human rights paradigm 
as a ‘normative master discourse’ and as a norm with reference to which states increasingly 
are evaluated and evaluate themselves. I also highlighted the similarity of the humanistic 
values advocated by the drug policy reform movement and the (particularly individualized) 
moral values institutionalized in the human rights paradigm. Furthermore, I claimed that the 
human rights, in a similar manner as harm reduction, through enacting a ‘global citizenship of 
rights’ questions the boundaries of the circuits of inclusion and creates new boundaries of 
inclusion where actors are evaluated in relation to their devotion to and compliance with 
humanistic values. Lastly, I argued that human rights can be seen as a normative 
counterweight to question the legitimacy and lawfulness of domestic laws criminalizing 
poverty as well as of the global drug prohibition paradigm.   
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7 Conclusion 
This thesis has sought to answer the questions: How does the drug policy reform movement 
attempt to change the global discourse on narcotic drugs? And: How is the drug policy reform 
movement in opposition to dominant power structures – and how is it not?    
I examined the drug policy reform movement as two interconnected and overlapping 
movements; the harm reduction movement and the drug law reform movement, and inquired 
dominant power structures and elements of opposition through a governmentalty perspective.  
In this thesis I have shown that the drug policy reform movement’s underlying humanistic 
values and philosophy, center around individually and liberally oriented norms and rights, 
such as autonomy, dignity, accept and respect for individual choices, participation, freedom 
from oppression, harm and discrimination, as well as social equality. These values and norms 
highly resemble the moral values institutionalized in the human rights paradigm – upon which 
the movement also increasingly draws in its argumentation.  
I have also shown that the rationalities and logics implicated in the policies advocated by the 
movement, with a focus on minimization of drug-related harm, risk and vulnerability to 
individuals, communities and society; based on the principles of pragmatism, community 
participation, low thresholds, cost-efficiency and priority of immediate goals, are in line with 
‘advanced liberal’ governmentalities and bio-politics; which are underpinning a range of other 
policy areas. So are the propositions for regulative forms of drug control that are 
individualized and decentralized rather than hierarchic, and where the focus is on harm 
minimization rather than on elimination of drug supply and demand. These rationalities are 
bolstered, rather than opposed, by the humanistic values. 
I argued that for the harm reduction movement it is particularly its inherent values that 
constitute the element of opposition to the prevailing, albeit increasingly contested, zero-
tolerance discourse. Prohibition and the zero-tolerance discourse are also based upon a 
different set of values and a different kind of rationality and ‘system of thought’; namely that 
of protecting the population against ‘evil’ and ‘immorality’ which it regards drugs and drug-
related activities to be. Nevertheless, the scientific evidence-base for the effectiveness of harm 
reduction policies and interventions, particularly in reducing epidemics such as HIV – seen in 
many countries as a larger immediate threat to society than drug use per se – , has elevated 
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harm reduction into official public health discourse. Still, however, harm reduction is 
contested in countries and environments devoted to the zero-tolerance discourse.  
Furthermore, I have claimed that there is a tendency of states and IOs to outsource the 
responsibility for the health and welfare of drug users to harm reduction NGOs, through 
which they govern as autonomous non-state partners.  
The movement’s propositions for alternative drug control – complete decriminalization of 
drug users or de jure legalization with government regulation – is primarily in opposition to 
prevailing drug policies due to their goal; a reduction in harms rather than a reduction in 
consumption prevalence. However, decriminalization and harm reduction also pose 
intellectual threats to prohibition in that they have demonstrated effectiveness – without 
fulfilling the prophecy about higher consumption prevalence. More and more countries have 
adopted these strategies, leading to cracks in the transnational consensus on zero-tolerance 
and increasingly also on prohibition. The international drug control institutions have managed 
this threat through adopting a stance of ‘reformed prohibition’ with a goal, not of a drug free 
world, but of containment. This position has allowed them to sustain an unsustainable 
prohibition paradigm. It is also a change which the drug policy reform movement has helped 
them in producing, and in this manner one might say that also the drug control institutions are 
governing through the drug policy reform movement. The movement has accordingly become 
better at working with the system and downplayed its elements of opposition, although they 
are still in fundamental opposition, which renders them autonomous subjects to be governed 
through. However, further change towards alternative drug control, and even to an informed 
debate on the issue, are hampered by barriers such as the character of political benefit and 
public opinion, securitization of the drugs issue, institutional barriers, a dichotomization of 
the debate as well as the framing of drugs in terms of immorality.  
Yet, the recent years have witnessed particularly rapid and accelerating changes in the global 
discourse on narcotic drugs. In the last month of the writing process I already noticed some of 
my sections to be partly outdated, as even current presidents are calling for a revision of the 
prevailing drug political approach. As Europe the last decades has been the cradle for drug 
political innovations through harm reduction and decriminalization, a wind of change is now 
blowing in Latin America, where governments seek progressive approaches to reduce the 
horrendous levels of violence – a policy priority which has become more pressing than drug 
control (Jelsma 2012). The president of Guatemala has recently called for an alternative drug 
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political approach which led to debates in the Sixth Summit of the Americas 14
th
 -15
th
 of 
April 2012. The Colombian president proposed a special task force of independent experts 
and economists to be put down to assess the prevailing drug policies and their alternatives in 
order for future policies to be based on scientific evidence. Such a task force will now be put 
down by OAS, where the results might have the potential to become a benchmark for future 
drug policies. What kind of experts will it employ and what will be its mandate? What will be 
the consequences of bringing in economists as experts to evaluate drug policies? What will be 
the result of this task force as well as the results of the new task forces within the UN system 
evaluating human rights compliance and system-wide coherence? What kind of impact will 
they have on future drug policies? 
In this thesis I have attempted to give both a historical account of the drug political discourse 
and of the efforts of the transnational drug policy reform movement to change it – as well as a 
snapshot of the current situation. The snapshot is, however, soon to become history and 
extensive research will be needed on the drug political innovations which are on the way. 
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9 Appendices 
9.1 Abbreviations 
ART – Antiretroviral therapy 
CAT – Convention Against Torture and Other Cruel and Degrading Treatment and 
 Punishment, 1984 
CND – Commission on Narcotic Drugs 
CSF – (EU) Civil Society Forum on Drugs 
CRC – Committee on the Rights of the Child 
CUPIHD – Colectivo por una política integral hacia las drogas 
DCR – Drug consumption room 
ECOSOC – UN Economic and Social Council 
ENCOD - European Coalition for Just and Effective Drug Policies 
EU – European Union 
HAT – Heroin assisted treatment 
HRI – Harm Reduction International (before, International Harm Reduction Association, 
 IHRA) 
ICCPR – International Covenant on Civil and Political Rights, 1966 
ICESCR – International Covenant on Economic, Social and Cultural Rights, 1966 
IDPC – International Drug Policy Consotrium 
IDU- Injecting drug user 
INCB - International Narcotics Control Board 
INGO – International non-governmental organization 
INPUD – International Network of People who Use Drugs 
IO – International Organization 
NGO – Non-governmental organization 
NSP – Needle and syringe program 
OAS – Organization of American States 
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OSF – Open Society Foundations 
OST – Opioid substitution therapy 
TNI – Transnational Institute 
UDHR - Universal Declaration of Human Rights 
UNAIDS – Joint United Nations Programme on HIV/AIDS 
UN – United Nations 
UNICEF – United Nations Children’s Fund 
UNDP – UN Development Program 
UNODC – United Nations Office on Drugs and Crime 
U.S. – United States of America 
WHO – World Health Organization  
WOLA – Washington Office on Latin America 
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9.2 Organizational chart of drug control in the UN system  
 
 
 
Source: “Cracks in the Vienna Consensus: The UN Drug Control Debate” (Jelsma 2004: 4)  
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9.3 Examples of thresholds used in decriminalization of possession for 
personal use 
Source: “Legislative Innovation in Drug Policy” (Jelsma 2009: 5) 
 
Country 
 
Quantity Threshold Defined by 
Law 
 
Judicial Practice 
Portugal The quantity required for an 
average individual consumption 
during 10 days 
25 gr cannabis, 2 gr cocaine ase 
used as indication, but without 
additional evidence on the intent to 
supply, larger quantities are 
regarded as possession for personal 
use. 
Uruguay Possession of “a reasonable 
quantity exclusively intended for 
personal consumption” is not 
punishable 
Left entirely to the discretion of the 
judge to determine whether the 
intent was consumption or supply. 
Finland 
 
15 gr cannabis, 1 gr heroin, 1,5 gr 
cocaine, 10 ecstasy pills only 
punishable by fine 
100 gr cannabis, 2 gr heroin, 4 gr 
cocaine, 40 ecstasy pills only 
punished by fine 
Spain  40 gr cannabis, 5 gr cocaine, not 
considered supply 
Netherlands 5 gr cannabis and 0,5 gr cocaine or 
heroin not punishable 
5 cannabis plants permitted, 
possession up to 30 gr only small 
fine, up to 1 kg larger fine, more is 
punishable with prison sentence; 
small amounts of “hard drugs” in 
practice left to police, prosecution 
and eventually judicial discretion 
to determine whether the intent 
was consumption or supply 
 
Mexico 5 gr cannabis, 2 gr opium, 0,5 gr 
cocaine, 0,05 gr heroin 
Any amount above the thresholds 
is considered intent to supply 
Paraguay 10 gr cannabis, 2 gr opium, 0,5 gr 
cocaine, 0,05 gr heroin 
 
Colombia 20 gr cannabis, 1 gr cocaine Supreme Court determined that 
further evidence is required to 
punish someone caught with more 
than threshold for supply 
Australia (states) Four states in Australia have 
decriminalized cannabis possession 
of quantities from 15 to 50 gr 
Administrative sanctions only 
US (states) 13 states decriminalized cannabis 
possession, several using 28,45 
grams (one ounce) as limit 
Schemes differ per state or county, 
most only applying small fines 
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9.4 Interview guides 
9.4.1 Interview guide German interviews 
THEME QUESTION FOLLOW-UP QUESTION 
1. THE IMPACT OF SOCIAL 
MOVEMENTS ON POLICIES  
 
1.1. IN EUROPE 
 
European drug policy and impact of 
social movements 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2. IN GERMANY 
 
Paradigms 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There has been a trend towards 
decriminalization in many European 
countries by three models; 1) formal 
procedural law decriminalization, 2) 
de facto and informal practices of 
not enforcing law and 3) substantive 
law decriminalization (Böllinger 
2004).  
- What do you think are the reasons 
for this trend?  
- What do you think is the impact of 
social movements on this trend? 
 
There has also been a wider 
acceptance of harm reduction 
measures in European countries, and 
harm reduction has also become part 
of the official EU policy. 
- What do you think has led to this?  
- What is the impact of social 
movements on this? 
 
 
 
 
 
 
 
 
Böllinger (2004) claims that there 
are basically 3 distinct drug policy 
paradigms; 1) criminalization, 2) 
medicalization and 3) acceptance.  
He also claims there has been a 
paradigm shift in Germany – away 
from the abstinence model – towards 
the acceptance model (and 
definitively also to the 
medicalization model).  
- What do you think about this 
statement?  
- What are the impacts of social 
movements on this shift?  
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German development in criminal 
justice practice in the drugs field 
 
 
 
 
 
 
In Germany there has been a 
procedural decriminalization of 
producing, obtaining and possessing 
small amounts of drugs for personal 
use, as well as a change in law 
enforcement practice.  
- What do you think are the reasons 
for this change?  
 
 
 
- Böllinger (2004): From hard to soft 
control and net widening….. 
 
 
 
 
 
 
2. THE MOVEMENT 
ITSELF 
 
2.1. IN GERMANY 
 
 
 
History of the German movement 
 
 
 
 
 
 
 
Frankfurt 
 
 
 
 
ECDP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- How did the NGOs working for 
harm reduction and policy change 
come to existence in the first place?  
- When / where / who/why/ how? 
 
- What was the role of civil society 
and social movements in the 
Montagsrunde?  
 
 
 
- To what extent was NGOs and civil 
society movements a part of the 
European Cities on Drug Policy 
movement?  
 
- What has been the role of  
scientists in this movement? 
 
 
 
 
 
-  Can you tell me about the 
collaboration in the ECDP? 
  
- What have happened with 
European Cities on Drug Policy? 
 
 
 
 
 
 
 
 
 
 
 - What lead to the first mobilization 
for action?  
Who/ When/Where? 
 
 
 
 
- The pragmatic harm reduction 
policies of Frankfurt – Were they 
merely a bureaucratic solution..? 
 
 
 
- As I understand the University of 
Frankfurt was actively involved in 
the establishing of the foundation 
“Integrative Drogenhilfe” in the last 
part of the 1980’s? And that this was 
also the background for the ECDP? 
(Who had contacts with the 
Lindesmith Center in USA)  
- Can you tell me more about this 
involvement?  
 
 
 
- Does the Montagsrunde still exist?  
 
 
 
- As Frankfurt, Hamburg and 
Hanover (and some more cities) 
joined the ECDP, Berlin joined the 
European Cities Against Drugs 
(ECAD) collaboration. Could you 
tell me what consequences and 
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Professionalization 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Movements in Germany now 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(To Stöver:) – In Lebanon you said 
that you perceived the movement to 
have evolved from grass-root 
movements to more professionalized 
movements, 
Could you explain this?  
 
 
 
 
 
 
 
 
- How has the professionalization of 
the movement affected on the drug 
policy making in Germany? 
Internationally? 
 
 
 
 
(To Stöver:)  
In one article in the Harm Reduction 
Journal that you wrote with Ingo Ilja 
Michels and Ralf Gerlach in 2007, 
you claim that there has been an 
opening up of the health sector to 
drug users’ own competence and 
voice as well as to acknowledging 
self-help groups as an important 
component in treatment.  
- Could you tell me more about this? 
 
 
 
 
 
 
- As I have understood, it is the 
NGOs themselves, or private 
organizations (Eingetragener Verein) 
that run most of the harm reduction 
measures in German cities – is this 
right?  
 
- Böllinger is in one article dividing 
between self-help groups and NGOs. 
What do you think about this divide? 
differences this has lead to?  
(German cities have left the ECAD 
as I understand…) 
 
 
 
- Key happenings ? 
- How did it happen?  
- What do you think about this 
development? What is good/bad 
about it?  
- What professions and type of 
knowledge is dominating the 
discourse of the movement? 
- Has the movement’s advocacy got 
more efficient?  
 
 
 
 
 
 
 
 
 
 
 
- In what ways have the self-help 
groups affected the orientation of the 
health sector? 
 
- Have they also affected on drug 
policy making in general? How? 
 
 
 
 
 
 
 
 
 
 
- How are they funded?  
- What are the biggest challenges for 
the self help-groups? 
 
- What have they accomplished? 
 
 
 
 
- Could you mention some of the 
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Could you explain it?  
 
 
 
 
 
 
 
 
- Could you tell me about the NGOs 
working for drug policy change? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Böllinger (2004) writes about certain 
institutional and organizational 
changes in Germany which indicate 
social change towards 
medicalization of the drug problem. 
He claims that the German Society 
for Drug and Substitution Medicine 
changed from being pro-prohibition 
and that also the Deutsche 
Hauptstelle für Suchtfragen changed 
from supporting prohibition to 
moderate themselves. What are your 
thoughts about this? 
 
most important/biggest organizations 
offering harm reduction measures? 
What/how do they do this? Do they 
meet opposition? 
 
 
 
The biggest NGOs I understand is 
Akzept, Deutsche AIDS-Hilfe and 
JES (?) 
- How do they work?  
 
- What are their advocacy strategies? 
- Who are their key partners?  
- Do they ally with other NGOs in 
other policy spheres?  
- Do they ally with particular 
political parties? 
- How are they targeting the 
politicians and the general public?  
- What are their main arguments and 
ideas for policy change? 
- What are their strategies in posing 
these arguments? 
- What are their main goals?  
- How do they get funded?  
- What are their outcomes? (Impact 
on German drug policy and popular 
opinion) 
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2.2. INTERNATIONALLY 
 
Relation German and international 
movement 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
International movement itself 
 
 
 
- How is the relation between the 
German NGOs and the international 
NGOs? 
 
 
 
 
 
- How do you think the international 
movement has affected the German 
movement and German drug 
policies?  
-. Have the German NGOs 
cooperated with the EU in some 
ways? 
 
 
 
- How do you think the international 
movement has impacted on the 
international drug policy discourse? 
 
 
 
 
 
 
 
 
- Which international NGOs are the 
main partners of the German NGOs? 
- How do they cooperate?  
- What are the challenges in the 
international cooperation?  
- What are the benefits from the 
international cooperation?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINAL QUESTIONS  
 
The Latin American Commission on 
Drugs and Democracy are stating 
that we are facing a paradigm shift in 
international drug policies.  
- What do you think about this 
statement?  
 
 
How do you see the development of 
international drug policies in the 
future?   
And of German drug polices? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- And how do you see the social 
movement advocating drug policy 
change in the future? 
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9.4.2 Interview guide Mexican interviews 
THEME QUESTION FOLLOW-UP QUESTION 
   
 
IMPACT OF SOCIAL 
MOVEMENTS ON LATIN 
AMERICAN DRUG POLICIES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HARM REDUCTION IN LATIN 
AMERICA 
 
 
 
 
 
 
 
 
 
 
 
 
 
Many Latin American countries have 
had law reforms the last years, 
decriminalizing use and possession of 
drugs to a certain amount or imposing 
alternative sanctions. 
- What do you think are the reasons 
for these changes/ this trend?  
- Do you think social movements 
have had any impact on this trend?  
 
Do you think the Latin American 
Commission on Drugs and 
Democracy has had any on drug 
policy in Latin America?  
 
 
 
 
 
 
 
- How would you define harm 
reduction in a Latin American 
context?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Do you think they will have any 
impact in the future? 
 
 
 
 
 
 
 
 
- And in a Mexican context?  
 
 
 
- The annual IHRA (now HRI) world 
report is using 1) amount of clean 
needles exchanged per IDU and 2) 
extent of OST treatment as the main 
measures for how good harm 
reduction measures are developed in 
a country or a region.   
- How good do you think these 
measures are for evaluating harm 
reduction in Latin America?  
 
- And for Mexico?  
 
- Martin Jelsma at the Transnational 
Institute is arguing for an 
incorporation of alternative 
development in drug producing 
countries in the concept of harm 
reduction. What are your thoughts 
about this?  
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HARM REDUCTION IN MEXICO 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOCIAL MOVEMENTS IN 
MEXICO AND THEIR IMPACT 
ON MEXICAN DRUG POLICIES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- How does the government tackle the 
trends of increasing numbers of drug 
users in Mexico? 
 
 
 
 
 
 
 
 
 
 
 
 
In 2009 there was a change in the 
Mexican criminal law; making the 
Ley de Narcomenudeo.  
- What do you think were the reasons 
for this?  
 
 
- Do you think NGOs and civil 
society (organizations) have had any 
impact on this change in law?  
 
- What consequences has it had for 
Mexican drug policy that the former 
presidents Zedillo and Fox have 
stated that an alternative political 
approach to drugs is necessary (partly 
through the Latin American 
Commission on Drugs and 
Democracy and through the Global 
Commission on Drug Policy)?  
- Do you think this will have 
consequences for future policy 
making in Mexico?  
 
(To Barra:) 
In Astrid’s interview in Lebanon you 
said that the process in the U.S. with 
Prop 19 opened up the debate in 
Mexico.  
- How (in what ways) did it open up 
the debate in Mexico?  
 
 
 
 
For some time now there have been 
mass demonstrations against the 
Mexican government’s war on drugs  
- Have these movements had any 
impact on policy?  
- Do you think they will get any 
 
As I understand, the law has 
mandatory treatment as an 
administrative reaction for people 
caught 3 times for drug use.  Have 
they done anything to improve or 
increase the treatment facilities? 
(what kind of mandatory treatment 
facilities)  
- What is your role in this process? 
(do you have any saying, consultation 
status in this matter?) 
 
 
- What have been the social 
consequences of this law until now? 
 
 
 
 
 
 
 
 
 
 
 
- What (practical) consequences has it 
had that the debate has been opened 
up?  
 
 
 
- How have the demonstrations 
impacted public opinion? 
- Question about the media coverage 
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impact on policy in the future? How? 
 
- Is your organization involved in this 
movement? How?  
 
of the demonstrations. 
 
RESEARCH 
 
 
 
 
 
 
 
(To Barra:)You told me 1,5 years ago 
that there is very little research on 
drugs and drug use in Mexico.   
 
 
 
 
(To Barra:)You told me that Espolea 
was also involved in a research 
project on the social consequences of 
the new law, the Narcmenudeo. Can 
you tell me more about this?  
 
 
 
 
- Can you tell me what you think are 
the reasons for this?  
- What kind of research on drugs is 
the government funding?  
 
 
 
- Can I ask you about what outcomes 
you have from this research so far? 
 
 
 
 
 
 
 
 
THE WORK OF ESPOLEA 
 
History 
 
 
 
 
 
 
 
Outcomes 
 
 
 
 
Practical work 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Can you tell me about the starting 
up of your organization?  
 
 
- How have you developed?  
 
 
 
- Do you think you’ve got a saying in 
Mexican politics?  
 
 
 
- Practically how do you approach the 
politicians? 
 
 
 
 
- Can you tell me about other types of 
practical work you do (and give 
examples)?  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Who, why, how?  
- Obstacles 
- Funding 
 
 
 
 
 
- How? On what issues?  
 
 
 
 
- What has proved to be the most 
successful/unsuccessful approaches 
(and what is success?) ? 
 
 
 
- Conferences, debates, workshops? 
- Campaigns? 
- Information and education? 
- Peer education?  
- Humanitarian work/field work? 
 
One study on harm reduction 
measures and the role of local 
stakeholders in Tijuana identified the 
important role of religious leaders in 
acceptance of harm reduction.  
- Are you, or any other organization, 
working towards religious leaders 
and communities? How? 
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Strategic partners  
 
 
 
 
 
 
 
 
 
International cooperation 
 
 
 
 
 
 
 
 
 
 
 - Who are you cooperating with in 
Mexico?  
- How do you see this cooperation?  
 
 
- Who are your main partners outside 
of Mexico?  
 
 
 
- I perceive you as working much 
towards, not only a national, but also 
a regional and international level, is 
that right?  
- Can you tell me about this?  
 
 
 
 
 
 
- How do you work to spread 
information and influence the general 
population? 
 
 
 
 
- (Professionals? Other 
organizations? Human rights 
activists? Political groups? Etc) 
 
 
- Can you tell me about how this 
cooperation is working (practically)?  
 
 
 
How do you work practically; 
- Conferences, debates? 
- Campaigns? 
- Peer education?  
- Humanitarian work/field work? 
 
 
IMPACT OF SOCIAL 
MOVEMENTS ON 
INTERNATIONAL DRUG POLICY 
 
 
 
- What do you think have been the 
impact of NGOs and civil society on 
the global discourse on narcotic 
drugs?  
 
 
- Do you think the report of the 
Global Commission on Drug Policy 
will have any impact on future 
policy-making?  
 
- How do you see the role of NGOs 
and civil society in the drug field in 
the future?  
 
 
 
 
 
- How has it affected on the work and 
discourse (of the different 
institutions) of UN? 
 
 
 
 
 
 
 
 
 
 
 
 
 
FINAL QUESTIONS 
 
 
The Latin American Commission on 
Drugs and Democracy are stating that 
we are facing a paradigm shift in 
international drug policies.  
- What do you think about this 
statement?  
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- How do you see international drug 
policy in the future?  
 
 
 
   
 
 
